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Cyanobacteria produce a variety of metabolites with diverse functions and bioactive 
properties that have potential uses in industrial biotechnology. Metabolomic profiles 
closely relate to the physiology of an organism and can be used to investigate any 
alteration in metabolism and production of industrially relevant metabolites. Little 
work has been conducted on metabolomic time-course profiles within cyanobacteria 
with the majority of research on targeted metabolite level changes during abiotic stress 
such as ultraviolet (UV) radiation. In this thesis the metabolite profile analysis of the 
less well investigated cyanobacterium; Chlorogloeopsis fritschii (C. fritschii) PCC 
6912 was undertaken. The main aim was to evaluate changes in low molecular weight 
metabolite levels during standard growth and UV exposure using gas chromatography-
mass spectrometry (GC-MS). The focus was on identifying biologically relevant 
metabolites with roles in cyanobacterial metabolism associated with growth phases 
and adaptation to UV stress. Extracts were assessed using in vitro assays for extraction 
of potential anti-inflammatory and antibacterial activity from the cyanobacteria with 
complementary metabolomic analysis utilised for identification of potential active 
metabolites. Results demonstrated a significant reduction in intracellular metabolites 
involved in carbon and nitrogen metabolism during UV-B exposure with a higher 
proportion of metabolites increasing in levels during UV-A exposure. Pre-treatment of 
C. fritschii to low dose UV prior to high dose UV had a lesser effect on metabolism
indicating stress tolerance and adaptation to UV stress. Metabolite levels were seen to
reflect the changing growth phases over 120 days during standard conditions with
overall similarity in metabolite levels between axenic and xenic cultures over 28 days.
Finally, extracts showed promising anti-inflammatory and antibacterial activity with
identification of potential active metabolites with relevance to personal care products.
This is the first GC-MS based metabolite profiling of C. fritschii during standard
growth and UV exposure. This builds on the experimental data and knowledge-base
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Cyanobacteria, also known as blue-green algae, are gram-negative bacteria that have 
the ability to photosynthesise [1]. They have evolved over billions of years and are 
thought to be the oldest microorganisms creating the earth’s oxygenic atmosphere and 
responsible for the evolution of eukaryotic photosynthesis [1,2]. These photosynthetic 
organisms’ are primary producers that contribute largely to global productivity [3,4].   
With diverse morphologies, cyanobacteria encompass a variety of forms including rod, 
spherical and spirals as unicellular; Microcystis sp., Synechococcus sp. and 
Synechocystis sp. or filamentous species; Anabaena sp., Nostoc sp. and Athrospira 
platensis [5]. Taxonomically they are distributed into the five major sub-sections: Sub-
section I (order: Chroococcales), II (order: Pleurocapsales), III (order: Oscillatoriales), 
IV (order: Nostocales) and V (order: Stigonematales) [5,6]. With much debate on the 
classification of cyanobacteria, newer systems using phylogenetic analyses are 
constantly evolving [7,8].  
Cyanobacteria have adapted to survive in an array of ecological habitats such as 
marine, terrestrial and freshwater environments which can involve exposure to 
extreme environmental surroundings [9]. They have adapted to survive and thrive 
under biotic and abiotic stress conditions such as ultraviolet (UV) radiation, high and 
low light and varying temperatures [6].  
Extremophilic cyanobacteria can be defined as thermophiles (high temperature 
tolerant), psychrophiles (cold tolerant), acidophiles (low pH tolerant), alkaliphiles 
(high pH tolerant) and halophiles (salt tolerant) [9].  Examples include the species 
Calothrix sp. and Leptolyngbya foveolaru living in high mountain habitats, dealing 
with temperature differences, limited water retention and high UV radiation [10]. In 
cold environments such as polar regions species such as Chroococcidiopsis sp. are 
adapted to persistent low temperatures, limited light, and high UV radiation [9,11].  
Adaptation of cyanobacteria to varying conditions is due to many factors including 





Cyanobacterial metabolism   
Cyanobacteria are photoautotrophic and perform oxygenic photosynthesis as their 
main source of energy in light conditions utilising water (H2O), carbon dioxide (CO2), 
inorganic compounds and light. They also have the ability to switch to different means 
of metabolism in different conditions. Heterotrophic growth in dark conditions 
produces energy by use of organic carbon substrates in fermentation reactions [1]. The 
specialised cells, heterocysts, allow some filamentous species to perform nitrogen 
fixation by conversion of atmospheric nitrogen into ammonia [12].   
Primary metabolites are involved in primary metabolism which is essential for growth 
within all organisms. End products of primary metabolism result in energy and 
intermediate production for the synthesis of proteins, lipids and carbohydrates [13].  
Cyanobacteria are a prolific source of secondary metabolites. Also known as natural 
products these are not required directly for an organisms’ primary metabolism but aid 
in survival by providing an advantage over other species [14]. They are often unique 
and species specific.  
There is some overlap between the two terms (primary and secondary) where some 
metabolites are essential for primary metabolism that are specific and present during 
abiotic and biotic pressures [6].  
Cyanobacteria have many adaptive capabilities to survive during environmental stress. 
Most interestingly is the rearrangement of metabolism and production of secondary 
metabolites. These unique metabolites are structurally diverse including; alkaloids, 
terpenoids, polyketides, peptides and UV-absorbing compounds. They possess a wide 
variety of functions to protect cyanobacterial cells such as photoprotection, defence 
against grazers, chemosensory and may also act as antioxidants[6,15]. There is much 
interest related to the use of cyanobacterial metabolites in industrial biotechnology as 
sustainable sources of natural ingredients [16] which will be discussed below and in 








Abiotic stress is the change in environmental parameters that affect cellular 
homeostasis in cyanobacteria and other organisms [17]. Adaptation and survival in 
these conditions are a result of many mechanism including  metabolic pathway shifts 
[17]. Many studies have been carried out to determine the effects of abiotic stress on 
cyanobacterial growth and metabolism including salt stress on trehalse production in 
Nostoc commune [18], heavy metal stress on Anabaena flos-aquae [19] and UV and 
osmotic stress on Chlorogloeopsis fritschii, (C. fritschii), PCC 6912 [20]. There is 
much interest in the use of abiotic stressors such as UV in cyanobacterial research to 
induce protective mechanisms to enhance the production of secondary metabolites 
which have potential for industrial purposes [21,22].  
 
Ultraviolet radiation  
UV radiation is the most common abiotic stress applied to cyanobacteria. This is due 
to cyanobacteria’s presence on earth during the Precambrian era, at a time with an 
absence of the ozone layer, which led to the adaptation to high solar UV radiation [23]. 
Solar light that reaches the earth’s surface (terrestrial and marine/freshwater 
environments) contains photosynthetically active radiation (PAR, 400-700 nm), 
infrared radiation (IR, >700 nm) and approx. 5% UV. 95% of which is comprised of 
UV-A (320-400 nm) and 5% of UV-B (280-320 nm) [24]. The majority of UV-B is 
absorbed by the stratospheric ozone layer (Figure 1).  
The effect of UV on cyanobacteria has been widely researched including the 
interaction with biomolecules, production of reactive oxygen species (ROS) which 
cause oxidative stress, impaired growth, partial inhibition of photosynthesis and 
decreased enzyme activity [24,25].  
Although a smaller proportion of UV-B reaches the earth, it has a more damaging 
effect on all organisms. A shorter wavelength results in higher energy (E=λν) owing 
to UV-B’s direct and indirect damage (Figure 1) whereas UV-A causes indirect 






Cyanobacteria have many protective strategies to counteract the effects of UV 
radiation including avoidance, programmed cell death, DNA repair and production of 
the photoprotective compounds, such as mycosporine-like amino acids (MAAs) 
[26,27]. They also produce antioxidants which counteract the oxidative damage caused 
by ROS [2]. UV radiation therefore also has a role as an activator of secondary 




Figure 1: Effect of Ultraviolet (UV) radiation on cyanobacteria 
Mycosporine-like amino acids (MAAs)  
MAAs are water soluble, low molecular weight (<400 Da) colourless molecules 
produced by cyanobacteria and other organisms including microalgae, macroalgae and 
fungi [29]. They have strong absorption in the UV region (310-365 nm) with high 
molar extinction coefficients (ε = 28100-50000 l mol-1 cm-1) (Table 1) [30]. They have 
the ability to absorb harmful UV and dissipate the energy without the production of 
ROS [23].  
They are a group of around 20 molecules which consist of a cyclohexenone or 
cyclohexenimine central ring that is responsible for absorption of the high energy UV 
photons [31]. Conjugation to nitrogen substituents from amino acids or imino alcohols 
also allows varying absorptions [29,31] (Table 1).  
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Table 1: Examples of MAAs produced by cyanobacteria [6,29,31] 
MAA Molecular structure λmax (nm),  


















330, 43800 Nostoc sp. 
R76DM [32] 
 
There are two biosynthetic routes involved in the production of MAAs (Figure 2). The 
first is the shikimate pathway (biosynthesis of aromatic acids) [33]. Deoxy-D-
arabinoheptulosonate-7-phosphate (DAHP) is formed from phosphoenolpyruvate 
(PEP) and erythrose-4-phosphate (E4P) using DAHP synthase. DAHP is then 
converted to 3-dehydroquinate and subsequent transformation into 4-deoxygadusol (4-
DG).  The primary MAA mycosporine-glycine (m-gly) is then formed from the 
addition of glycine to 4-DG which can be further converted into a secondary MAA by 
addition of other amino acids such as serine (to produce shinorine) and threonine (to 
produce porphyra-334) [34]. The other pathway involves the pentose-phosphate 
6 
 
pathway by forming the common intermediate 4-DG from sedoheptulose-7-phosphate 
via 2-epi-5-epi-violiolone [28].  
 
 
Figure 2: Biosynthetic pathways for the production of mycosporine-like amino acids (MAAs) via 1) 
Shikimate pathway and 2) pentose phosphate pathway via the common intermediate 4-deoxygadusol 
(4-DG) [28].  
To understand secondary metabolite production, primary metabolite levels need to be 
investigated which will be discussed further throughout the thesis within Chapters 2, 











Metabolomics is the newest member of the –omics group which includes genomics, 
proteomics and transcriptomics. It is a systems biology technology for the study of 
metabolism in a variety of biological systems. It is used to estimate and analyse the 
low molecular weight metabolites (<1000 Da) produced by  biological samples such 
as; whole organisms, cells, tissues and biological fluids [35,36]. As it closely relates 
to the physiology of an organism, it can be used to analyse the altered metabolite levels 
in respect to external stimuli. This principle has been thoroughly developed within 
human health for biomarker discovery for improved diagnostics of diseases including 
cancer [37] and cardiovascular diseases [38]. It is also used in chemical ecology [39], 
plant sciences [40] and in microbial research [41]. 
There are five main types of analysis used in metabolomics research [36]: 
i. Targeted analysis: Pre-selection of specific metabolites which are usually 
involved in common pathways. 
ii. Metabolite profiling: Investigates a group of known metabolites using a 
common technique.  
iii. Metabolite fingerprint: A non-biased, untargeted approach to analyse 
intracellular metabolite pools, often referred to as endo-metabolome.  
iv. Metabolite footprint:  Analysis of excreted metabolites (extracellular 
metabolites), usually referred to as exo-metabolome analysis.  
v. Flux analysis: Application of stable isotopes (13C, 15N or 18O) to analyse 
pathways in organisms or cells.  
A detailed experimental design is essential for successful metabolomics investigations. 
From biological material to sampling and quenching of metabolism, sample 
preparation, sample analysis using high throughput analytical techniques, data export 








Cell harvest, quenching and metabolite extraction 
In order to capture a true in situ metabolome of an organism, a snap-shot of the cellular 
metabolic activity at an exact time point must be taken. This is a difficult aspect of the 
analysis as the metabolites are constantly changing over time with changes in 
environmental conditions. Steps for harvesting and inactivation need to be rapid. Light 
intensity, temperature and other environmental conditions must be maintained in order 
to prevent metabolite degradation [43].  
Many different methods of harvesting (removal of cells from growth media) followed 
by quenching (halting metabolism) can be achieved [44]. These include; fast filtration 
and centrifugation which can be done at cold temperatures to separate and remove cells 
from growth media [45] or using a super cooled (-50°C) buffer such as 70% cold 
methanol (MeOH) [44] to quench before separation of cells from media [45]. These 
cells and supernatant are then preserved using liquid nitrogen or freezing at -80 °C 
followed by sample concentration by freeze drying [44]. The efficiency of these 
protocols are dependent on the microorganism [46]. 
Extraction of metabolites from cyanobacterial cells and other microorganisms is 
dependent on the analysis to be used. No single method has the ability for efficient 
global extraction of all metabolites [47]. A variety of cell disruption techniques 
combined with solvent extractions have been evaluated for untargeted and targeted 
metabolomics (Table 2).   
Method development for the extraction of metabolites from C. fritschii for gas-
chromatography-mass spectrometry (GC-MS) analysis will be discussed further at the 














Extraction Technique Reference 
MAAs Chlorogloeopsis 
fritschii 
25% (v/v) MeOH(aq) 
with shaking at 45 °C 
HPLC [48] 
 Lyngbya sp., 
 
100% MeOH, 





incubation at 4 °C. 
LC-MS [50] 
 Nostoc sp. 100% MeOH, 
incubation at 4 °C 
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Analytical techniques  
The two most successful techniques in metabolomics include nuclear magnetic 
resonance (NMR) and mass spectrometry (MS). NMR has lower sensitivity than MS 
(described below) but can detect and quantify more abundant compounds within 
samples [56]. The sample itself can be re-used which is important in experiments with 
limited amounts. Many compounds are hard to ionise and derivatisation is needed in 
MS which can be avoided with NMR. Structure elucidation of unknowns is also 
possible, including stereochemistry [56,57].  
MS based metabolomics can analyse a variety of biological samples at speed, with 
high sensitivity and a wide dynamic range [58]. MS generates gas phase ions by use 
of ionisation techniques such as; electrospray ionisation (ESI-MS) and electron 
ionisation (EI-MS). Ions are accelerated into a magnetic field and are separated 
according to their mass-to-charge ratio (m/z). Ions are then detected at different 
intensities. Separation free MS technologies include direct infusion (DI)-MS, matrix 
assisted laser desorption ionisation (MALDI) MS and desorption electrospray 
ionisation (DEI) MS [42]. 
MS is most commonly used in combination with high resolution separation techniques 
including liquid chromatography (LC) and gas chromatography (GC) [42].  
GC-MS is the most standardised method in metabolomics [59] and the technique of 
choice within this research project. Analysis of low molecular weight metabolites 
(<650 Da) including; acids, alcohols, hydroxyl-acids, amino acids, sugars, fatty acids 
and sterols can be achieved [59]. It does not require prior knowledge (i.e. genomic 
data) and can be applied to a variety of biological or environmental samples especially 
with limited amounts. It is highly sensitive with high resolution and reproducibility 
with repeatable fragmentation patterns produced, which allows for metabolite 
identification [58].  
Disadvantages include the need for sample processing and derivatisation of non-
volatile compounds. Derivatisation is required to increase thermal stability and 
volatility of polar metabolites. Trimethylsilation and methoxymation are the most 
common types of derivatisation methods [58]. 
Active hydrogens, -COOH, -OH, -NH and –SH, can be protected by replacement with 
alkylsilyl groups to produce trimethylsilyl (TMS) derivatives. These TMS derivatives 
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produce better mass spectral profiles. Methoxymation provides protection of 
exchangeable protons and converts carbonyl groups into oximes which can result in 
stabilisation of α-ketoacids and open-ring conformation of sugars.  Conversion 
reactions can also occur as well as formation of artefacts that can interfere with data 
interpretation [42,60].  
Advantages of GC-MS include the standardised public libraries that have been 
extensively developed to include mass spectral data and retention times of many 
different chemicals. The most popular includes the publicly available NIST Mass 
Spectral Library collection of the U.S. National Institute of Standards and Technology 
(NIST) [61]. Other examples include the Golm Metabolome Database (GMD) [62].  
Open access, and commercial software/websites are readily available for peak 
alignment, extraction, identification and pathway analysis of GC-MS data (and other 
MS techniques). All software/websites will provide varying results which affect the 
interpretation [58] and therefore reporting of all metadata associated with 
metabolomics experiments is important to provide biological and empirical context of 
the data. Proposed minimum reporting standards for chemical analysis have been 
reported by the Chemical Analysis Working Group (CAWG) as part of the 
Metabolomics Standards Initiative (MSI) [63].  
In this thesis a consistent freely available workflow was employed for all experimental 




Figure 3: Final metabolite profiling workflow using GC-MS. After cultivation and harvest of biomass; 
(1) metabolite extraction and derivatisation, (2) GC-MS data acquisition, (3) deconvolution and peak 
detection using AMDIS, (4) conservative peak alignment using SpectConnect, (5) statistical analysis 
using MetaboAnalyst (PCA, ANOVA, heatmap) and Excel (t-Test), (6) semi-quantification by 
normalisation to dry weight (intracellular only) and internal standard, (7) identification using GMD and 













Cyanobacterial metabolomics  
As metabolomics closely relates to the physiology of an organism, it is useful in 
cyanobacterial research due to their adaptation to a variety of biotic and abiotic factors 
(as described above) [43].  
Many studies have been conducted to identify targeted intracellular metabolites within 
cyanobacteria during abiotic stress. Investigations include the production of MAAs 
using high performance-liquid chromatography (HPLC) in Lyngbya sp. CU2555, 
Nostoc commune, Anabaena variabilis PCC 7937, Calothrix sp. and C. fritschii PCC 
6912 [10,48,49,64,65], pigment concentrations using UV-visible spectroscopy in 
Nostoc flagelliforme [66] and pigment composition of Nostoc punctiforme ATCC 
29133 using HPLC [52]. 
Less research has been conducted on metabolite profiling of intracellular metabolites 
within cyanobacteria. Some examples include; the analysis of the model 
cyanobacterium Synechocystis sp. PCC 6803 from high to low CO2 using GC-MS [53], 
GC-MS analysis of Nostoc punctiforme ATCC 29133 during UV-A exposure [52] and 
a comparison between strains using both LC-MS and GC-MS; Synechococcus 
elongates PCC 7942, Synechococcus sp. PCC7002 and Synechocystis sp. PCC6803 
[67]. 
Cyanobacteria, like many other microorganisms release carbon-based primary and 
secondary metabolites into their surroundings. Released metabolites are by-products 
of metabolism. The uptake and release of metabolites change with varying 
environments [54]. Monitoring industrially relevant metabolites released by 
microorganisms into their surroundings is a widely used technique in the fermentation 
industry. It can be used in bioprocess monitoring, fermentation biomarker 
identification, for monitoring metabolite levels in fermentation processes and 
microbial contamination [68,69].  
Combining intracellular and extracellular analysis is useful to provide a more holistic 
picture of metabolite production during growth and in response to different 






Industrial biotechnology  
With the depletion of fossil fuels and growing concerns of global warming, a more 
sustainable approach is necessary to continue to produce consumer goods and 
pharmaceuticals for growing global markets. A considerable amount of research has 
been conducted to find new sources of industrially relevant compounds to reduce the 
carbon footprint and increase sustainability by replacing oil-based ingredients with 
naturally derived products [21,22].  
Cyanobacteria have received much interest in becoming a promising alternative due 
to their diversity, simple growth needs and simple genetic background which are easily 
manipulated to form cell factories [1,71]. Many industrial processes rely on 
heterotrophic bacteria to produce many different useful compounds. These 
fermentation processes rely on carbon substrates which can be costly. Cyanobacteria 
are able to utilise CO2 from flue gas as a carbon source for photosynthesis [1,72].  
The main drawback with the use of cyanobacteria in industry is the difficulty in 
achieving regular high production yields for commercialisation. The use of 
bioengineering to increase yields has been researched by introducing enzymes from 
different organisms to increase production of valuable compounds [1,72].    
Useful compounds include bulk (commodity) chemicals of low value but high 
productivity to high value products that are usually produced in low concentrations 












Figure 4: Generalised biosynthetic pathway schematic of key metabolite production from CO2 assimilation in cyanobacteria. 
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Some strains of cyanobacteria are readily used in industry, including the edible 
Arthrospira (Spirulina) and Nostoc which have been used as a food source for 
thousands of years [73].  
Spirulina has been well researched for its application within industry. With a GRAS 
status (Generally Regarded As Safe) it is used as a health food due to its extensive 
source of proteins, polyunsaturated fatty acids (γ-linoleic acid, GLA), antioxidants 
(phycocyanin and carotenoids) and vitamins [74].  
C. fritschii is a less well-known species and a potential candidate for use in industrial 
biotechnology. C. fritschii is a sub-section V cyanobacterium, first isolated from soil 
crusts in India with diverse morphology and function [75]. This strains potential is due 
to its robustness and scalability [76]. It is moderately thermophilic which enables 
growth at higher temperatures thus reducing contamination risk by other non-
thermophilic species [20] and tolerant to a variety of growth conditions [20,51,75]. It 
also has auto-flocculating capabilities providing an easier and cheaper way of large 
scale separation [76]. A complete metabolome analysis has not yet been conducted on 
C. fritschii which would assist in determining its feasibility within the biotechnology 
industry. 
Natural products from cyanobacteria usually have bioactive properties. They can be 
used in the pharmaceutical industry as lead compounds in drug discovery. They can 
be used as templates for synthesis of new drugs to treat complex diseases. 
Cyanobacteria have been widely researched for their applications in this field. They 
have found to possess a wide range of potential antimicrobial, anticancer, antiviral and 










Table 3: Potential applications of cyanobacterial natural products in pharmaceuticals and beauty 





Biological activity References 
Spirulina platensis Spirulan Antiviral [13] 
γ-linolenic acid Precursor to 
prostaglandins 
[77] 
 Phycocyanin Cosmetic colourants [30] 
Lyngbya majuscule Apratoxins Anticancer  
Nostoc commune Nostodione Antifungal [13] 
 Carotenoids Antioxidant [74] 
 MAAs Sunscreen [78] 
Anabaena circinalis Anatoxin-a Anti-Inflammatory [13,16] 
Fischerella 
muscicola 





Secondary metabolites can also be used as natural ingredients in the cosmetics 
industry. Uses include the photoprotective MAAs in sunscreens to protect the skin 
from harmful UV exposure [31]. Pigments such as carotenoids and phycobiliproteins 
can be used as natural colourants but also as antioxidants to protect the skin from 
damage caused by UV exposure  [16].   
A challenge remains in assessing and understanding the ability of cyanobacteria to 
produce target metabolites in sufficient quantities under repeatable conditions.   
By combining both metabolomics and bioactivity via in vitro assays, other 
cyanobacterial strains, including C. fritschii, can be profiled for their potential use in 
industrial biotechnology (Chapter 5).  
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Aims and objectives  
The overall aim of this thesis is to evaluate the metabolite profile of the less 
investigated cyanobacterium Chlorogloeopsis fritschii (C. fritschii) PCC 6912, as a 
potential candidate for use in industrial biotechnology. To construct a GC-MS 
workflow to evaluate the changes in low molecular weight metabolite levels of C. 
fritschii over varying time-series under standard and UV stress growth conditions. The 
main goal is to identify biologically relevant metabolites with roles in cyanobacterial 
metabolism for evaluation of growth phases, adaptation to UV stress and applications 
for use in consumer goods. 
A brief description of each chapter, including specific ojectives, is presented below: 
Chapter 1: Materials and Methods  
This chapter includes all general materials and methods used throughout the research 
study. Additional information about design of experiments specific to each research 
topic is included at the beginning of each chapter.  
Chapter 2: Time-Series Metabolite Level Investigation of Chlorogloeopsis fritschii, 
PCC 6912, During Standard Growth Conditions  
The first results chapter is an investigation into changes in the low molecular weight 
metabolite levels of C. fritschii over varying time-series during standard growth 
conditions. Firstly, extraction of metabolites were optimised for GC-MS analysis this 
was followed by an assessment into the changes in metabolite levels over short term 
(48 h) and long term cultivation (120 d) as well as between axenic and xenic cultures 
of C. fritschii (28 d).  
Chapter 3: Intracellular and Extracellular Metabolite Level Changes of 
Chlorogloeopsis fritschii, PCC 6912, During Ultraviolet (UV) A and UV-B Exposure  
The main objective was to investigate the changes in intracellular and extracellular 
metabolite levels changes of C. fritschii during UV-B exposure and intracellular 
metabolite level changes during UV-A exposure over 48 h. The 48 h standard growth 




Chapter 4: Acclimation vs. Shock: The Stress Response of Chlorogloeopsis fritschii, 
PCC 6912, to Ultraviolet Radiation 
This chapter investigates the response of C. fritschii to pre-acclimation to low dose 
UV followed by shock UV exposure. The main objective was to evaluate the 
metabolite level changes and MAA levels during a low dose UV acclimation phase 
followed by shock UV exposure to assess shock response and tolerance of C. fritschii 
to UV exposure.  
Chapter 5: Bioactivity Assessment of Chlorogloeopsis fritschii, PCC 6912, for use in 
Consumer Goods 
The final results chapter assesses extracts from C. fritschii in in-vitro assays to evaluate 
anti-inflammatory, proliferation and antibacterial activity with complementary GC-
MS analysis for further elucidation of active ingredients with relevance to personal 
care products.  
Chapter 6: General Discussion  
A final discussion on the results including the potential application of C. fritschii in 















Chapter 1: Materials and Methods 
 
1.1 Organism and growth conditions 
The cyanobacterium Chlorogloeopsis fritschii (C. fritschii), PCC 6912, was obtained 
from Pasteur Culture Collection (PCC) and grown in autoclaved deionised water with 
filtered BG-11 [5] growth medium (Product number: C3061, Sigma Aldrich, UK). The 
strain was maintained as a master culture in 50 mL BG-11 at a temperature of 27 °C ± 
2 °C under continuous PAR illuminated at 15 µmol m-2 s-1 (measured using a PAR 
light sensor, Enviromonitors, UK). Experimental cultures were pre-grown in 300 mL 
BG-11 media under the same conditions with constant shaking at 80 rpm. Growth was 
monitored using optical density at 750 nm (OD750nm) using a UV-visible 
spectrophotometer (Shimadzu, UV-2550, Kyoto, Japan). pH was also measured 
throughout growth using pH indicator paper (Fisherbrand™, product no. 10642751).  
 
1.2 Sample harvest and growth analysis  
Forty mL volumes (unless otherwise stated) of experimental cultures were harvested 
in triplicate (biological replicates) at each time point by centrifugation at 4400 rpm for 
20 min to produce a pellet and supernatant which were stored at –80 °C. The 
supernatants (40 mL) were collected and freeze-dried (Edwards, super modulyo) for 
72 h. The remaining pellets were transferred into pre-weighed Eppendorf’s and freeze 
dried for 24 h (Scanvac, CoolSafeTM, LaboGeneTM, Vassingerød, Denmark) and re-
weighed for dry weight measurements. Both pellets and dried supernatant were stored 
at -20 °C until analysis. Specific growth rate of the cultures during each experiment 





   (1)   
Equation 1: Specific growth rate (µ), where N1 and N2 are the dry biomass values at time 1 (t1) and 2 




1.3 Analysis of metabolites using gas chromatography-mass 
spectrometry (GC-MS) 
1.3.1 Evaluation of intracellular metabolite extraction techniques 
1.3.1.1 C. fritschii growth and harvest  
1 mL of culture (at OD750nm =1) was harvested by centrifugation at 2500 rpm for 5 
min. Supernatant was removed and cell pellets were extracted immediately. 
1.3.1.2 Extraction of intracellular metabolites 
Three different mechanical disruption procedures (sonication, ice bath and freeze-
thaw) were coupled with three solvent systems; methanol (MeOH) chloroform 
(CHCl3) and a combination of the two (1:1, MeOH:CHCHl3) were tested for the 
extraction of intracellular metabolites from C. fritschii. Cell pellets (n=2) were re-
suspended in 1 mL cold MeOH, CHCl3 or MeOH:CHCl3 and placed in an ice-bath for 
30 min, sonicated for 30 min or frozen at -80 °C and subjected to three freeze-thaw 
cycle. After extraction, cells were centrifuged at 2500 rpm for 5 minutes. 200 µL of 
each extract was aliquoted and evaporated to dryness using a rotary vacuum 
concentrator and derivatised as below (Section 1.3.3).  
1.3.2 Experimental C. fritschii sample preparation 
Polar and non-polar metabolites were extracted from dried cell pellets for GC-MS 
analysis from optimised extraction protocol above (Section 1.3.1.2). Briefly a known 
weight of dried biomass was re-suspended in MeOH:CHCl3:H2O (1 mL, 2:2:1) and 
sonicated using a sonicator probe (Fisher Scientific, product no: FB50) using 6 cycles 
of 20 s pulses at 40 Hz at 0 °C. After centrifugation (5 min at 12000 rpm), 100 µL of 
each solvent layer (both methanolic and chloroform layers) was aliquoted into new 
Eppendorf’s and evaporate to dryness using a rotary vacuum concentrator (Eppendorf 
concentrator 5301) and derivatisation as below. 
Dried supernatant (where applicable) was re-suspended in 1 mL of methanol and 
centrifuged (4000 rpm, 5 min). Two hundred µL was aliquoted into new Eppendorf’s 
followed by evaporation to dryness and derivatisation as below.  
1.3.3 Sample derivatisation  
To each 200 μL dried sample, 30 μL of methoxyamine hydrochloride (23 mg) in 
pyridine (1.5 mL) was added and samples were heated at 70 °C for 45 min. Once 
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cooled to room temperature, MSTFA + 1% TMCS (50 μL, Thermo ScientificTM, 
product no: TS-48915) was added and samples heated for an additional 90 min at 40 
°C. Once cooled to room temperature, 10 μL of tetracosane dissolved in hexane (2 mg 
mL-1) was added as an internal standard. Derivatised samples were transferred into 
auto-sample vials ready for analysis.  
1.3.4 GC-MS analysis 
Derivatised sample (1 µL) was loaded onto an Agilent HP-5MS capillary column (30 
m x 0.25mm x 0.25 µm) in splitless mode at 250 °C. The GC was operated at a constant 
flow of 1 mL min-1 helium. The temperature program started at 60 °C for 1 min, 
followed by temperature ramping at 10 °C min-1 to a final temperature of 180 °C, this 
was followed by a second temperature ramping at 4 °C min-1 to a final temperature of 
300 °C and held constant at 300 °C for 15 min. Data acquisition included a mass range 
of 50 to 650 and resulted in .D data files for analysis.   
Chromatograms were deconvoluted using AMDIS (Automated Mass Spectral 
Deconvolution and Identification System) followed by alignments using the online 
portal SpectConnect, http://spectconnect.mit.edu/ [81], before identifying peaks using 
Golm metabolome database, www.gmd.mpimp-golm.mpg.de/, and the NIST 05 
(National Institute of Standards and Technology) library. MetaboAnalyst, 
www.metaboanalyst.ca/, was used for statistical analysis [82,83]. 
1.3.5 GC-MS data processing 
GC-MS data sets need deconvolution of co-eluting compounds, the freely available 
software AMDIS (Automated Mass Spectral Deconvolution and Identification 
System) was used to process the chromatograms (.D) and produce .ELU files. Settings 
for AMDIS were as followed [52]; resolution = medium, sensitivity = medium, shape 
requirement = medium and component width was 10. The resulting .ELU files were 
uploaded to SpectConnect, http://spectconnect.mit.edu/, for alignment and 
conservative component identification [59,81].  Aligned matrices were further 
analysed and processed using Excel 2010 (Microsoft, USA). The integrated signal (IS) 
matrix generated was used for relative quantification of peaks. Triplicate missing data 
points (within time points) were assumed to be lower than detection limit and replaced 
with half of the minimum integrated signal within each data set. Data normalisation 
was carried out using the peak area of the internal standard tetracosane and dry weight 
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of each sample (intracellular samples only). All duplicate retention times were 
removed before further analysis.  
1.3.6 Identification  
Identification of peaks was carried out in AMDIS by analysing each chromatogram 
using the Golm metabolome database (GMD), www.gmd.mpimp-golm.mpg.de/, as a 
target library, followed by searching the National Institute of Standards and 
Technology (NIST) 05 library (Scientific Instrument Service, Inc., NJ, USA) with a 
match factor of ≥60% [62]. Identifications from GMD and NIST were as TMS/MeOX 
derivatives and names were converted to non-derivatised form for pathway analysis.  
Reports were exported in .xls format from AMDIS with first hit only included for 
further processing using Excel 2010 (Microsoft, USA). A true hit was considered when 
two or more biological replicates (within the same time-point) contained the peak. If 
none of the time points contained ‘true hits,’ the peaks were removed before further 
analysis. The peaks were reported belonging to level 2 (putatively annotated 
compounds) or level 4 (unknown compounds) in accordance with the Metabolomics 
Standards Initiative [63].  
1.3.7 Pathway analysis  
Each identified peak was manually searched in the Kyoto Encylopedia of Genes and 
Genomes (KEGG) to find biologically relevant metabolites [84]. KEGG name and 
pathway information was noted to construct generalised pathway schematics.   
1.3.8 Statistical analysis  
MetaboAnalyst was used for multivariate statistical analysis including principle 
component analysis (PCA), Analysis of Variance (ANOVA) and hierachial heat-map 
clustering. Statistical analysis of the IS peak lists (in .csv format) of the time-series 
data was conducted using the time-series/two-factor module. Multivariate analysis was 
carried out using each column as a different time point and each row representing a 
metabolite (data type = peak intensity table; study design = time-series only; data 
format = samples in columns) [83]. Missing data points were uploaded as blanks and 
replaced with half of the minimum integrated signal within each data set. Peaks were 
normalised to total sum of peaks, log transformed and mean centred prior to statistical 
analysis (unless otherwise stated). PCA, a one-way repeated ANOVA (p <0.05) and 
hierachial heat map clustering was used to evaluate the data. A two sample t-Test with 
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equal variance was also used as a univariate statistical tool to evaluate data comparing 
each treatment time point in Excel unless otherwise stated.  
 
1.4 Analysis of mycosporine-like amino acids (MAAs) using High 
Performance Liquid Chromatography (HPLC) 
1.4.1 Method development 
1.4.1.1 Crude MAA sample preparation  
Crude mycosporine-like amino acid (MAA) extracted from dulse was donated by 
Sarah Twigg and Steve Wilson (Unilever, Colworth) for use in High Performance 
Liquid Chromatography (HPLC) method development. Crude sample 1 was known to 
contain shinorine, palythine, porphyra, usijurene and palythene. Crude sample 2 was 
known to contain shinorine, palythine and porphyra and crude sample 3 contained 
porphyra and shinorine.  
Each extract was re-constituted in 1 mL of water and absorbance was measured in 
quartz cuvettes using a UV-visible spectrophotometer between 200-450 nm. Extracts 
were further diluted until an absorbance of 1 AU was measured.  
1.4.1.2 Macroalgal sample preparation 
The rhodophyta (red alga) Palmaria palmata (P. palmata) was collected from 
Langland bay, Wales in June 2017. The biomass was washed with deionised H2O to 
remove sediment and stored at -80 °C until analysis.  
1.4.1.3 Macroalgal MAA extraction  
Three replicate P. palmata samples were ground using a pestle and mortar and 
transferred into a 50 mL centrifuge tube for extraction. 10 mL 50% aqueous (aq) 
MeOH was added and the samples were sonicated on ice using a sonicator probe for 5 
min at 50 Hz. The samples were centrifuged at 4400 rpm for 10 min and the 
supernatant removed. The extraction protocol was repeated 3 times and supernatants 
combined.  
MeOH was removed under vacuum and water was removed by freeze-drying for 24 h. 
Dried extracts were re-constituted with 90% Ethanol (EtOH, aq) and left at -20 °C 
overnight. Samples were centrifuged for 5 min at 4400 rpm and supernatant retained. 
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EtOH was removed under vacuum and samples were freeze-dried to remove water. 
Dried extracts were re-dissolved in 1 mL of water and absorbance measured in quartz 
cuvettes using a UV-visible spectrophotometer between 200-450 nm. Samples referred 
to as crude PP. 
1.4.1.4 HPLC analysis  
Method development was performed using a HP Agilent 1100 HPLC system equipped 
with a binary pump (G1312A), an autosampler (ALS) injector (G1313A), 
thermostatted column compartment (G1316A) and diode array detector (DAD, 
G1315A) connected via an interface module to a computer running ChemStation 
software. All analyses were carried out at 35 °C with a flow rate of 0.5 mL min-1 and 
injection volume of 5 µL. Detection of peaks were made by monitoring absorbance at 
310, 320, 330 and 360 nm as well as absorption spectra measured between 200-400 
nm which were recorded and stored within each detected peak.  
1.4.1.5 Mobile phase optimisation 
The three crude extracts (n=5, technical replicates) were separated firstly using an 
Alltima Altech polymeric double encapped reverse phase C18 column (5 µm, 4.6 x 
150 mm) for mobile phase development. Eluent A was a solution of (1) 0.06% aqueous 
trifluoroacetic acid (TFA) (v/v) or (2) 0.01% aqueous TFA (v/v) or (3) 0.001% 
aqueous TFA (v/v) while eluent B was kept constant as 70% MeOH (aq) containing 
0.054% TFA (v/v). The optimum gradient used was kept constant as in (Table 4) 
1.4.1.6 Stationary phase optimisation  
The crude extract 1 only (n = 5, technical replicates) was then separated using six 
different RP-HPLC columns :  (Column A) Alltima® Altech C18 column (5 µm, 4.6 
x 150 mm), (Column B) SynergiTM  Fusion C18 column (4 µm, 4.6 x 150 mm, 80 Å), 
(Column C) Hichrom ACE excel super-C18 column (3 µm, 4.6 x 250 mm, 80 Å), 
(Column D) Hichrom ACE excel C18- Amide column (3 µm, 4.6 x 250 mm, 100 Å), 
(Column E) Hypercarb® C30 column (5 µm, 4.6 x 100 mm, 250 Å) and (Column F) 
Develosil® C30-UG column (5 µm, 4.6 x 250 mm, 140 Å). The mobile phase and 
gradient used were as in Section 1.4.1.5 (Mobile phase 2) and Table 4.   
Table 4: High-performance liquid chromatography (HPLC) gradient protocol for mycosporine-like 
amino acid (MAA) separation used throughout method development. 
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Time (min) Eluent A (%) Eluent B (%) 
0 99 1 
10 99 1 
15 80 20 
20 1 99 
23 1 99 
25 99 1 
30 99 1 
 
1.4.1.7 Data analysis  
For both mobile and stationary phase optimisation, mean values of five replicates and 
standard error was calculated for each crude extract. Peaks were identified using online 
absorption spectra and maximum absorbance readings (λmax). Resolution (Rs) 
between peaks was calculated using Equation 2a, where RT1 and RT2 are the retention 
times of the two peaks and Wt1 and Wt2 are the widths of those peaks at the baseline 
[33].  Relative standard deviation (RSD%) of each detected peak was also calculated 
to analyse precision and repeatability of each method using Equation 2b, where ?̅? is 









) 𝑥 100         (Equation 2b) 
Equation 2: Equations for the (a) calculation of resolution between two peaks and (b) calculation of 
the relative standard deviation (%).  
 
1.4.1.8 Method validation 
All crude extracts (1, 2 and 3) as well as crude PP samples (n = 3 biological replicates, 
n = 3 technical replicates) were used to validate the HPLC method as known and 
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unknown samples. Extracts were separated using an Alltima Altech polymeric double 
encapped reverse phase C18 column (5 µm, 4.6 x 150 mm). The mobile phases were 
0.01% aqueous TFA (v/v, eluent A) and 70% MeOH (aq) containing 0.054% TFA 
(v/v, eluent B). The gradient used was as in Table 4.  
1.4.2 C. fritschii MAA extraction 
Each pellet of a known weight was re-suspended in 100% HPLC grade MeOH (1 mL) 
and left in the dark at 4 °C overnight (24 h). After centrifugation (5 min at 12000 rpm), 
the supernatant was removed and evaporated to dryness using a rotary vacuum 
concentrator. The dried extract was re-dissolved in 600 µL of deionised water and 
transferred to autosample vials for HPLC analysis [78].  
1.4.3 Developed HPLC analysis 
HPLC analysis was performed using an Agilent 1100 system equipped with a binary 
pump (G1312A), an autosampler injector (ALS, G1313A), thermostatted column 
compartment (G1316A) and diode array detector (DAD, G1315A) connected via an 
interface module to a computer running ChemStation software. The stationary phase 
was an AlltimaTM AltechTM C18, 4.6 x 150 mm, 5 µm column heated to 35 °C. The re-
suspended extracts were injected (100 µL) using an auto-sampler.  The mobile phases 
consisted of; Eluent A: Water (0.01% TFA, v/v) and Eluent B: 70% methanol (0.054% 
TFA, v/v) with a gradient of; 99% A for 10 min, to 80% A over 5 min, to 1% A over 
5 min, held for 3 min and increased to 99% A over 2 min (Table 4). MAA’s were 
monitored at wavelengths of; 310, 320 and 330 nm, absorption spectra between 200 – 
400 nm were stored within each detected peak.   
1.4.3.1 Data analysis  
For each detected MAA peak, retention time, peak area and absorbance at the 
maximum wavelength (λmax) were collected. The estimated concentration (g L-1) of 







A =  ε. c. l                          (3a) 
c (M) =  
A
ε.l
                        (3b) 
c (g L−1) = c (M)x MW        (3c) 
Equation 3: Estimation of MAA concentration using the Beer-lambert law where; A = absorbance at 
λmax (shinorine, λmax = 334 nm; m-gly, λmax = 310 nm), ε = extinction coefficient (shinorine, ε = 
44700 M-1 cm-1; m-gly, ε = 28790 M-1 cm-1), c = concentration, l = path length and MW = molecular 
weight (shinorine, MW = 332.306 g mol-1; m-gly, MW = 245.229 g mol-1) 
 
All values were normalised to dry weight of samples (mg mL-1) and expressed as mg 
of MAA per mg of dry weight unless otherwise stated.  Statistical analysis was carried 
out in Excel using a two-sample t-Test with equal variance comparing each time point.     
 
1.5 Pigment analysis 
1.5.1 Sample preparation for UV-Visible spectroscopy  
To each pellet of a known weight, 100% HPLC grade MeOH (1 mL) was added and 
vortexed to re-suspend. Samples were sonicated under low light conditions using a 
sonicator probe for 6 cycles of 20 s pulses at 40 Hz at 0 °C. After centrifugation (5 min 
at 12000 rpm) the supernatant was removed and absorbance spectra measured using a 
UV-visible spectrophotometer between 400-800 nm with 100% MeOH as a blank. 
Chlorophyll (Chl) a and carotenoid concentrations were calculated using the equations 
as described in Equation 4a and b [85,86]. 
 
𝑐ℎ𝑙 𝑎 (µ𝑔 𝑚𝐿−1) = 13.43 𝑥 𝐴665 𝑥 
𝑣
𝑙𝑉
    (4a) 
𝑇𝑜𝑡𝑎𝑙 𝑐𝑎𝑟𝑜𝑡𝑒𝑛𝑜𝑖𝑑𝑠 ( µ𝑔 𝑚𝐿−1) =





   (4b) 
Equation 4: Equation for a) chl a and b) total carotenoids concentrations. A(XXX) = Absorbance at 665 




1.6 Total protein analysis  
Total protein analysis was measured using a modified version Lowry protein assay 
using bovine serum albumin (BSA) as a standard [87,88]. All measurements were 
carried out in triplicate.  
1.6.1 Preparation of reagents standards 
Lowry A (2% (w/v) anhydrous sodium carbonate, Na2CO3, in 0.1 M sodium 
hydroxide, NaOH) was prepared by dissolving 2 g of Na2CO3 in 0.1 M NaOH (aq) (4 
g of NaOH in 1 L H2O). Lowry B consisted of 1 g potassium sodium tartrate 
tetrahydrate, KNaC4H4O6.4H2O, in 100 mL of H2O (1% (w/v) KNaC4H4O6.4H2O in 
H2O) and Lowry C was 0.5 g of copper sulfate pentahydrate, CuSO4.5H2O, in 100 mL 
H2O (0.5% (w/v) CuSO4.5H2O in H2O). Lowry D was then prepared on the day of 
amalysis by combining Lowry A, B and C in the ratio of 48:1:1 respectively and the 
solution was incubated for 10 min before use. 1 M Folin-Ciocalteu’s phenol reagent 
was prepared by diluting a 2 M solution (Sigma-Aldrich, product no.F9525) with H2O 
in ratio of 1:1 on the day of assay. 24% Trichloroacetic acid (TCA) was prepared by 
adding 2.4g of TCA to 10 mL of H2O. BSA stock solution was prepared by dissolving 
10 mg of BSA in 10 mL of H2O to a final concentration of 1 mg mL
-1. 
1.6.2 BSA standard curve  
Standard BSA concentrations of 1, 0.8, 0.6, 0.4, 0.2, 0.1, 0.08, 0.06, 0.04, 0.02 and 0 
mg mL-1 were prepared using the table below (Table 5) 
BSA standard concentrations (50 μL) were added to new 1.5 mL Eppendorf’s along 
with Lowry D solution (950 μL) in triplicate. Samples were vortexed for 30 s and 
incubated for 10 min at room temperature. 1 M Folin-Ciocalteu’s phenol reagent (0.1 
mL) was added and samples vortexed immediately to mix. Samples were incubated 
for a further 30 min at room temperature and absorbance read at 750 nm using a UV-
visible spectrophotometer. A plot of OD at 750 nm vs. standard concentration was 






Table 5: Dilution series for BSA standard curve. 
Standard (mg mL-1) Volume Stock (mL) Volume H2O (mL) 
 
1 1 0 
 
0.8 0.8 0.2 
 
0.6 0.6 0.4 
 
0.4 0.4 0.6 
 
0.2 0.2 0.8 
 
0.1 0.1 0.9 
 
0.08 0.08 0.92 
 
0.06 0.06 0.94 
 
0.04 0.04 0.96 
 
0.02 0.02 0.98 
 




Figure 5: Lowry assay standard curve using BSA. Straight line equation: y = 0.6981x + 0.0027, R2 = 
0.9975. 
1.6.3 C. fritschii sample analysis  
Dry C. fritschii biomass of a known weight was re-suspended in TCA (200 µL, 24% 
(w/v)) and incubated at 95 °C for 15 min. Once cooled, the suspension was diluted to 
6% (w/v) TCA by adding 600 µL of H2O. Samples were centrifuged (5500 rpm, 5 min) 
31 
 
and the supernatant was discarded. The remaining pellets were re-suspended in Lowry 
D (500 µL) with mixing and incubation at 55 °C. Samples centrifuged (5500 rpm, 5 
min) and supernatant retained for analysis.  
C. fritschii protein extracts (50 μL) were added to new 1.5 mL Eppendorf’s along with 
Lowry D reagent (950 μL). Samples were vortexed for 30 s and incubated for 10 min 
at room temperature. 1 M Folin-Ciocalteu’s phenol reagent (0.1 mL) was added and 
samples vortexed immediately to mix. Samples were incubated for a further 30 min at 
room temperature and absorbance read at 750 nm using a UV-visible 
spectrophotometer. Concentration was calculated using straight line equation above 
followed by data normalisation using dry weight (mg mL-1) for final protein 
concentration reported as mg/mg dry weight. 
 
1.7 Total carbohydrate analysis 
Total carbohydrates within C. fritschii cells were analysed using the colourimetric 
phenol-sulfuric acid method where simple sugars, oligosaccharides, polysaccharides 
and derivatives are hydrolysed using 1 M sulfuric acid (H2SO4) followed by 
dehydration using concentrated H2SO4 which then react with phenol to produce a 
yellow colour change  [89,90].  
1.7.1 Preparation of reagents and standards 
A 5% phenol solution was prepared by dissolving 5 g of phenol in 100 mL of deionised 
water. 1 M H2SO4 (aq) was prepared by adding 55.6 mL (98% H2SO4) to 944.4 mL of 
deionised water (total volume 1 L). 1 mg mL-1 of glucose stock solution was prepared 
by adding 100 mg of glucose to 100 mL of deionised water. 
1.7.2 Glucose standard curve  
Standard glucose concentrations of 1, 0.8, 0.6, 0.4, 0.2, 0.1, 0.08, 0.06, 0.04, 0.02 and 
0 mg mL-1 were prepared using the table below (Table 6).  
0.1 mL of each glucose concentration (in triplicate) was added to 2 mL Eppendorf’s 
followed by addition of 1 mL conc. H2SO4 and rapid addition of 5% phenol to surface 
of liquid for good mixing. Once cool, colour change was measured in acid resistant 
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cuvettes at 485 nm using a UV-visible spectrophotometer. A plot of OD at 485 nm vs. 
standard concentration was created using Excel (Figure 6). 
 
Table 6: Dilution series for glucose standard. 


























 Figure 6: Phenol-sulfuric acid assay standard curve using glucose. Straight line equation: y = 1.9516x-
0.0102, R2 = 0.9987. 
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1.7.3 C. fritschii sample analysis  
To each dry weight pellet, 0.5 mL of 1 M H2SO4 was added and heated to 90 °C for 1 
h. Once cooled samples were centrifuged (5500 rpm, 10 min) and 0.1 mL was added 
to a new Eppendorf. 1 mL conc. H2SO4 was added followed by rapid addition of 5% 
phenol to surface of liquid for good mixing. Once cool, colour change was measured 
in acid resistant cuvettes at 485 nm using a UV-visible spectrophotometer. 
Concentration was calculated using straight line equation above and data was 
normalised using dry weight (mg mL-1) for final carbohydrate concentration reported 
as mg/mg dry weight.  
 
1.8 Anti-inflammatory and Antibacterial activity assessment of C. 
fritschii extracts 
1.8.1 Cultivation of C. fritschii under industrial conditions 
C. fritschii was pre-cultivated in autoclaved deionised water (20 min at 121 °C) from 
50 mL to 1 L flasks using BG-11 media at 27 °C ± 2 °C with continuous light at 15 
µmol m-2 s-1 and shaking at 100 rpm. Once a dense 1 L culture was obtained, up-scaling 
and acclimatisation to industrial conditions was required.  
Conditioning of indoor cultures was carried out in the Centre for Sustainable Aquatic 
Research (CSAR). A 1 L culture was used to inoculate 4 L of autoclaved tap water 
with 50 mL of BG-11 in a 20 L carboy. Once dense, 5 L of filtered tap water and 
standard F/2 commercial media (3.5 mL L-1 of H2O, Cell-Hi F2P, Varicon Aqua 
Solutions, UK) was added and cultures were left to grow until an OD of 0.9-1 was 
achieved. Once this density was reached, the final 10 L of tap water was added, which 
was sterilised by adding 10 mL of sodium hypochlorite and left running overnight. The 
sodium hypochlorite was neutralised using sodium thiosulfate (0.3 g L-1 of treated 
water). The sterilised water was added to the carboy along with F/2 media. This culture 
was left to grow until dry weight of 1.2 g L-1 was achieved. Fresh F/2 media was added 
every 5 days to maintain nutrient levels. The abiotic parameters were a temperature of 
20 °C ± 1 °C, aeration was achieved with filtered (0.2 µm) ambient air (0.039% CO2) 
at a rate of 0.6 min-1 (v/v) using a 1 mm capillary glass tube inside the carboy and a 
light/dark cycle of 18/6 h with cool white fluorescent tubes at 60 µmol m-2 s-1, pH was 
measured every other day and remained at 7-8 throughout growth.  
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1.8.1.1 Harvest of 20 L carboy  
After 3 months of growth, 17 L of culture was harvested and concentrated to 2 L using 
a crossflow membrane filtration system (Membranology, UK). The 2 L of culture was 
washed thoroughly with deionised water and freeze-dried yielding 20 g of dry weight 
biomass. 
1.8.1.2 UV-B exposure 
3 x 1 L of the 20 L culture at OD of 1 was harvested and transferred into Quartz flasks 
(H. Baumbach & Co.LTD, Suffolk, UK) for UV-B experiments. Cultures were 
exposed to 24 h of UV-B at an intensity of 3 µmol m-2 s-1 and continuous white light 
at 15 µmol m-2 s-1 and a temperature of 27 °C ± 2 °C with continuous shaking at 100 
rpm. Cultures were harvested via centrifugation and freeze-dried for 48 h to yield 
approx. 1 g of biomass for extraction.         
1.8.1.3 Extraction of dried biomass for analysis 
Both UV-B treated (3 x 1 g) and control (no UV-B) (4 x 2 g) biomass was extracted 
using sequential solvent extraction. 20 mL of hexane (hex) was added to each 50 mL 
Falcon tube containing weighed biomass. Cells were sonicated for 10 min on ice to 
extract non-polar metabolites into the solvent. The suspension was centrifuged (20 
min, 8000 rpm, 4 °C) and the hex supernatant was removed and filtered (0.2 µm) into 
a new Falcon tube, 200 µL was used for GC-MS analysis as described above (Section 
1.3). The solvent was removed using a vacuum concentrator by drying in aliquots of 2 
mL and combining all extracts to a single Eppendorf. This process was repeated for 
ethyl acetate (EtOAc), ethanol (EtOH) and MeOH.  
1.8.1.4 Extract preparation 
All extracts were re-suspended in 100% dimethylsulfoxide (DMSO) to a final 
concentration of 10 mg mL-1. Extracts were also combined to form pooled samples of 
UV-B and control extracts for analysis in anti-inflammatory and antibacterial assays. 
1.8.2 Heterologous expression of mycosporine-glycine in Escherichia coli  
Conducted by Steve Wilson at Unilever, Colworth  
The bacterium Escherichia coli (E. coli) was genetically modified to include the Myl 
synthase gene cluster for the biosynthesis of mycosporine-glycine (m-gly). A starter 
culture of the expression strain was grown overnight (approx. 20 h) in M9 minimal 
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medium at 37 °C and continuous shaking. This starter culture was used to inoculate a 
total of 2 L of M9 minimal media supplemented with glycerol (20 g), kanamycin (50 
µg mL-1) and chloramphenicol (34 µg mL-1). The cultures were incubated at 37 °C 
with continuous shaking until an optical density at 600 nm (OD600) between 0.5 and 
0.7 was reached (approx. 4 h). The culture was cooled to room temperature by placing 
on ice and isopropyl-β-D thiogalactopyranoside (IPTG) was added and cultures 
incubated with shaking at 25 °C for 24 h.  
2 L cell culture was harvested by centrifugation (5000 rcf, 20 min at 4 °C) and 
supernatant was collected followed by filtration. The filtered supernatant was clarified 
using a cross-flow membrane filtration system to remove proteins. 20 g of activated 
charcoal was added and gently mixed for 10 min. The suspension was filtered 
(supernatant kept) and washed with 50% MeOH. UV-visible spectrum of supernatant 
fraction was collected and absorbance at 310 nm was noted as m-gly. Fractions with 
m-gly present were further purified by ion exchange chromatography, acidifying with 
HCl and eluting with H2O. Fractions were freeze-dried to yield partially purified (16%) 
m-gly.  
1.8.2.1 M-gly extract preparation  
891 µL of H2O was added to the partially pure m-gly to make up a 2 mM stock 
solution. This was further diluted with DMEM (10% FBS) to make up concentrations 
of 50, 25, 12.5, 6.25, 3.125 and 0 µM for use in anti-inflammatory assays (Table 12, 
Section 1.8.3).  
1.8.3 Mammalian Cell Culture for in vitro anti-inflammatory assessment  
1.8.3.1 Cell line, media composition and growth conditions   
Immortalised human keratinocyte (HaCaT) cells were donated by Dr Mark Fowler 
(Unilever, UK). The cells were maintained in a T175 flasks with approximately 2x106 
cells per flask containing 25 mL of Dulbecco’s Minimum Eagle Medium (DMEM) 
with GlutaMAXTM (GibcoTM, product no. 31966021) supplemented with heat 
inactivated 10% Fetal Bovine Serum (FBS, GibcoTM, product no. A3160802). The 
flasks were incubated in 5% CO2 atmosphere in a humidified incubator at 37 °C for 
approximately 3-4 days. 
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1.8.3.2 Maintenance of cell culture   
The cells were split once a confluency of 80% was reached. Briefly, the cells washed 
thoroughly with 10 mL Dulbecco’s Phosphate Buffered Saline (dPBS, Sigma Aldrich, 
product no: D8537). The dPBS was aspirated and 4 mL of TrypLETM Express 
(GibcoTM, product no: 12604013) was added and cells incubated for 8 min to detach 
the cells (tryptanization). 8 mL fresh media was added to re-suspend the trytanized 
cells. The volume of cell suspension was measured (approx. 12 mL) and added to a 
universal tube.  
100 µL of the cell suspension was removed from the universal and added to 9.9 mL of 
ISOTON® II solution for cell counts (Z-series Coulter Counter, Beckman Coulter, Inc, 
US). Cell numbers were counted twice (blanks of ISOTON® II only were run before 
and after cell counts) and total cell number per flask was calculated using Equation 
5a and 5b below; 
 
(𝐶𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡 1 + 𝐶𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡 2) 𝑥 100 = 𝐶𝑒𝑙𝑙𝑠 𝑚𝐿−1                                             (5a) 
𝐶𝑒𝑙𝑙𝑠 𝑚𝐿−1 𝑥 (𝑡𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑒𝑙𝑙 𝑠𝑢𝑠𝑝𝑒𝑛𝑠𝑖𝑜𝑛 − 100 µ𝐿) = 𝐶𝑒𝑙𝑙𝑠 𝑓𝑙𝑎𝑠𝑘−1  (5b) 
Equation 5: Equations for the calculation of cell numbers (a) per mL of culture and (b) total per flask.  
The cell suspension was centrifuged (1000 rcf, 5 min) and the old medium was 
aspirated. The remaining cell pellet was re-suspended in the equivalent amount of fresh 
medium to make up a suspension of 1 x 106 cells mL-1 (e.g. 8.5 mL of medium added 
to 8.5 x 106  total cells to make 1 x 106 cells mL-1).  23 mL of fresh medium was added 
into new T175 flasks and 2 mL of the 1 x 106 cells mL-1 suspension was added to a 
final concentration of 2 x 106 cells mL-1. Flasks were incubated at 37 °C in 5% CO2 
atmosphere in a humidified incubator until confluent (3-4 days).  
1.8.3.3 Anti-inflammatory assay 
1.8.3.3.1 Seeding density experiment  
For the HaCaT cell seeding density experiment, a dilution series of cell concentrations 
was prepared as below ( 
Table 7). Cells were tryptanized using TrypLETM Express and cells counted as above 
(Section 1.8.3.2). The cell suspension in the universal tube was centrifuged (1000 rcf, 
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5 min) and the old medium was aspirated (removing bubbles first then slowly 
aspirating the medium). The cell pellet was agitated by tapping the tube to prevent 
clumping during re-suspension. Cells were diluted to 1 x 106 cells mL-1 (e.g. 9.9 mL 
of fresh medium added to 9.9 x 106 cells) and pipetted repeatedly to re-suspend the 
cells homogeneously; this dilution was known as cell stock A.  
The dilution of cell stock A to the working stocks of 1 x 105, 5 x 104, 1 x 104, 5 x 103 
and 1 x 103 cells mL-1 was calculated as below ( 
Table 7).  
Each dilution was added to a 24 (1 mL well-1) and an E8 iCELLigence plate (320 µL 
well-1). Plates were rested for 15 min before placing in an incubator for 48 h at 37 °C 
in 5% CO2 atmosphere in a humidified incubator. Cell density was monitored using a 
microscope and iCELLigence real time measurements (Section 1.8.4). 
 
Table 7: Dilution series for dose seeding experiment 
Dilution Cells mL-1 DMEM (mL) Stock (mL) Stock/dilution 
Stock A 1 x 106 3.5 - Re-suspended 
cell pellet 
A 1 x 105 9 1 Stock A 
B 5 x 104 9.5 0.5 Stock A 
C 1 x 104 9 1 A 
D 5 x 103 9 1 B 
E 1 x 103 9 1 C 
 
1.8.3.3.2 Cell seeding  
For the dose response experiments, cells were tryptanized using TrypLETM Express 
and cells counted as above (Section 1.8.3.2) to create cell stock A at 1 x 106 cells mL-
1 (Section 1.8.3.3.1). The dilution of cell stock A to a working stock of 1 x 105 cells 
mL-1 was calculated as followed:  
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A total volume of 28 mL was needed to seed a 24 well plate at 1 mL well-1 (plus 
pipetting error). The total volume of fresh media and volume of cell stock A needed 
was calculated using Equation 6a, b and c below; 
 
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (1 𝑥 106  𝑐𝑒𝑙𝑙𝑠 𝑚𝐿−1)
𝐹𝑖𝑛𝑎𝑙 𝑐𝑒𝑙𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (1 𝑥 105 𝑐𝑒𝑙𝑙𝑠 𝑚𝐿−1)
= 𝐷𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (10)                   (6a) 
𝑇𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (28 𝑚𝐿)
𝐷𝐹 (10)
= 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑡𝑜𝑐𝑘 𝐴 𝑛𝑒𝑒𝑑𝑒𝑑 (2.8 𝑚𝐿)                                (6b) 
𝑇𝑜𝑡𝑎𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 (28 𝑚𝐿) − 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑡𝑜𝑐𝑘 𝐵 (2.8 𝑚𝐿) =
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑎𝑑𝑑𝑖𝑡𝑖𝑜𝑛𝑎𝑙 𝑚𝑒𝑑𝑖𝑎 (25.2 𝑚𝐿)                                                              (6c) 
Equation 6: Equations for the dilution of cells to experimental seeding density. (a) Calculation of 
dilution factor, (b) volume of initial cell volume needed and (c) volume of addition media needed.  
 
1 mL of 1 x 105 cells mL-1 was seeded in each well of a 24-well plate. Plates were left 
to rest for 15 min followed by incubation at 37 °C in 5% CO2 atmosphere in a 
humidified incubator for 24 - 48 h until a monolayer of cells had formed. 
1.8.3.3.3 Pro-inflammatory dose response in HaCaT cells  
After 48 h of HaCaT cell incubation (Section 1.8.3.3.2), the spent media was aspirated 
and the cells were washed with 1 mL of dPBS. 1 mL of pro-inflammatory mediator 
stocks, Tumour necrosis factor–α (TNF-α) and Interleukin-1β (IL-1β) (Table 8) were 
added to the corresponding wells (n = 3), each stock was vortexed to ensure even 
mixing. For cell only control samples, mediators were replaced with H2O as a vehicle 
control (n = 3). The plates were incubated for 24 h in 5% CO2 atmosphere in a 









Table 8: Dilution series for TNF-α and IL-1β dose response 
TNF-α (µg mL-1) TNF-α stock (µL) H2O (µL) Stock used (µg 
mL-1) 
10 10 0 10 
5 5 5 10 
1 2 18 10 
0 0 10 - 
IL-1β (µg mL-1) IL-1β stock (µL) H2O (µL) Stock used (µg 
mL-1) 
1 10 0 1 
0.5 5 5 1 
0.1 2 18 1 
0 0 10 - 
*1:1000 dilution: 3.5 µL of TNF-α/ IL-1β stocks or vehicle control  into 3.5 mL DMEM (10% and 
1% FBS) 
1.8.3.3.4 Pro-inflammatory dose response of TNF-α (10% FBS in DMEM)  
After 48 h of HaCaT cell incubation (Section 1.8.3.3.2), the spent media was aspirated 
and the cells were washed with 1 mL of dPBS. 1 mL of pro-inflammatory mediator 
stocks (Table 9) were added to the corresponding wells (n = 3, each stock was vortexed 
to ensure even mixing). For cell only control samples, mediators were replaced with 
H2O as a vehicle control (n = 3). The plates were incubated for 24 h in 5% CO2 










Table 9: Extended dilution series for TNF-α dose response 
TNF-α (µg mL-1) TNF-α stock (µL) H2O (µL) Stock used  
(µg mL-1) 
10 (Stock C) 10 0 10 
5 5 5 10 
1 2 18 10 
0.5 2 18 5 
0.1 2 18 1 
0.01 2 18 0.1 
0 (VC) 0 10 - 
*1:1000 dilution: 3.5 µL of TNF-α or vehicle control (H2O)  into 3.5 mL DMEM (10% FBS) 
 
1.8.3.3.5 Anti-inflammatory dose response of hydrocortisone 
After 48 h of HaCaT cell incubation (Section 1.8.3.3.2), anti-inflammatory dose 
response of hydrocortisone was investigated. Spent medium was aspirated and 
washed with 1 mL of dPBS. 1 mL of each hydrocortisone (HC) stock (Table 10) was 
added to the monolayer of cells (n = 3, each stock was vortexed to ensure even 
mixing). For cell only control samples, HC was replaced with DMSO as a vehicle 
control (n = 3). The plates were incubated for 24 h at 37 °C in 5% CO2 atmosphere in 
a humidified incubator.  
After 24 h, the spent medium was aspirated and cells were washed with 1 mL of dPBS. 
Active stock concentrations were freshly prepared as above with the addition of 1 ng 
mL-1 TNF-α (1:1000 dilution). For cell only control samples, actives were replaced 
with DMSO and TNF-α was replaced with H2O as vehicle controls (n = 3). The plate 
was incubated for a further 24 h in 5% CO2 atmosphere in a humidified incubator at 






Table 10: Dilution series for HC anti-inflammatory dose response 
HC (mM) HC stock (µL) DMSO (µL) Stock used (mM) 
10 10 0 10 
1 2 18 10 
0.1 2 18 1 
0.01 2 18 0.1 
0.001 2 18 0.01 
0.0001 2 18 0.001 
0 (VC) 0 20 - 
*1:1000 dilution: 3.5 µL of HC or vehicle control (DMSO) into 3.5 mL DMEM (10% FBS) 
 
1.8.3.3.6 Anti-inflammatory dose response of pooled C. fritschii extracts  
After 48 h of HaCaT cell incubation (Section 1.8.3.3.2), anti-inflammatory dose 
response of C. fritschii pooled extracts (Section 1.8.1.3 and 1.8.1.4) was investigated 
at concentrations of 10, 5, 1, 0.5, 0.1, 0.01 and 0 µg mL-1. Spent medium was aspirated 
and washed with 1 mL of dPBS. 1 mL of each C. fritschii stock (Table 11) was added 
to the monolayer of cells with HC (10 µM) as a positive control (n = 3, each stock was 
vortexed to ensure even mixing). For cell only control samples, extracts were replaced 
with DMSO as a vehicle control (n = 3). The plates were incubated for 24 h at 37 °C 
in 5% CO2 atmosphere in a humidified incubator.  
After 24 h, the spent medium was aspirated and cells were washed with 1 mL of dPBS. 
Active stock concentrations were freshly prepared as above with the addition of 1 ng 
mL-1 TNF-α (1:1000 dilution). For cell only control samples, actives were replaced 
with DMSO and TNF-α was replaced with H2O as vehicle controls in triplicate. The 
plate was incubated for a further 24 h in 5% CO2 atmosphere in a humidified incubator 




Table 11: Dilution series for dose response of C. fritschii extracts 




DMSO (µL) Stock used 
(mg mL-1) 
10 10 0 10 
5 5 5 10 
1 2 18 10 
0.5 5 5 1 
0.1 2 18 1 
0.01 2 18 0.1 
0 (VC) 0 20 - 
*1:1000 dilution: 3.5 µL of C. fritschii extracts or vehicle control (DMSO) into 3.5 mL DMEM 
(10% FBS) to produce final concentration of 10-0 µg mL-1. 
 
1.8.3.3.7 Anti-inflammatory dose response of individual C. fritschii extracts  
The procedure above was repeated with individual C. fritschii extracts (Section 1.8.1.3 
and 1.8.1.4) at concentrations of 1, 0.5. 0.1 and 0 µg mL-1 with HC as a control (10 
µM) and TNF-α (1 ng mL-1) as a pro-inflammatory mediator. 
1.8.3.3.8 Anti-inflammatory dose response of m-gly  
The procedure above was repeated with partially pure m-gly (Section 1.8.2) at 
concentrations of 50, 25, 12.5, 6.25, 3.125 and 0 µM (Table 12). 3.5 mL of each stock 
was added to the corresponding wells (n=3) with HC as a control (10 µM) and TNF-α 







Table 12: Dilution series for m-gly anti-inflammatory dose response.  
M-gly (µM) M-gly stock (mL) DMEM (mL) Stock used (mM) 
50 0.2 8 2 mM 
25 4 4* 50 µM 
12.5 4 4* 25 µM 
6.25 4 4* 12.5 µM 
3.125 4 4* 6.25 µM 
0 0 4* - 
*Vehicle control = 23.4 mL of DMEM (10% FBS) + 600 µL of H2O, to use as diluent to take into 
account H2O added to cells. 
 
1.8.3.3.9 Supernatant and cell lysate preparation  
After 24 or 48 h the supernatant of each well was collected and centrifuged in a deep-
well 96 microplate (600 rcf, 5 min). The cell free supernatant was then aliquoted into 
two round-bottomed 96 microplates and frozen at -20 °C until cytokine analysis. 250 
µL of RIPA buffer (Sigma Aldrich, product no: R0278) was added to the remaining 
cells and the plates were frozen at -20 °C until protein analysis.  
 
1.8.3.3.10  Analysis of secreted inflammatory cytokines using an Enzyme-linked 
immunosorbent assay (ELISA) 
For cytokine quantification, IL-6 and IL-8 secretion was monitored using enzyme-
linked immunosorbent assays (Human IL-6 DuoSet® ELISA, DY206 and Human 
IL-8/CXCL8 DuoSet® ELISA, DY208, R&D systems, UK). The following 
procedure was carried out according to the manufacturer’s instructions with 
preparation of IL-6 and IL-8 reagents as in Table 13. 
1.8.3.4 Plate preparation 
To prepare the 96-well plates for IL-6 and IL-8 analysis, 100 µL of capture antibody 
was added to each well (IL-6 & IL-8; 58.3 µL of stock into 7 mL of PBS) and the 
plates were sealed and left at room temperature overnight (approx. 15 h). The wells 
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were washed (3 x 300 µL well-1) with wash buffer (0.05% TWEEN® in PBS) followed 
by the addition of 300 µL well-1 of block buffer (1% BSA in PBS). The plates were 
sealed and left for 1 h at room temperature.  
1.8.3.5 Assay procedure  
The wells were washed with wash buffer (3 x 300 µL well-1), for IL-6 analysis, 100 
µL well-1 of sample was added and for IL-8 analysis, 50 µL of sample was diluted with 
50 µL of IL-8 reagent diluent (0.1% BSA, 0.05% TWEEN®). IL-6 and IL-8 standards 
were added to each plate using a two-fold serial dilution (Figure 7).  The plates were 
sealed and incubated at room temperature for 2 h with shaking at 300 rpm. Wells were 
washed with wash buffer (3 x 300 µL well-1) and 100 µL well-1  of detection antibody 
was added (IL-6; 116.67 µL in 7 mL 1% BSA and  IL-8; 116.67 µL in 7 mL 0.1% 
BSA), the plates were sealed and left shaking at 300 rpm for an additional 2 h at room 
temperature. Plates were washed again with wash buffer (3 x 300 µL well-1) and 100 
µL well-1 of Streptavidin-HRP (IL-6; 175 µL in 7 mL 1% BSA and  IL-8; 175 µL in 7 
mL 0.1% BSA) was added, the plates were sealed and incubated in the dark at room 
temperature for 20 min. Plates were washed with wash buffer (4 x 300 µL well-1) and 
100 µL well-1 of the substrate solution was added (1:1 dilution; 7 mL of colour reagent 
A (H2O2) and 7 mL of colour reagent B (tetramethylbenzidine)), the plates were sealed 
and left in the dark for 15 min (IL-6) or 10 min (IL-8) for colour development. 50 µL 
well-1 of stop solution (1 N H2SO4) was added after the specified times and a colour 
change from blue to yellow was observed. The plates were read immediately at 450 











Table 13: Preparation of IL-6 and IL-8 reagents. IL-6 reagent diluent = 1% BSA in PBS, IL-8 reagent 
diluent = 0.1% BSA, 0.05% TWEEN® 20 in Tris-Buffered Saline.  






Capture Antibody 240 2 1:120 (PBS) 
Detection Antibody 3 0.05 1:60 (1% BSA) 
Standard 180 (ng mL-1) 0.6 (ng mL-1) 1:300 (1% BSA)* 
Streptavidin-HRP   1:40 (1% BSA) 
IL-8 
Capture Antibody 480 4 1:120 (PBS) 
Detection Antibody 1.2 0.02 1:60 (0.1% BSA) 
Standard 100 (ng mL-1) 2 (ng mL-1) 1:50 (0.1% BSA)* 
Streptavidin-HRP   1:40 (0.1% BSA) 






Figure 7: Two-fold dilution series of IL-6 and IL-8 standards. Standards are analysed in duplicate and 
used to calculate concentration of secreted IL-6 and IL-8 in samples using quadratic equation of plotted 
values (concentration vs. absorbance); y = ax2 + bx + c.  
 
1.8.3.6 ELISA Data analysis 
All absorbance values at 540 nm were subtracted from absorbance’s read at 450 nm. 
These values were then used to calculate the concentration using the IL-6 and IL-8 
standard curve quadratic equation. Coefficient of variation (%CV) was used to 





 𝑥 100   (7) 
Equation 7: General formula to calculate coefficient of variation (%CV) to assess repeatability of assay. 
Where σ = standard deviation and µ = mean. For ELISA assays a %CV ≤5 and for protein assay a %CV 
≤10 shows good repeatability.  
 
1.8.3.6.1 Protein concentration assay  
Protein concentration for each well was calculated using the PierceTM BCA protein 
assay (Product no: 23225, Thermo ScientificTM). The following procedure was carried 
out according to the manufacturer’s instructions. Frozen cells containing RIPA buffer 
were thawed and lysate centrifuged in Eppendorf’s to remove cell debris. 12.5 µL of 
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each lysate was added to each well of a 96-well microplate with 12.5 µL of PBS. 25 
µL of standards (Table 14) were added to the corresponding wells followed by 200 
µL well-1 of working reagent (A:B, 50:1, 20 mL A + 0.5 mL B). The plates were 
incubated at 37 °C for 15 min and absorbance read at 540 nm.  
 
Table 14: BCA standard preparation for protein assay  
BCA (mg/mL) Stock (mL) RIPA:PBS* 
(50:50) (mL) 
Stock used 
2 1 0 2 
1 0.5 0.5 2 
0.5 0.5 0.5 1 
0.125 0.5 0.5 0.5 
0.0625 0.5 0.5 0.125 
0 0 1 - 
* Standards are supplied in PBS, need to dilute with RIPA to consider lysate composition (lysed 
using RIPA).  
 
1.8.3.7 Data analysis 
Protein concentration was calculated by using equation of standard curve. %CV was 
used to determine repeatability of assay (Equation 7). IL-6 and IL-8 secretion was 
normalised to protein data to remove unwanted variation due to cell numbers.  
1.8.4 Cell proliferation assay using real time iCELLigence system 
Proliferation experiments were carried out using the label free real-time cell analyser 
(RTCA) iCELLigenceTM system (ACEA Biosciences, Inc., USA). Two E8 well plates 
were incubated prior to analysis for 10 min in 5% CO2 atmosphere in a humidified 
incubator at 37 °C. 
Initially 150 μL of cell free DMEM supplemented with 10% FBS was added to the 
wells and a background reading was recorded. HaCaT cells were harvested (Section 
1.8.3.2) and seeded (300 μL) at 5 x 103, 1 x 104, 5 x 104 and 1 x 105 cells mL-1 for the 
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seeding density experiment and 2 x 104 cells mL-1 for subsequent proliferation assays 
with C. fritschii extracts.  
For seeding density experiments, cell index was measured every 1 min for 2 h for 
attachment of cells followed by readings every 15 min for 48 h for proliferation.  
For C. fritschii extract proliferation activity, cell index was measured every 1 min for 
2 h for attachment of cells followed by readings every 5 min for 22 h for pre-treatment 
proliferation. After 24 h, 50 μL of the pooled control extracts at 10, 5, 1, 0.5, 0.1 and 
0.05 μg mL-1 (n=2) were then added and measured every 1 min for 1h to evaluate 
initial effect of extract followed by readings every 5 min for a further 24 h for post 
treatment proliferation. A blank (DMSO) was also used to see the effects of the vehicle 
control on proliferation.  
The assay above was repeated with control and UV-B pooled extracts at concentrations 
of 0.5, 0.25 and 0.1 μg mL-1 (n=2) and proliferation was measured over 72 h.  
1.8.5 Antibacterial activity of extracts  
Antibacterial activity of extracts were assessed against the test bacterium 
Staphylococcus epidermis, ATCC® 12228TM (S. epidermis) using the microdilution 
method. A stock of S. epidermis was inoculated into 50 mL (TSB) and incubated 
overnight at 35 °C with shaking at 120 rpm for growth of an even cell suspension. The 
inoculum was centrifuged (3500 rcf, 10 min), re-suspended and diluted to an OD of 
0.1 using 10 % TSB in H2O for use in the assay. 
Pooled UV-B and control extracts (Section 1.8.1.3 and 1.8.1.4) were diluted with 
culture broth (10% TSB) to a concentration of 0.5 mg mL-1 (1:20). Further 1:2 serial 
dilutions were performed by addition of culture broth to produce concentrations 
ranging from 0.5 - 0.0156 mg mL-1. 270 µL of each concentration was added to wells 
of a 96 microplate along with 30 µL of bacterial suspension (n=2). Growth controls 
were used with DMSO diluted as above and 30 µL of bacterial suspension. Wells were 
included with diluted extracts only (no bacterial cells) to account for pigment 
interference. The plates were incubated for 24 h at 35 °C and bacterial growth was 
measured by an end-point growth reading measured at 590 nm.  
Antibacterial activity was repeated with individual UV-B extracts and control extracts 
at concentrations of 0.5 - 0.03125 mg mL-1.  
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Chapter 2: Time-Series Metabolite Level Investigation of 
Chlorogloeopsis fritschii, PCC 6912, During Standard 
Growth Conditions  
Aims 
• Investigations into the metabolite profiles of C. fritschii during standard 
conditions.  
• To optimise the extraction of metabolites from C. fritschii for GC-MS analysis.  
• To evaluate the similarities and difference in growth, protein, carbohydrate content 
and GC-MS profiles of axenic and xenic C. fritschii cultures over 28 days.  
• To identify metabolites produced by C. fritschii during 120 days of growth. 
• Evaluation of metabolite level changes over 48 h to use as a control for UV 


















Use of metabolomics in cyanobacterial research is a useful tool. As candidates for 
industrial biotechnology it is important to evaluate the production of metabolites to 
help understand the mechanisms behind their growth and survival. This can also give 
an insight into secondary metabolite production. GC-MS is a well-used technique in 
metabolomics research giving advantages over other analytical techniques. It is a well-
known metabolomics tool to investigate metabolite levels in a variety of biological 
samples. The study of plants and microalgae under different growth and development 
phases [91–95],  and during abiotic stress response [96–98] have been widely 
investigated. Little work has been conducted on metabolite profiles within 
cyanobacteria with the majority of research on metabolite changes during abiotic stress 
including; CO2 limitation [53] and UV-B/UV-A exposure [52,99].   
Extraction of a wide variety of metabolites is well documented in metabolomics 
research and is dependent on the material to be extracted and the intended metabolites 
to be evaluated. Extraction methods for GC-MS analysis in a variety of biological 
material is well documented, from human tissue, plants, and microorganisms 
including; the yeast S. cerevisiae [100], the bacterium Escherichia coli [101] and the 
diatom Skeletonema marinoi [94]. A variety of metabolite classes need to be extracted 
to gain a good insight into the metabolome.  
It is important to analyse the metabolome during standard conditions as well as abiotic 
stress to get a better understanding of metabolism within cyanobacteria. This can then 
be used to identify potentially relevant metabolites for use in industrial biotechnology.  
To begin, an assessment of extraction techniques of metabolites from C. fritschii was 
conducted to determine the best combination of solvent and mechanical disruption to 
extract a variety of metabolites from C. fritschii for GC-MS analysis. All subsequent 
experiments used the same techniques and analysis for consistency throughout the 
work. The analysis of axenic and xenic cultures investigates any differences in 
metabolites identified between the two culture conditions. A long term, 120 day time-
series experiment was then investigated to analyse the metabolite level changes over 
different growth phases. A 48 h control experiment was undertaken to analyse the 
changes in metabolite levels during standard conditions over a short time-series. These 
results were then used to compare to UV-A and UV-B exposure experiments (Chapter 
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3). These experiments can be used to improve knowledge-base in novel non-model 

























2.1  Experimental design 
2.1.1 Evaluation of intracellular metabolite extraction techniques 
See Section 1.3.1 for C. fritschii growth, harvest and extraction of intracellular 
metabolites and Section 1.3.3-1.3.6 for GC-MS derivatisation and analysis. 
2.1.2 Axenic vs. Xenic: 28 day analysis of C. fritschii 
C. fritschii cultures were pre-grown for 6 days prior to experimental analysis (Section 
1.1). After 6 days of pre-growth, triplicate experimental axenic and xenic (non-axenic) 
C. fritschii cultures (OD750nm of approx. 0.1 and 0.13 respectively) were grown at a 
temperature of 27 °C under continuous PAR (15 µmol m-1 s-1) and shaking at 100 rpm. 
For time course analysis samples were harvested at 0, 4, 8, 14, 20 and 28 d for dry 
weight (Section 1.2), total protein (Section 1.6), total carbohydrate (Section 1.7) and 
GC-MS analysis (Sections 1.3.2 – 1.3.6). Significant differeces in metabolite levels 
were calculated between time points (d); 0 vs. 4, 4 vs. 8, 8 vs. 14, 14 vs. 20 and 20 vs. 
28. 
2.1.3 120 day analysis of C. fritschii  
C. fritschii cultures were pre-grown for 6 days prior to experimental analysis (Section 
1.1). After 6 days of pre-growth, triplicate experimental C. fritschii cultures (OD750nm 
of approx. 0.08) were grown at a temperature of 27 °C under continuous PAR (15 
µmol m-1 s-1) and shaking at 100 rpm. For time course analysis samples were harvested 
every 8 days for 120 days (0-120) for dry weight (Section 1.2) and GC-MS analysis 
(Sections 1.3.2 – 1.3.6). Significant differeces in metabolite levels were calculated 
between time points (d); 0 vs. 8, 8 vs. 16, 16 vs. 24, 24 vs. 32, 32 vs. 40, 40 vs. 48, 48 
vs. 56, 56 vs. 64, 64 vs. 72, 72 vs. 80, 80 vs. 88, 88 vs. 96, 96 vs. 104, 104 vs. 112 and 
112 vs. 120 unless otherwise stated.  
2.1.4 48 h analysis of C. fritschii  
C. fritschii cultures were pre-grown for 6 days prior to experimental analysis (Section 
1.1). After 6 days of pre-growth, triplicate experimental C. fritschii cultures (OD750nm 
of approx. 0.13) were grown at a temperature of 27 °C under continuous PAR (15 
µmol m-1 s-1) and shaking at 100 rpm. For time course analysis samples were harvested 
at 0, 2, 6, 12, 24 and 48 h for dry weight (Section 1.2) and GC-MS analysis (Sections 
1.3.2 – 1.3.6).  
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2.2  Results  
2.2.1 Evaluation of intracellular metabolite extraction techniques  
Different solvents combined with disruption techniques were evaluated to determine 
the best extraction protocol of metabolites from C. fritschii. The number of peaks 
detected, the number of identifiable peaks and the recovery of different compounds of 
different polarity of each protocol was evaluated [94].   
Table 15: Combination of disruption techniques and solvents for extraction of metabolites from C. 
fritschii  
Disruption technique Solvent 
(A) Ice-bath 
(1) MeOH 
 (2) CHCl3 
 (3) CHCl3:MeOH 
(B) Sonication 
(1) MeOH 
 (2) CHCl3 
 (3) CHCl3:MeOH 
(C) Freeze-thaw 
(1) MeOH 
 (2) CHCl3 
 (3) CHCl3:MeOH 
 
To assess the extraction of metabolites, C. fritschii at an OD of 1 was extracted using 
different mechanical disruption techniques (ice-bath, sonication, freeze-thaw) 
combined with the extraction solvents MeOH, CHCl3 and CHCl3:MeOH (Table 15).  
To visualise the differences between extraction procedures, the aligned IS matrix from 
SpectConnect was analysed using PCA (Figure 8) in MetaboAnalyst. This plot 
condenses the data into three principle components and shows the total variation 
between samples as 53.9%. A clear separation was seen between CHCl3 and the other 
solvent types with 40.8% of the variation explained by PC1. Less variation was seen 
between MeOH and CHCl3:MeOH indicating these extraction solvents are more 
closely related. Strong clustering was observed within each solvent. No clustering was 




Figure 8: Principle component analysis (PCA) of metabolites extracted using different techniques and 
solvents. Plot generated from 288 peaks detected across all samples. Each ring represents the 
distribution of the three different solvents used.  
The results of the PCA were confirmed by analysis using ANOVA- Simultaneous 
Component Analysis (ASCA). 54.92% of the variation between samples can be 
explained by the technique in component 1 with sonication samples showing more 
variation than freeze thaw and ice bath (Figure 9a). 87.1% of the variation can be 
explained by the solvent used (Figure 9b) with CHCl3 less similar to MeOH and 
MeOH:CHCl3 extraction as seen in the PCA (Figure 8). 
 
Figure 9: ANOVA-Simultaneous Component Analysis (ASCA) scree plots showing major patterns 
associated with A) technique and B) solvent generated from total peaks detected across all samples.  
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The hierarchial heatmap (Figure 10) again shows a high statistical significance 
(p<0.05) between solvents (57 peaks), with less significance observed between 
technique (21). 
 
Figure 10: Hierarchial heatmap visualisation of the significanty different peaks (p<0.05), using 
identified peaks only, comparing each extraction protocol using a two-way between samples ANOVA 
in MetaboAnalyst. Clustering distance was measured using Euclidean and the clustering algorithm was 
ward. The samples are ordered by solvent; CHCl3, CHCl3:MeOH and MeOH from left to right 
respectively. 
Overall a total of 288 peaks were detected across the whole data series. Using the Golm 
Metabolome Database (GMD) and NIST library, a total of 158 peaks were identified 
(Level 2 [63]) with a match factor ≥60% with 130 remaining unassigned (Level 4 [63]). 
The identified compounds were classified according to their identification using 
GMD/NIST library as; acids, alcohols, hydrocarbons, amino acids/alcohols, aromatics, 
esters, ethers and ketones, fatty acids and fatty alcohols, heterocycles, N-compounds, 
other, sterols and sugars (and derivatives).  
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Peak numbers across MeOH and CHCl3:MeOH for all disruption techniques were 
similar, with peak identification of all CHCl3:MeOH protocols slightly higher overall. 
All CHCl3 extractions had the lowest peak detection and number of identifications. 
Sonication had the highest number of detected peaks with each solvent system (Figure 
11). 
 
Figure 11: Total number of peaks detected across all extraction protocols including number of identified 
and unassigned peaks.  
The different procedures extracted compounds of varying chemical classes. The non-
polar solvent CHCl3 extracted more non-polar compounds such as fatty acids and 
sterols. The polar protic solvent MeOH extracted a higher percentage of polar 





Figure 12: Number of identified peaks extracted from C. fritschii cells by chemical class for each 
extraction protocol.  
49 metabolites were identified with biological relevance to metabolic pathways within 
cyanobacteria including fatty acid and amino acid biosynthesis, galactose, fructose and 
mannose metabolism, glycerophospholipid metabolism to name a few. Four 
metabolites involved in fatty acid biosynthesis were extracted in all extraction 
protocols. Sugars involved in fructose, mannose, galactose and sucrose metabolism 
were extracted in MeOH and CHCl3:MeOH protocols. Whereas sugar alcohols 
involved in fructose and mannose metabolism were extracted in all solvents. Acyl 
glycerols involved in glycerolipid biosynthesis were extracted in CHCl3 protocols 
only.   
From these results, a biphasic liquid extraction protocol using CHCl3:MeOH coupled 
with sonication was chosen for subsequent experiments. A sonicator bath was replaced 
with a sonicator probe to ensure maximum cell disruption and extraction of 
metabolites. H2O added as a phase separator to enhance separation of polar and non-
polar phases. 
2.2.2 Axenic vs. xenic: Metabolite profiling of C. fritschii over 28 days  
Both axenic and xenic C. fritschii cultures were compared to determine any differences 
between the two culture conditions. In this work an axenic culture is defined as the 
cultivation of C. fritschii only (no contamination with other microorganisms) whereas 
a xenic culture refers to C. fritschii cultures grown with a small proportion of other 
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microorganisms such as other bacteria (as seen by streaking samples on nutrient agar). 
The analyses of metabolite levels of both axenic and xenic cultures were examined to 
see any major differences over 28 days of cultivation.  
The starting biomass concentration (mg L-1) was lower for axenic compared to xenic 
cultures due to its slower growth. Similar growth rates were measured overall between 
days 8 and 28 (axenic, µ = 0.233 ± 0.009; xenic, 0.234 ± 0.012, Figure 13). Differences 
in growth rate can be seen up to day 8 (Figure 14). A lag phase was observed with 
xenic cultures up to day 4 with a growth rate of µ = 0.55 ± 0.012 compared to the 
axenic cultures, µ = 0.88 ± 0.035 (0 vs. 4 d, p<0.01) this was followed by significant 
increase between days 4 and 8 in the xenic cultures (µ = 1.06 ± 0.098, p<0.01) 
compared to axenic cultures (µ = 0.78 ± 0.089, p>0.05).  
 
 
Figure 13: Dry weight of axenic and xenic C. fritschii cultures (n=3) during growth over 28 days under 
control conditions sampling at 0, 4, 8, 14, 20 and 28 days. Each data point is the mean value of biological 





Figure 14: Specific growth rate (µ) of axenic and xenic C. fritschii cultures between time points 
showing mean values ± SE. Significant difference was measured using a two-sample t-Test with equal 
variance comparing each time-point, * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001.  
Bulk carbohydrate and protein content was measured using the colourimetric sulfuric 
acid-phenol [89] and Lowry [87] method respectively. Results showed significant 
differences in carbohydrate content between days 4 and 8 in axenic cultures (p<0.05) 
with no significant difference in xenic cultures (Figure 15A). Protein levels remained 
steady throughout the time series with no significance in both axenic and xenic cultures 
(p>0.05) (Figure 15B). Comparing the two cultures, a statistical significance was 
observed at day 0 (p<0.05) and day 8 (p<0.001) for carbohydrate content but no 







Figure 15: (A) Bulk carbohydrate content of axenic and xenic C. fritschii cultures during 28 days of 
growth. (B) Bulk protein content of axenic and xenic C. fritschii cultures during 28 days of growth. 
Significant difference was measured using a two-sample t-Test with equal variance comparing each 
time-point and between treatments, * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001. 
2.2.2.1 Intracellular metabolites  
564 and 535 peaks were detected across the whole 28 day time-series in axenic and 
xenic cultures respectively. From axenic cultures 241 peaks were identified with a 
match factor ≥60% (level 2 [63]) with 323 remaining unassigned (level 4 [63]) whereas 
238 peaks from xenic cultures were identified with a match factor ≥60% (level 2) with 
297 peaks left unassigned (level 4).  
In axenic cultures, the greatest significant difference in metabolite levels (two-sample 
t-Test, p<0.05) was observed between 0 and 4 days with 93% of peaks decreasing in 
abundance (433 with negative log2 Fold Change (FC)). Significant difference in 
metabolite levels between time points decreased with increasing time. The lowest 
significant differences was calculated between 20 and 28 days with 93 peaks reducing 
in levels and 42 increasing in levels between the two time points (Table 16).  
In xenic cultures the greatest significant difference in metabolite levels was seen 
between days 0 and 4 with 95% of peaks decreasing in abundance (negative log2FC). 
The lowest significant difference was calculated comparing days 14 and 20 with the 




Table 16: Comparison of significantly different (p<0.05) peaks (out of 564) and number of those 
significantly different peaks with a positive or negative log2 Fold Change (FC) within axenic cultures. 
Both significant different and log2FC was calculated comparing between time points (d); 0 vs. 4, 4 vs. 
8, 8 vs. 14, 14 vs. 20 and 20 vs. 28. 
Axenic 
 (d) 
No. of peaks, 
p<0.05a 
No. of peaks, 
positive log2FC 
No. of peaks, 
negative log2FC 
0 vs. 4 466 33 433 
4 vs. 8 407 58 349 
8 vs. 14 183 113 70 
14 vs. 20 141 60 81 
20 vs. 28 135 42 93 
a = Significant difference was calculated using a two sample t-Test with equal variance.  
 
Table 17: Comparison of significantly different (p<0.05) peaks (out of 535) and number of those 
significantly different peaks with a positive or negative log2FC within xenic cultures. Both significance 
and log2FC was calculated comparing between time points (d); 0 vs. 4, 4 vs. 8, 8 vs. 14, 14 vs. 20 and 
20 vs. 28. 
Xenic 
 (d) 
No. of peaks, 
p<0.05a 
No. of peaks, 
positive log2FC 
No. of peaks, 
negative log2FC 
0 vs. 4 181 10 171 
4 vs. 8 177 163 14 
8 vs. 14 170 50 120 
14 vs. 20 131 86 45 
20 vs. 28 151 37 114 






The peak lists were further analysed using PCA. The normalised abundance data (by 
dry weight and internal standard) was further processed in MetaboAnalyst by 
normalising by the sum followed by log transformation and Pareto scaling. Total 
variance was calculated as 38.8% (PC1 17%, PC2 11.8% and PC3 10%) for axenic 
cultures. Clustering of peaks was observed between day 0, 4 and 8 with separate 
clustering of day 14 and 20 across PC1. Day 28 showed most separation compared to 
each time point (Figure 16A). Total variance for xenic cultures was calculated as 
42.8% (PC1 16.1%, PC2 15.6% and PC3 11.1%). Clustering of peaks by replicates 
was observed with good separation of time points (Figure 16B). 
 
Figure 16: PCA of detected peaks over 28 days from A) axenic and B) xenic C. fritschii cultures. Each 
ring represents distribution of replicates from each time points. Samples from axenic day 4 (S2), 8 (S1) 
and 28 (S3) and xenic day 4 (S1), 14 (S3) and 28 (S3) have been omitted. Data was normalised by sum, 
log transformed with Pareto scaling.  
Peak matrices for both axenic and xenic cultures were analysed for significant 
differences using a one-way ANOVA. 100 peaks were found to be significantly 
different (p<0.05) across the whole time-series in axenic cultures with 22 remaining 
significant after Bonferroni (BF) correction. This correction was chosen to adjust the 
p values (by multiplying by number of tests, k, in this case 137) thus reducing the 
amount of false-positives due to the multiple analysis of a single data set [44,102]. 135 
peaks with significant difference (p<0.05) across the whole time-series were found in 
xenic cultures, 14 of those remained significant after BF correction.  
A total of 70 metabolites were identified within the two data sets with biological 
relevance to cyanobacterial metabolism 73% (51) of those were identified in both 
axenic and xenic cultures. 27% (19) were different between the two with 11 found 
exclusively in axenic cultures (Table S1) and 8 from xenic cultures only (Table S2). 
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The greatest significant difference in metabolite levels was seen within the first 4 days 
between axenic and xenic cultures with 34 significantly different metabolites (axenic 
vs. xenic, 0 vs. 4 d) this then decreased with increasing time to a minimum of 7 
significantly different metabolites comparing days 14 and 20 (axenic vs. xenic, Table 
18). Overall axenic cultures showed more significant differences between time points 
compared to xenic cultures, but little differences were observed after 4 days comparing 
axenic and xenic results (Table 18).  
Table 18: Number of significantly different (p<0.05) biologically relevant metabolite levels from 
axenic and xenic cultures including comparison between the two. Significant difference was calculated 
between axenic and xenic by comparing log2FC between the time points (d); 0 vs. 4, 4 vs. 8, 8 vs. 14, 
14 vs. 20 and 20 vs. 28. 
Days (d) No. of axenic 
peaks, p<0.05a 
No. of xenic peaks, 
p<0.05a 
No. of peaks 
p<0.05a, axenic vs. 
xenic 
0 vs. 4 46 20 34 
4 vs. 8 34 28 11 
8 vs. 14 14 21 8 
14 vs. 20 12 9 7 
20 vs. 28 15 19 11 
a = Significant difference was calculated using a two sample t-Test with equal variance.  
The % composition of all detected metabolites over the 28 days was very similar 
between the two cultures (Figure 17A and Figure 18A).  
Axenic and xenic cultures detected 13 and 12 amino acids respectively across the 
whole time-series with varying abundances and significance. These included the 
hydrophobic aliphatic; alanine (ala), isoleucine (ile), and valine (val), the hydrophic 
aromatic; phenylalanine (phe) and tyrosine (tyr), the polar neutral; serine (ser) and 
threonine (thr), the acidic-polar; aspartate (asp) and glutamate (glu) the basic-polar; 
arginine (arg) and lysine (lys) as well as glycine (gly) and proline (pro). 
Six (6, axenic and xenic) metabolites were found to be involved in fatty acid 
biosynthesis with 9 (axenic) and 7 (xenic) involved in sugar metabolism with 3 
identified metabolites involved in the tricarboxylic acid (TCA) cycle in both cultures.  
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Differences in axenic cultures included the amino acid ile and tyr as well as the sugars 
mannose, fructose and galactose (Figure 17). Difference in xenic cultures included ala 
and glucose to name a few (Figure 18). 
 
Figure 17: Overview of biologically relevant metabolites detected, at each time-point combined, in 
axenic cultures over the whole time-series of 28 days. A) Overall % composition of detected metabolites 
by chemical class. B, C, D and E) Identified metabolites by class as acids (involved in TCA), amino 
acids, fatty acids and sugars (and derivatives) over the whole time-series. Metabolites in bold were 





Figure 18: Overview of biologically relevant metabolites detected at each time-point combined, in 
xenic cultures over the whole time-series of 28 days. A) Overall % composition of detected metabolites 
by chemical class. B, C, D and E) Identified metabolites by class as acids (involved in TCA), amino 
acids, fatty acids and sugars (and derivatives) over the whole time-series. Metabolites in bold were 











2.2.3 Metabolite profile of C. fritschii over 120 days  
A long term experiment was conducted over a 120 day time-series to analyse the 
changes in metabolite levels during the growth of C. fritschii. Samples were harvested 
every 8 days for 120 days from three separate flasks (biological replicates, n=3) and 
metabolite profiles analysed. As expected, significant differences in dry weight 
comparing day 0 and each time point was observed (day 0 vs. 16 up to 120, p<0.05, 
Figure 19). Less significant difference in dry weight values was seen between time 
points and was only observed comparing day 8 vs.16 (p<0.05), 16 vs. 24 (p<0.01) and 
24 vs. 40 (p<0.001).  
 
Figure 19: Dry weight of C. fritschii cultures (n=3) during growth over 120 days under control 
conditions sampling every 8 days between 0 and 120 days, day 32 data omitted. Each data point is the 
mean value of biological triplicates ± SE.  
Triplicate flasks had similar dry weight values up to day 40. After this, an increased 
SE was calculated between the replicates (Figure 20). All GC-MS data was 




Figure 20: Dry weight of individual C. fritschii cultures during growth over 120 days under control 
conditions sampling every 8 days between 0 and 120 days, day 32 data omitted. Each data point is the 
dry weight value of each flask. Graph phases are represented by: (1) Phase 1, (2) phase 2 and (3) phase 
3.  
Intracellular metabolite level changes  
GC-MS was used to analyse metabolite level changes during the different growth 
phases of C. fritschii over 120 days, sampling every 8 days. Due to the large amount 
of data produced over the time-series only identifiable peaks were investigated (match 
factor ≥60%, level 2).  A total of 369 were identified. One-way ANOVA revealed 277 
peaks which were significantly different (p<0.05) across the whole time-series with 95 
of those remaining significant after BF correction. In general, the majority of identified 
peak levels reduced significantly comparing day 0 with each time point (t-Test 
p<0.05). Highest significant difference was calculated at day 80 (174 peaks) followed 
by day 112 (154 peaks) and day 120 (160 peaks). t-Test results between time points 
revealed highest significant differences in metabolite levels between days 32 and 40 
with a total of 89 peaks. 48 of those reduced significantly with 41 increaing 
significantly. Comparing days 56 and 64, 79 peaks showed significant difference in 
normalised abundances with 39 peaks decreasing significantly and 40 increasing 
significantly in levels. Lowest significant difference was calculated between days 16 
and 24 (total of 44 peaks) with 21 increasing significantly and 23 peaks reducing 
significsntly in levels.  
PCA revealed a total variance of 37.3% (PC1 = 24.3%, PC2 = 7.7% and PC3 = 5.3%) 
with good clustering of time points by replicates. Day 48 (sample 3) and day 104 
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(sample 3) were omitted from analysis as anomalies. Separation can be seen across 
PC1 with increasing time. Separation between days 0 to 56 and 64 to 120 was observed 
(Figure 21).   
 
Figure 21: PCA of identified peaks (367) over 120 days from C. fritschii cultures. Samples from day 
48 (S3) and 104 (S3) have been omitted. Data was normalised by sum, log transformed with Pareto 
scaling.  
55 metabolites were identified overall with biological relevance to cyanobacterial 
metabolism (Table S3). Metabolites were classified according to chemical class as; 
acids, alcohols, amino acids, aromatics, fatty acids and sugars involved in a variety of 
metabolic pathways (Figure 22).  The highest percentage of chemical class detected 
was acids (25%). This included the four TCA metabolites fumarate, malate, citrate and 





Figure 22: Overview of biologically relevant metabolites detected at each time-point combined, over 
the whole time-series of 120 days. A) Overall % composition of detected metabolites by chemical class. 
B) Overall % of metabolites identified as acids by associated pathway. C, D, E and F) Identified 
metabolites by class as acids (involved in TCA), amino acids, fatty acids and sugars (and derivatives) 
over the whole time-series.  
 
Overall, the number of detected biologically relevant metabolites increased with 
increasing time (Figure 23). Acids detected increased with time, with highest values 
at days 88, 112 and 120. The number of metabolites classified as alcohols remained 
steady throughout the time-series. The fatty acids detected increased at day 56 (9 
detected) and remained consistent until the end of the time-series. Sugars and 
derivatives also increased in numbers with time with the exception of days 56 to 72. 
Amino acids numbers varied with the highest numbers at day 32 (5) with a decrease 




Figure 23: Composition of identified biologically relevant metabolites over time by chemical class.  
45 biologically relevant metabolites were found to be significantly different after one-
way ANOVA (p<0.05) with 25 remaining significant after BF correction. Only ~18% 
of metabolites were consistently identified across the whole time-series.  
Malate and succinate, involved in the TCA cycle, showed an initial increase in levels 
on day 8 (0 vs 8 d, p<0.01) and day 16 (0 vs 16 d, p<0.001) respectively. This was 
followed by a decreasing trend over time Figure 24). 
 
Figure 24: Metabolites involved in TCA cycle identified using GC-MS presented as mean values of 
normalised abundance ± SE. Statistical significanct difference comparing day 0 to each time point (not 
displayed) as well as between time points was measured using a two sample t-Test with equal variance; 




Metabolites involved in amino acid biosynthesis (Figure 25) had varying detection 
and changes in levels over time. Glu increased significantly up to day 40 (0 vs 8, 16 
and 40 d, p<0.05) whereas a significant decrease was measured up to 112 days (0 vs. 
64, 72, 80, 88, 96 and 112 d, p<0.05).  Lysine (lys) accumulation was seen at day 104 
(96 vs. 104 d, p<0.05), with val levels increasing significant at days 40 (0 vs. 40 d, 
p<0.01) and 64 (0 vs. 64 d, p<0.05) followed by a decrease in levels with time (64 vs. 
120 d, p<0.05). Asp levels decreased significantly (0 vs. 96 d, p<0.01). Phe increased 
in normalised abundance in the first 8 days (0 vs. 8, p<0.01), no significant changes 
were calculated up to day 48; phe was not detected from day 56 to 120. Benzoic acid 
was detected with accumulation at day 56 (48 vs. 56 d, p<0.05) followed by a decrease 
in levels after 120 days (112 vs. 120 d, p<0.05).  
 
Figure 25: Metabolites involved in amino acid biosynthesis identified using GC-MS presented as mean 
values of normalised abundance ± SE. Statistical significance comparing day 0 to each time point (not 
displayed) as well as between time points was measured using a two sample t-Test with equal variance; 
* = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001. 
The shorter chained saturated fatty acids (Figure 26); caprylic (C8:0) and capric 
(C10:0) were detected from day 56 only. They showed similar patterns of significant 
accumulation up to day 120 (0 vs. 120 d, caprylic acid p<0.05, capric acid p<0.001). 
A similar pattern was observed for lauric acid (C12:0) but levels were detected during 
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days 0 to 40, an overall decrease in levels was calculated (0 vs. 120 d, p<0.01).  The 
longer chained saturated fatty acids (Figure 26); mystiric acid (C14:0), palmitic acid 
(C16:0), stearic acid (C18:0) and eicosanoic acid (C20:0) all showed similar patterns 
of decreasing levels (0 vs. 120 d, p<0.05). The unsaturated palmitoleic acid (C16:1) 
and oleic acid (C18:1) significantly increased in normalised abundance (0 vs 8 d, 
p<0.05 and 0 vs. 24 d, p<0.05 respectively). 
 
Figure 26: Metabolites involved in fatty acid biosynthesis identified using GC-MS presented as mean 
values of normalised abundance ± SE. Statistical significance comparing day 0 to each time point (not 
displayed) as well as between time points was measured using a two sample t-Test with equal variance; 
* = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001. 
The sugar sorbose had an initial increase in levels (0 vs. 24 d, p<0.01) followed by a 
decrease after day 96 (96 vs. 104 d, p<0.05). Galactose also had an initial increase after 
8 days (0 vs. 8 d, p<0.05) with an overall decrease in normalised abundance (0 vs. 32 
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to 120 d, p<0.05). Fructose had an overall accumulation with increasing time (0 vs. 
80, 88, 112 and 120 d, p<0.01). Sucrose, raffinose and trehalose levels remained 
relatively consistent throughout. The alcohol glycerol showed decreasing levels 
throughout (0 vs. 8 to 120 d, p<0.01) with glycerol 3-phosphate levels accumulating 
compared to day 0 (0 vs. 24, 32, 40, 72, 80, 96, 104 and 120 d, p<0.05) (Figure 27). 
 
Figure 27: Metabolites involved in sugar biosynthesis identified using GC-MS presented as mean 
values of normalised abundance ± SE. Statistical significance comparing day 0 to each time point (not 
displayed) as well as between time points was measured using a two sample t-Test with equal variance; 






2.2.4 Time-series analysis of C. fritschii over 48 h  
A time-series analysis over 48 h was then undertaken to analyse the short-term changes 
in metabolite levels as measured by GC-MS. This experiment was also used as a 
control for standard growth conditions (PAR only) comparing to the UV exposure 
experiments (UV-B + PAR and UV-A + PAR, Chapter 3). 
 The dry weight (Figure 28) during the time-series was measured and an increase was 
observed after 48 h with a significant increase as measured by a two-sample t-Test 
(p<0.05, 0 vs. 24 h).  
 
Figure 28: Dry weight of C. fritschii cultures (n=3) during growth over 48 h under control conditions 
sampling at 0, 2, 6, 12, 24 and 48 h. Each data point is the mean value of biological triplicates ± SE.  
2.2.4.1 Intracellular metabolite level changes  
At each time point, samples were extracted using the optimised extraction protocol 
above (Section 2.2.1) and analysed using GC-MS. 169 peaks were detected with 137 
peaks identified as ‘true hits.’ Of those 137 peaks, 70 were putatively identified (match 
factor ≥ 60%, level 2) and 67 left unassigned (match factor <60%, level 4).   
A two-sample t-Test with equal variance was used to evaluate the significant 
differences of normalised metabolite level changes comparing 0 h to each time-point 
(2, 6, 12, 24, and 48 h). Overall 76 peaks showed significance (p<0.05) between one 
or more time point with 22 peaks remaining significant (p<0.05) after BF correction.  
Twenty-four (24) h had the highest significant difference with 35 statistically 
significant peaks (0 vs. 24 h, p<0.05), 71% of those had elevated levels (positive log2 
FC) whereas 29% reduced in levels (negative log2FC, Table 19). This is consistent 
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with the dry weight values (Figure 28) where a significant increase in biomass was 
observed after 24 h (0 vs. 24 h, p<0.05).  
Table 19: Comparison of significantly different (p<0.05) peaks (out of 137) and number of those 
significantly different peaks with a positive or negative log2FC during PAR only exposure. A positive 
log2FC indicates an increase in metabolite level and a negative log2FC value indicates a decrease in 
metabolite level. Both significance and log2FC was calculated comparing control (0 h) and 2, 6, 12, 24 
and 48 h of PAR only exposure. 
PAR only 
 (h) 
No. of peaks, 
p<0.05a 
No. of peaks, 
positive log2FC 
No. of peaks, 
negative log2FC 
0 vs. 2 20 18 2 
0 vs. 6 11 4 7 
0 vs. 12 26 21 5 
0 vs. 24 35 25 10 
0 vs. 48 32 24 8 
a = Significant difference was calculated using a two-sample t-Test with equal variance.  
 
38 key primary metabolites were detected and identified during the time-series (20 
highlighted for simplicity, Figure 29) which are involved in cyanobacterial 
metabolism including; the pentose phosphate pathway, glycolysis, TCA, amino acid 




Figure 29: Schematic representation of a generalised reduced carbon metabolism in the cyanobacterium 
C. fritschii showing glycolysis, TCA cycle, amino acid and fatty acid biosynthesis. Primary metabolites 
identified in intracellular samples using GC-MS are highlighted in orange. 
12 proteinogenic amino acids were detected during the 48 h time series. Five amino 
acids showed statistically significant accumulation; glu (0 vs. 12, p<0.01; 0 vs. 24 h, 
p<0.05; 0 vs. 48 h p<0.05), methionine (met, 0 vs. 12 h, p<0.001), asp (0 vs. 48 h, 
p<0.05), tyr (0 vs. 2 h, p<0.01; 0 vs. 12 h, p<0.001; 0 vs. 24 h, p<0.05; 0 vs. 48 h 
p<0.001) and lys (0 vs. 2 h, p<0.05; 0 vs. 12 h, p<0.001; 0 vs. 24 h, p<0.05; 0 vs. 48 h 
p<0.001). Tyr and lys also showed significance after BF correction (Tyr: 0 vs. 12 h, 
BF p<0.05; 0 vs. 48 h, BF p<0.001 and lys 0 vs. 48 h, BF p<0.01).  
Three of the 12 amino acids showed decreasing levels throughout the time series 
comparing 0 h with each time point including; phe (0 vs. 24 h, p<0.01; 0 vs. 48 h, 
p<0.05), leu (0 vs. 24 h, p<0.05) and ile (0 vs. 24 h, p<0.01). 
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Ala, thr, ser and gly showed steady metabolite levels with no statistical significance 
(p>0.05).  
 
Figure 30: Metabolites involved in amino acid biosynthesis identified using GC-MS presented as mean 
values of normalised abundance ± SE. Statistical significance comparing 0 h to each time point as well 
as between time points was measured using a two sample t-Test with equal variance; * = 0.05>p≥0.01, 
** = 0.01>p≥0.001 and *** = p<0.001.  
Six sugars were identified during the time-series (Figure 31), glucose accumulation 
was seen after 2 h (0 vs. 2 h, p<0.01) with a decrease in levels after 24 h (2 vs. 24 h, 
p<0.01). Sorbose levels were similar to glucose where an accumulation was observed 
after 2 h followed by a decrease after 24 h (0 vs. 2 h, p<0.05; 2 vs. 24 h, p<0.05). 
Sucrose accumulated after 2 h (0 vs. 2, p<0.01) with levels remaining steady with 
increasing time. Rhamnose showed a decrease in normalised abundance after 6 h, 24 
h and 48 h which remained significant after BF correction (0 vs. 6, p<0.001; 0 vs. 24, 
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p<0.001; 0 vs.48 h, p<0.001). Fructose and trehalose levels remained constant 
throughout with no significant changes (p>0.05). The sugar-phosphate, mannose-6-
phosphate accumulated after 24 and 48 h and also remained significant after BF 
correction after 48 h (0 vs. 24, p<0.05; 0 vs.48 h, p<0.001, BF p<0.01). 
The sugar acid glycerate increased in levels after 2 and 12 h (0 vs. 2, p<0.01; 0 vs. 12, 
p<0.001, BF p<0.05). Glycerol-3-phosphate, a phosphoric ester of glycerol, decreased 
in normalised abundance after 24 and 48 h (0 vs. 24 h, p<0.05; 0 vs. 48 h p<0.05). 
 
Figure 31: Metabolites involved in sugar biosynthesis identified using GC-MS presented as mean 
values of normalised abundance ± SE. Statistical significance comparing 0 h to each time point as well 
as between time points was measured using a two sample t-Test with equal variance; * = 0.05>p≥0.01, 
** = 0.01>p≥0.001 and *** = p<0.001. 
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Two metabolites were identified as being involved in TCA cycle (Figure 32), a 
significant accumulation of malate was seen after 48 h (0 vs. 48 h, p<0.01) whereas no 
significant changes in citrate levels were observed (p>0.05). 
 
Figure 32: Metabolites involved in the TCA cycle identified using GC-MS presented as mean values 
of normalised abundance ± SE. Statistical significance comparing 0 h to each time point as well as 
between time points was measured using a two sample t-Test with equal variance; * = 0.05>p≥0.01, ** 
= 0.01>p≥0.001 and *** = p<0.001.  
The fatty acids stearic and palmitic acid (Figure 33) had steady levels throughout with 
no significance (p>0.05). 
 
Figure 33: Metabolites involved in fatty acid biosynthesis identified using GC-MS presented as mean 
values of normalised abundance ± SE. Statistical significance comparing 0 h to each time point as well 
as between time points was measured using a two sample t-Test with equal variance; * = 0.05>p≥0.01, 





2.3  Discussion 
This chapter presents an overview of the metabolites detected and identified using GC-
MS over a variety of time-series during standard growth conditions (27 °C with 
continuous PAR at 15 µmol m-1 s-1). Metabolite level changes were investigated and 
the differences between axenic and xenic cultures were explored.   
Firstly, the extraction protocol was investigated. Unbiased characterisation of 
metabolites is difficult within metabolomics due to the chemical complexity within 
biological systems [45]. Results showed that solvent type was the main factor to 
consider when extracting metabolites. The more polar solvent MeOH extracted polar 
metabolites and non-polar CHCl3 extracting non-polar metabolites. These results 
confirmed that CHCl3:MeOH was the best combination of solvent to extract the most 
variety of metabolites. By adding H2O, phase separation was possible to easily decant 
the same volume of both layers for GC-MS analysis, this step was added in further 
experimental extractions. For cyanobacteria, a suitable disruption technique is also 
required to break down the cell wall. Analysis of sonicated samples showed increased 
number of detected peaks throughout. Compared to the other disruption techniques 
(ice-bath and freeze-thaw), sonication was seen as a more aggressive form of 
disruption to break down the cell wall. As consistency is important in metabolomics 
analysis, the same procedure was used in all subsequent experiments using 
CHCl3:MeOH:H2O with sonication (probe).  
During this research, one of the main bottlenecks was the low biomass production and 
difficulty in maintaining axenic C. fritschii cultures. For the true metabolome to be 
identified, monocultures need to be analysed. In industrial biotechnology, cultivation 
of cyanobacteria and other microalgal species at large scale increases the risk of 
contamination. Cyanobacteria form symbiotic relationships with other bacteria that 
can increase growth and has potential in biotechnology by producing novel industrially 
relevant metabolites [4]. Exclusion of bacterial communities would not reflect the 
situation more closely related to their natural environment and could cause additional 
stress [94]. Metabolite production in both axenic and xenic cultures was therefore 
examined to observe any differences in growth, bulk carbohydrate, protein and 
metabolite identification over 28 days of growth.  
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Initial biomass concentration was greater in xenic cultures due to their higher 
productivity in pre-experimental cultivation. Growth rate showed differences up to day 
8 but were similar between the two cultures from day 8 to 28 (Figure 13 and Figure 
14). Carbohydrate levels also differed up to day 8 with no significance observed in 
protein levels. Although axenic cultures detected more peaks overall during GC-MS 
analysis, 73% of biologically relevant metabolites were identified in both cultures. 
These metabolite levels differed significantly between the first 4 days (axenic vs. 
xenic) but significance reduced with increasing time. Overall composition was very 
similar between the two with differences including the amino acids ile, tyr (axenic 
only) and ala (xenic only) as well as the sugars mannose, fructose and galactose 
(axenic only) and glucose (xenic only). These differences were due to missing data 
points in either axenic or xenic cultures. Missing values in GC-MS analysis is a 
common drawback [103]. Within these biological experiments, missing values are 
assumed to be below detection limit.  
The overall similarity in both cultures could indicate the low impact of additional 
microorganisms to the culture after the first 8 days with C. fritschii remaining the 
dominant species within the flask (evaluated using microscopic analysis). Variation in 
the first 8 days could be due to the inevitable varying growth of C. fritschii from 
separate cultures. These results could also indicate the contamination of axenic 
cultures after day 8. Further work into the characterisation of the specific 
microorganisms present within C. fritschii cultures, using a combination of 
metabolomics, metagenomics and transcriptomics [4],  should be considered followed 
by controlled co-culture experiments to determine contributions to the metabolites 
detected [104].  
Cyanobacterial growth relies on light to drive photosynthesis and nutrient levels and 
space within culture vessels. Typical growth profiles consist of an initial lag phase, 
exponential phase (cell proliferation), stationary phase, and declining phase [105]. 
Metabolites have varying levels during these different growth phases as seen in the 
diatom Skeletonema marinoi [94], green microalga Chlorella sorokiniana [106] the 
marine roseobacter Pharobacter gallaeciensis DSM 17395 [107] and the 
cyanobacterium Synechococcus elongates PCC 7942 [108].  
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Increasing SE bars can be explained by the inconsistent dry weight measurements 
between the replicate flasks (Figure 20) where flask 3 began to decline and had lower 
dry weight values overall after day 40. 
A pattern between days 0 to 48 (phase 1), 56 to 104 (phase 2) and 112 to 120 (phase 
3) can be seen within the growth curve (Figure 19 and Figure 20). This could 
correspond to the different cyanobacterial growth phases as lag, exponential and 
stationary phases. The composition of biologically relevant metabolites detected over 
the whole time-series (Figure 23) also shows a pattern associated with this grouping 
of days. This can also be seen within individual metabolite level changes such as; 
succinate (Figure 24), phe, benzoic acid (Figure 25), caprylic aicd, capric acid and 
lauric acid (Figure 26).  
In lag phase, growth is low while cells prepare for exponential phase. TCA substrates 
and amino acids (glu, val, asp and phe) accumulate to prepare for cell proliferation 
[108]. Amino acids are required for protein synthesis and formation of nitrogen 
containing metabolites as indicated by a decrease in levels. Phe was undetected after 
day 48, possibly due to the conversion to benzoic acid, a precursor to many essential 
compounds and natural products, which accumulated at day 56 [109].  
Many identified metabolites have potential uses in biotechnology including glycolic 
acid, lactic acid, pyruvic acid, succinate, malate and fumarate and adipic acid which 
can be expoited as platform chemicals [110]. Bioactive metabolites will be explored 
further in Chapter 5.   
As seen in the axenic vs. xenic experiment, many metabolites were not identified 
within all time-points. Intracellular metabolites have a high turnover rate. With a gap 
of 8 days between each sampling point much biological data is lost and difficulties are 
presented in biological interpretation. Sampling more frequently within this time frame 
of 8 days would be more beneficial, increasing sampling points increases the 
complexity of data analysis as seen within this 120-day experiment. From an industrial 
biotechnology perspective, the identification of a variety of metabolites is essential for 
understanding the production of potential relevant metabolites for industry over the 
growth of C. fritschii and for further investigations during stress conditions which will 
be discussed in more detail throughout the remaining chapters. This study presents the 
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first metabolomic data set for C. fritschii as measured by GC-MS over a long growth 
period and a good base platform for further systems biology investigation.  
Time-series metabolomics is becoming more common to evaluate changes in 
metabolite levels over time and to allow better insight into the physiology of the cells 
[111]. As seen in the previous experiment the correct sampling points are needed for 
relevant biological interpretation due to the high turnover rates of intracellular 
processes.   
The limited statistical significance in metabolite levels reflects the slow growth of C. 
fritschii over a short time-series of 48 h indicating little changes in metabolism during 
standard growth conditions. The majority of significant metabolites increased in levels 
preparing cells for further exponential growth (Table 19) [108].  
This experimental analysis will be used as a control for the UV exposure experiments 
in Chapter 3.  
 
2.4 Conclusion 
During the course of this research, a more realistic approach was taken to use unialgal 
cultures (other microorganisms may be present in small amounts), because the 
presence of other microorganisms would have a limited effect on the metabolites 
produced as seen in the axenic vs. xenic experiment and would not produce the chosen 
targeted metabolites MAAs (target analysis in Chapter 3 and 4).  
Metabolite level changes during 48 h showed little significant differences as expected 
in this short timescale. Combination of long-term analysis with shorter term samplings 
at each growth phase would give a better insight in the changes in metabolite levels. 
Analysing the metabolite levels can help to characterise the observable phenotype and 
production of useful industrially relevant metabolites over a time-series. This data can 
be used to further investigate C. fritschii with other –omic techniques including flux-






Chapter 3: Intracellular and Extracellular Metabolite Level 
Changes of Chlorogloeopsis fritschii, PCC 6912, During 
Ultraviolet (UV) A and UV-B Exposure  
Aims  
• To optimise a HPLC method (mobile and stationary phase optimisation) for the 
analysis of MAAs using macroalgal extracts with known MAA compositions.  
• To analyse the intracellular untargeted metabolite profile of C. fritschii using GC-
MS during supplemented UV-B (PAR + UV-B) or UV-A (PAR + UV-A) over a 
48 h time-series.  
• To analyse extracellular low molecular weight compounds from C. fritschii using 



















The effect of UV radiation on cyanobacteria has been widely researched including the 
interaction with biomolecules, production of ROS which cause oxidative stress, 
impaired growth, partial inhibition of photosynthesis and decreased enzyme activity 
[24,25,112]. UV radiation also has a role as an activator of secondary metabolite 
production such as MAAs [23] and other protective secondary metabolites [28]. Many 
studies have been conducted to identify these targeted intracellular metabolites during 
UV-B and UV-A exposure in Lyngbya sp. CU2555 [49], Nostoc commune [64], 
Anabaena variabilis PCC 7937 [65], Calothrix sp. [10] and C. fritschii PCC 6912 [48]  
to name a few. Other studies conducted have sought to evaluate changes at the protein 
level [113,114], targeted and untargeted metabolomic analysis using different 
intensities of UV-B [99] and combined metabolomic and proteomic analysis during 
UV-A exposure [52].  
Cyanobacteria convert CO2 into reduced carbon which forms the backbone of 
metabolites and are central to life. Like many other microorganisms, cyanobacteria 
release these carbon-based primary and secondary metabolites into their surrounding 
area which drives carbon cycling within microbial communities [54,115]. These 
released metabolites are by-products of metabolism within cells and make up a small 
proportion of the dissolved organic matter (DOM) pool within freshwater and marine 
ecosystems [54]. Consisting of a variety of chemical compositions such as; 
polysaccharides, proteins, lipids, organic compounds or inorganic molecules, they are 
released for communication, structural organisation, and defence against biotic and 
abiotic factors [115–117]. The uptake and release of metabolites change with varying 
environments; examples include the release of exopolysaccharides during high light 
and UV radiation [64,118].  
Monitoring industrially relevant metabolites released by microorganisms into their 
surroundings is a widely used technique in the fermentation industry. It can be used in 
bioprocess monitoring, fermentation biomarker identification, for monitoring 
metabolite levels in fermentation processes and microbial contamination [68,69].  
Combining intracellular and extracellular analysis is useful in the study of 
cyanobacteria providing a more holistic picture of metabolite production during 
growth and its response to different environmental conditions [69,70]. Metabolite 
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profiling can be used to view the physiological changes at the metabolite level in 
response to changing environments and is a useful tool in cyanobacterial research [43].  
Little work has been undertaken on monitoring both intracellular and extracellular 
metabolites in cyanobacteria. It is important to investigate the changes in primary 
metabolites in order to understand secondary metabolite production. Manipulating 
abiotic stress such as UV radiation can be used to enhance production of useful 
metabolites for uses in industrial biotechnology [16,21,22].  
In this chapter, we observe the changes in metabolites produced by C. fritschii during 
48 h of UV-A and UV-B exposure as detected by GC–MS. We were able to identify 
metabolites with altered levels comparing UV-B (PAR + UV-B) and UV-A 


















3.1 Experimental design  
3.1.1 MAA HPLC method development  
See Section 1.4 for the HPLC method development for the detection of MAAs.  
3.1.2 UV-B exposure over 48 h 
After 6 days of pre-growth (Section 1.1), triplicate experimental C. fritschii cultures 
were transferred into three Quartz Erlenmeyer flasks (H. Baumbach & CO. LTD, 
Suffolk) at an OD750nm of approx. 0.14 to allow even UV-B exposure. The cultures 
were exposed to a total of 48 h of UV-B radiation using a UVB broadband (290-315 
nm, centered at 310 nm) fluorescent tube (Philips TL 20W/12 RS SLV/25, Proflamps) 
emitting 3 µmol m-2 s-1 of UV-B radiation (measured using a UVR light sensor, 
Enviromonitors, UK). The experiment was carried out under continuous PAR at 15 
µmol m-2 s-1 and shaking at 100 rpm for even UV-B exposure of cells. For time- series 
analysis samples were harvested at no UV-B (0 h), 2, 6, 12, 24 and 48 h for dry weight 
(Section 1.2), pigment (Section 1.5.1), MAA (Section 1.4.2-1.4.3) and GC-MS 
analysis (Sections 1.3.2 – 1.3.6). 
3.1.3 UV-A exposure over 48 h 
After 6 days of pre-growth (Section 1.1), triplicate experimental C. fritschii cultures 
were transferred into three Quartz Erlenmeyer flasks (H.Baumbach & CO.LTD, 
Suffolk) at an OD750nm of approx. 0.16 to allow even UV-A exposure. UV-A was 
supplied by a Philips TL-D 18 W black light blue fluorescent tube (315-400 nm, 
centred at 360 nm) emitting 11 µmol m-2 s-1 (measured using a UVR light sensor, 
Enviromonitors, UK). The experiment was carried out under continuous PAR at 15 
µmol m-2 s-1, a temperature of 27 ± 2 °C and shaking at 100 rpm for even UV-A 
exposure of cells. For time-series analysis samples were harvested at no UV-A (0 h), 
2, 6, 12, 24 and 48 h for dry weight (Section 1.2), pigment (Section 1.5.1), MAA 





3.2 Results  
3.2.1 Method development for the detection of mycosporine-like amino acids 
(MAAs) using High Performance Liquid Chromatography (HPLC). 
Method optimisation for extracts with known MAA content was evaluated using the 
macroalgae, P. palmata due to its accumulation of the MAAs; shinorine, pathythine, 
porphyra, usijurene and palythene in high concentrations under natural sunlight. This 
optimised method was then used for the detection of MAAs in C. fritschi in subsequent 
experiments.  
3.2.1.1 Mobile and stationary phase optimisation 
TFA is a common ionic mobile phase additive, three concentrations were chosen to 
evaluate the lowest amount needed for good separation of peaks by calculating 
resolution (Rs, Figure 34A) and repeatability using relative standard deviation 
between technical replicates (RSD %, Figure 34B). The results showed little 
difference between 0.06% and 0.01% TFA with a higher Rs between peaks 3 and 4 
(asterina and porphyra-334 respectively) using 0.06% TFA and a higher Rs between 4 
and 5 (porphyra-334 and palythinol respectively) using 0.01% TFA. The lowest Rs 
was seen using 0.001% TFA. The RSD% between replicates (n=5) showed 0.01% TFA 
to have better repeatability. A concentration of 0.01% was therefore chosen as all of 
the peaks were eluted with a good separation and good repeatability. 
 
 
Figure 34: A) Resolution factor (Rs) between MAA peaks detected separated using the three different 
compositions of eluent A and B) Relative standard deviation (RSD %) of the detected MAA peak areas 
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for the three compositions of eluent A. Peak no: 1 = shinorine; 2 = palythine; 3 = asterina; 4 = 
porphyra-334; 5 = palythinol. 
Six different reverse phase (RP) columns were used to evaluate the resolution of peaks 
separated from crude extract 1 using varying column lengths and stationary phases; 
A) Alltima® Altech RP C18 column (5 µm, 4.6 x 150 mm); B) SynergiTM  Fusion RP 
C18 column (4 µm, 4.6 x 150 mm, 80 Å); C) Hichrom RP ACE excel super-C18 
column (3 µm, 4.6 x 250 mm, 80 Å); D) Hichrom RP ACE excel C18- Amide column 
(3 µm, 4.6 x 250 mm, 100 Å), E) Hypercarb® RP C30 column (5 µm, 4.6 x 100 mm, 
250 Å) and F) Develosil® C30-UG column (5 µm, 4.6 x 250 mm, 140 Å).  
Only two columns (Figure 35A/2C) separated all peaks with good Rs (Table 20) and 
high repeatability, with RSD% less than 5 for all peaks (Table 21). The best Rs was 
seen with ACE excel Super C18 column (C) with a length of 250 mm and a smaller 
particle size of 3 µm. Although the Rs is larger, the run time would need to be increased 
due to the final peak eluting at 25 min just before the equilibrating processes begins. 
Column A was therefore chosen as the Rs was still acceptable along with good 
repeatability and all peaks were eluted before the 25 min.     
 
Table 20: Resolution factor (Rs) between detected peaks separated using different RP-columns                                           
  Resolution factor (Rs) 
Peak  Column A Column B Column C Column D Column E Column F 
1-2 9.03 2.85 14.96 5.28 2.45 3.55 
2-3 7.95 2.45 14.67 4.33 - 7.04 
3-4 8.85 8.34 22.39 7.12 - 25.66 
4-5 14.22 - 19.06 - - 22.08 
5-6 75.29 - 35.63 - - - 








Figure 35: HPLC chromatograms of the MAA profile of crude extract 1 monitored at 330 nm using 
different columns: A) Alltima® Altech RP C18 column (5 µm, 4.6 x 150 mm); B) SynergiTM  Fusion 
RP C18 column (4 µm, 4.6 x 150 mm, 80 Å); C) Hichrom RP ACE excel super-C18 column (3 µm, 
4.6 x 250 mm, 80 Å); D) Hichrom RP ACE excel C18- Amide column (3 µm, 4.6 x 250 mm, 100 Å), 
E) Hypercarb® RP C30 column (5 µm, 4.6 x 100 mm, 250 Å) and F) Develosil® C30-UG column (5 
µm, 4.6 x 250 mm, 140 Å). 
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Table 21: Retention time (RT), relative standard deviation (RSD %) and UV-absorbance maxima (λmax) for each peak detected using different RP-columns. Non-detected 
peaks are represented by n.d.  





























1 4.56 1.36 3.97 37.40 8.28 1.00 6.06 14.53 22.11 1.47 9.98 1.37 332 
2 5.65 1.84 4.31 15.12 10.40 0.95 6.83 32.75 22.68 1.76 9.09 1.18 320 
3 6.82 1.01 4.62 25.72 12.81 1.38 8.28 17.34 n.d   - 10.85 2.88 330 
4 8.34 0.68 6.00 30.68 17.60 0.39 6.98 15.63 n.d   - 18.69 2.65 332 
5 11.06 1.47 n.d   - 21.46 1.42 n.d   - n.d   - n.d   - 330 
6 21.34 3.30 18.20 13.86 24.96 2.01 n.d   - n.d   - 23.95 2.12 356 







                                                                            
92 
 
3.2.1.2 Method validation 
Crude extracts 1, 2 and 3 
Following the optimisation of the protocol, all crude extracts were analysed to ensure 
good separation and repeatability with the chosen concentration of TFA and column 
type (Figure 36).  
 
Figure 36: Optimisation protocol showing the different concentrations of TFA in eluent A followed by 
the different columns used.  
Firstly, all three extracts were analysed using UV-visible spectroscopy (Figure 37) 
which showed the similar λmax of crude extract 1 and 2 with the characteristic 
usujirene shoulder seen in crude extract 1 only. Crude extract 3 is shifted to λmax of 
334 nm as it contains shinorine and porphyra-334 only.  
 
Figure 37: UV-visible spectra (295 – 455 nm) of crude extract 1 (+ usujirene), crude extract 2 (- 
usujirene) and crude extract 3 (Shinorine & Porphyra-334).  
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Good separation was seen with all crude extracts (Figure 38) with RSD% (n=3) less 
than 2.5 in all samples (Table 22) when using the optimised method.  
 
Figure 38:  HPLC chromatograms of the MAA profiles of; A) crude extract 1 at 330 nm; B) crude 
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Table 22: Peak identifications including retention time (RT), relative standard deviation (RSD %), 
resolution factor (Rs) between peaks and UV-absorbance maxima (λmax). 
Crude extract 1 (+ usujirene)   
Peak no. MAA RT (min) RSD % Rs (between peaks)  λmax (nm) 
1 Shinorine 4.56 1.36 - 332 
2 Palythine 5.65 1.84 9.03 (1/2) 320 
3 Asterina 6.82 1.01 7.95(2/3) 330 
4 Porphyra-334 8.34 0.68 8.85 (3/4) 332 
5 Palythinol 11.06 1.47 14.22 (4/5) 330 
6 Usujirene 21.34 3.3 75.29 (5/6) 356 
7 Palythene 21.43 1.71 1.35  (6/7) 360 
Crude extract 2 (- usujirene)   
Peak no. MAA RT (min) RSD % Rs (between peaks)  λmax (nm) 
1 Shinorine 4.62 2.16 - 332 
2 Palythine 5.69 1.47 9.22 (1/2) 320 
3 Asterina 6.73 1.07 7.44(2/3) 330 
4 Porphyra-334 8.24 0.92 8.76 (3/4) 332 
5 Palythinol 10.97 0.41 13.76 (4/5) 330 
6 Usujirene n.d - - - 
7 Palythene n.d - - - 
Crude extract 3 (Shinorine & Porphyra-334) 
Peak no. MAA RT (min) RSD % Rs (between peaks)  λmax (nm) 
1 Shinorine 4.62 2.1 - 332 
2 Palythine  n.d - - - 
3 Asterina n.d - - - 
4 Porphyra-334 8.21 1.22 24.84 (1/4) 332 
5 Palythinol n.d - - - 
6 Usujerine  n.d - - - 
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3.2.1.3 P. palmata crude extracts  
P. palmata was collected from the Welsh coast (Langland) during summer 2017 to 
extract and use in method validation of the optimised HPLC analysis to use as an 
unknown sample. All MAAs were extracted and eluted with good separation (Figure 
39).   
 
 
Figure 39: HPLC chromatograms of the MAA profile of the crude PP extract showing absorbance at 
330 nm (top) and 360 nm (bottom): 1) Shinorine, λmax = 332 nm; 2) Palythine, λmax = 320; 3) Asterina, 
λmax = 332 nm; 4) Porphyra-334, λmax = 334; 5) Usujirene, λmax = 356 nm and 6) Palythene, λmax 
= 358 nm. 
The validated method was used in subsequent analyses of MAA production in C. 
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Time-series analysis of C. fritschii during UV exposure  
3.2.2 Intracellular and extracellular analysis of C. fritschii during UV-B stress  
The metabolite profiles of C. fritschii cultures (n = 3) were investigated during 48 h of 
UV-B exposure. At each time point (0, 2, 6, 12, 24 and 48 h) intracellular and 
extracellular metabolites were analysed by untargeted GC-MS to evaluate the global 
changes in metabolite production during UV-B stress. Dry weight, carotenoid and 
MAA analysis was also conducted at each time-point.  
A reduction in average dry weight was measured over 24 h of UV-B exposure with 
recovery of the initial biomass concentration and further growth measured between 
24 and 48 h (Figure 40Error! Reference source not found.). 
 
Figure 40: Dry weight measurements of C. fritschii cultures during 48 h of supplemented UV-B 
exposure. All values are the mean of three biological replicates ± SE.  
Carotenoid concentration (Figure 41A) and MAA content (Figure 41B) were 
analysed by UV-visible spectroscopy and high performance liquid chromatography 
(HPLC) respectively. Total carotenoid concentration decreased after 2 h (p<0.05); 
with a steady significant increase up to 48 h with a final concentration of 2.59 μg/mg 
dry weight (p<0.05).  
As described above, UV-B also induces the production of the photoprotective 
compounds, MAAs. The two forms found in C. fritschii are mycosporine-glycine (m-
gly) and shinorine [20], both were detected during this experiment with peaks 
identified using their retention time and absorption maxima (λmax) values. As 
expected, an increase in shinorine (retention time ~4.9 min, λmax = 334 nm) was 
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observed with increasing length of UV-B exposure. No significance was observed with 
m-gly (retention time ~10.8 min, λmax = 310 nm) content during this experimental 
time series. 
 
Figure 41: Carotenoid and mycosporine-like amino acid (MAA) analysis of C. fritschii extracts during 
UV-B exposure. A) Total carotenoid concentration as measured by UV-visible spectroscopy and B) 
shinorine and mycosporine-glycine (m-gly) content measured by HPLC analysis. All values are the 
mean of three biological replicates (normalised to dry weight) ± standard error. Statistical significance 
was measured using a two sample T-test with equal variance; * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and 
*** = p<0.001. 
A total of 300 and 412 peaks were detected from the intracellular and extracellular 
time-series data respectively. Using a match factor of 60% or above, 135 and 218 peaks 
were putatively identified within the intracellular and extracellular data respectively. 
The identified chemical structures belonged to a variety of classes such as; acids, 
alcohols, amino acids, aromatics, fatty acids, heterocycles and sugars. 
 





Figure 42: Principle component analysis (PCA) of A) intracellular and B) extracellular GC-MS data of 
UV-B exposed (PAR + UV-B) C. fritschii cultures showing PC1 vs PC2 only. Each ring represents 
distribution of biological replicates.  
A Principle Component Analysis (PCA) model was used as an unsupervised 
multivariate statistical tool to plot and visualise the variance between UV-B exposed 
samples over time. A total variance of 37.4% for intracellular (Figure 42A, PC1 = 
17.4%, PC2 = 10.9%, PC3 = 9.1%) and 36.5% for extracellular (Figure 42B, PC1 = 
18.9%, PC2 = 9.3%, PC3 = 8.3%) was observed.  
The results of the PCA for intracellular samples (Figure 42A) showed good separation 
over time between the control (0 h) and 6, 12, 24 and 48 h of UV-B. Less variation 
was observed between 0 and 2 h of UV-B with clustering seen between 12, 24 and 48 
h of UV-B. This result was consistent with the two-sample t-Test results comparing 
control (0 h) with each time point where the number of significant features reducing 
in levels increases with length of UV-B exposure. After a one-way analysis of variance 
(ANOVA) with repeated measures, 109 peaks with overall significant differences 
within the time-series were observed with p<0.05 (Figure 43A), 10 of which remained 
significant after BF correction.  
From the extracellular data PCA (Figure 42B) a similar pattern was observed with 
increasing variance with increasing length of UV-B exposure. Statistically significant 
changes between control (0 h) and each time point, measured using a two-sample t-
Test also showed increasing significance (p<0.05) with increasing length of UV-B up 
to 24 h. A one-way ANOVA with repeated measures calculated 117 statistically 
significant peaks with p<0.05 (Figure 43A).  




Figure 43: Hierarchical heatmap visualisation of the significant A) intracellular and B) extracellular 
peak intensities (p<0.05) during UV-B exposure using a one-way repeated measure ANOVA in 
MetaboAnalyst. Data is arranged in triplicate with increasing length of UV-B exposure from left to right 
(0–48 h).  
3.2.2.1 Intracellular metabolites   
28 metabolites (13 represented for simplicity Figure 44), selected as being involved 
in the central carbon and nitrogen metabolism within cyanobacteria, were identified 
within the intracellular GC-MS results (Table S5). Many changes in metabolite levels 
were observed comparing between time points. Glucose, pyruvate and lactate all 
decreased in abundance after UV-B exposure with significant reduction after 2 h 
(pyruvate p<0.05, 0 vs. 2 h), 6 h (glucose p<0.05, 2 vs. 6 h) and 12 h (lactate p<0.05, 
0 vs. 12 h). Lactate was present during the whole time-course whereas glucose and 
pyruvate were not detected after 6 h (p<0.05) and 24 h (p<0.001) respectively.  
6 proteinogenic amino acids were detected; ser, gly, glu, pro, tyr and phe. All detected 
amino acids decreased after 6 or 12 h of exposure with the exception of pro. A decrease 
in tyr, phe and gly was seen after 6 h (tyr p<0.05, 0 vs. 6 h; phe p<0.01, 2 vs. 6 h; gly 
p<0.05, 2 vs. 6 h) of UV-B followed by no detection at 6, 12, 24, and 48 h (tyr p<0.05; 
phe p<0.01; gly p<0.05). Ser and glu decreased significantly after 12 h of treatment 
(ser p<0.05, 0 vs. 12 h; glu p<0.05, 0 vs. 12 h), ser was not detected between 12 and 
48 h (p<0.05) whereas glu was detected throughout the time series. Proline showed no 
significant decrease after UV-B exposure with a significant increase observed after 24 
h (p<0.05, 6 vs. 24 h). 
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The fatty acids stearic acid, palmitic acid and mystiric acid all decreased significantly 
after 2 h of treatment (p<0.05) and their abundance remained lowered throughout the 
time series (stearic acid p<0.01, 0 vs. 48 h; palmitic acid p<0.05, 0 vs. 48 h; mystitric 
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Figure 44: Schematic representation of a generalised reduced carbon metabolism in the cyanobacterium 
C. fritschii showing glycolysis, the TCA cycle, amino acid and fatty acid biosynthesis. Primary 
metabolites identified in intracellular samples using GC-MS are highlighted in blue with each insert 
presenting mean values of normalised abundance (normalised to internal standard and dry weight) ± SE 
of each metabolite during supplemented UV-B exposure (PAR + UV-B). Statistical significance 
between control (0 h) and UV-B exposure (2, 6, 12, 24 and 48 h) and between each treatment time point 
was measured using a two sample t-Test with equal variance; * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and 
*** = p<0.001. 
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3.2.2.2 Extracellular metabolites  
 29 biologically relevant dissolved metabolites (Table S5) were detected within the 
extracellular data set (13 represented for simplicity, Figure 45). Citrate, a component 
of BG-11 medium [5] and involved in TCA cycle, was consistently detected 
throughout the time series (ANOVA, p<0.05) along with succinate. Other TCA 
substrates; malate and fumarate were also detected at 0 h with decreasing abundance 
after 2 h of UV-B (malate, p<0.001). Other metabolites detected at 0 h which 
decreased after UV-B exposure were leucine (p<0.01, 0 vs. 6 h), putrescine (p<0.05, 
0 vs. 2 h) octanoic acid (p<0.001, 0 vs. 24 h) mystiric acid (p<0.01, 2 vs. 24 h) and 
fructose (p<0.01, 0 vs. 2 h). Accumulation of the sugars galactose, xylose, lyxose and 
arabinose was seen after 6 h (galactose p<0.01; arabinose p<0.01) 12 h (arabinose 
p<0.05), 24 h (arabinose p<0.05; xylose p<0.05; lyxose p<0.01) and 48 h (galactose 
p<0.05; arabinose p<0.001; lyxose p<0.01) of UV-B exposure. Trehalose was also 
identified throughout the time series with no significant changes.  




Figure 45: Time-series extracellular GC-MS data of C. fritschii over 48 h of UV-B exposure showing 
primary metabolites found in extracellular samples only. Significant difference in metabolite levels were 
measured using a two-sample t-Test comparing control (0 h) and UV-B exposure (2, 6, 12, 24 and 48 
h) and between each treatment time point, * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001. 
7 metabolites from the identified biologically relevant pool were found in both intra- 
and extracellular metabolite samples (Figure 46). The fatty acid mystiric acid shows 
a similar pattern of reduced abundance with increasing length of UV-B in both samples 
(intracellular 0 vs. 48 h, p<0.05; extracellular 2 vs. 24 h, p<0.05). Ethanolamine and 
2-oxobutanoate show opposite patterns with intracellular levels decreasing (0 vs. 48 h, 
p<0.05) and extracellular levels increasing (ethanolamine 0 vs. 24 h, p<0.01, 2-
oxobutanoate 0 vs. 24 h, p<0.001).  
 




Figure 46: Time-series GC-MS data of C. fritschii during 48 h of UV-B exposure showing primary 
metabolites found in both intra- and extracellular samples. A) Metabolites showing significantly 
different changes (p<0.05) over time in both intra- and extracellular data; B) metabolites showing 
significantly different changes (p<0.05) over time in intracellular samples only. Significant differences 
were measured using a two-sample t-Test comparing control (0 h) to each treatment time point (2, 6, 
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3.2.3 Intracellular analysis of C. fritschii during UV-A stress response 
C. fritschii cultures were exposed to supplemented UV-A for 48 h. The dry weight 
measured decreased significantly to an average of 54.2 mg L-1 after 6 h of 
supplemented UV-A exposure (p<0.01, 0 vs 6 h) with an increase up to an average of 
62.5 mg L-1 after 48 h with no significance measured (Figure 47A). Total carotenoid 
content (Figure 47B) decreased after 2 h of UV-A exposure (p>0.05, no significance) 
with a statistically significant increase after 12 h (2 vs. 12 h, p<0.05) and 48 h (2 vs. 
48 h, p<0.05).  
 
Figure 47: A) Dry weight (mg L-1) and B) carotenoid content of C. fritschii cultures (n=3) during 
supplemented UV-A exposure over 48 h. Statistical significance was calculated comparing control (0 
h) and each time point (2, 6, 12, 24 and 48 h) using a two-sample t-Test, * = 0.05>p≥0.01, ** = 
0.01>p≥0.001 and *** = p<0.001. 
 
Intracellular metabolite levels within C. fritschii were investigated during 48 h of UV-
A exposure using GC-MS analysis. After data processing the peaks were aligned in 
SpectConnect to yield a total of 210 detected peaks throughout the 48-h time-series. 
Of the 210 peaks detected, 175 were classified as ‘true-hits’ with 91 putatively 
identified (level 2; identified due to similarity to online spectra [63]) and 84 remaining 
unassigned (level 4; unknown [63]) using a match factor of ≥ 60% comparing to online 
spectra  
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Comparing control (0 h) and each time point using a two sample t-Test, 24 h of UV-A 
had the highest significant difference in peak levels with 115 peaks (out of 175), of 
those 84 increased in levels (positive log2FC) and 31 reduced in levels (negative 
log2FC, (Table 23). 6 h of UV-A had the highest percentage (78%) of significantly 
different peaks with elevated levels (81 with a positive log2FC). After 48 h of UV-A 
exposure a larger percentage (57%) of significantly different peaks showed a reduction 
in normalised abundance (34 with a negative log2 FC).  
Table 23: Comparison of statistically significant (p<0.05) peaks (out of 175) and number of those 
significant peaks with a positive or negative log2FC. A positive log2FC indicates an increase in 
metabolite level and a negative log2FC value indicates a decrease in metabolite level. Both significance 
and log2FC were calculated comparing control (0 h) and 2, 6, 12, 24 and 48 h of UV-A exposure.  
UV-A exposure 
(h) 
No. of peaks, 
p<0.05a 
No. of peaks, 
positive log2FC 
No. of peaks, 
negative log2FC 
0 vs. 2 49 28 21 
0 vs. 6 104 81 23 
0 vs. 12 100 70 30 
0 vs. 24 115 84 31 
0 vs. 48 60 26 34 
a = Significanct differences wascalculated using a two sample t-Test with equal variance comparing 
control (0 h) to each UV-A exposed time point.  
Twenty-nine metabolites (10 shown for simplicity in, Figure 48) were identified 
throughout the time-series that have roles as primary metabolites within cyanobacterial 
metabolism including; glycolysis, the TCA cycle, amino acid and fatty acid 
biosynthesis (Table S6). The four amino acids; glu, leu, ser and phe were identified 
with a match factor of ≥ 60%. A significant reduction in leu and phe levels was seen 
after 6 h (p<0.01 and p<0.001 respectively) of supplemented UV-A exposure (UV-A 
+ PAR), with glu decreasing significantly after 24 h (p<0.05). Ser levels increased 
significanty after 2 h of UV-A (p<0.01).  
Four saturated fatty acids were also putatively identified, 3 of which showed 
significant increases after 2 h (eicosanoic acid, p<0.05), 12 h (stearic acid, p<0.05) and 
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24 h (palmitic acid, p<0.05) of UV-A exposure with mystiric acid levels showing 
steady levels with no significant changes (p>0.05).  
The sugars mannose and sucrose were identified with significance during UV-A 
exposure, with sucrose levels decreasing significantly (0 vs. 24 h, p<0.05) and 
mannose increasing significantly (0 vs. 2 h, p<0.01) during the time-series.  
 
 
Figure 48: Schematic representation of a generalised reduced carbon metabolism in the cyanobacterium 
C. fritschii. Ten primary metabolites were identified in intracellular samples using GC-MS and are 
highlighted in purple with each graph presenting mean values of normalised abundance (normalised to 
internal standard and dry weight) ± standard error of each metabolite during supplemented UV-A 
exposure (UV-A + PAR). Significant difference between control (0 h) and UV-A exposure (2, 6, 12, 24 
and 48 h) was measured using a two-sample t-Test with equal variance; * = 0.05>p≥0.01, ** = 
0.01>p≥0.001 and *** = p<0.001. 
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3.2.4 UV-A vs. UV-B vs. PAR only exposure 
It is widely researched the effect of UV-B on cyanobacteria with less focus on UV-A 
exposure. UV-A and UV-B have different effects on photosynthetic organisms and 
mechanisms of protection will vary during supplemented UV-A and UV-B.  
By comparing the UV-A results described (Section 3.2.3) with the UV-B (Section 
3.2.2) and PAR only (Section 2.4.2) time-series experiments differences were 
observed. PAR only had the lowest overall number of significant peaks across the 
time-series comparing 0 h to each time point but, showed the highest percentage of 
elevated metabolite levels (Figure 49, Table 19).  
Supplemented UV-B showed an increasing amount of significant peaks reducing in 
levels with increasing length of UV-B. 48 h of UV-B showed the highest amount of 
significance with 146 significant peaks, of those reduced in levels (0 vs. 48 h) 
compared to the 63 decreasing in normalised abundance after 2 h of UV-B (Table 
24). 
UV-A showed the majority of significantly different peaks increasing in metabolite 
levels up to 24 h (positive log2FC, Table 23). 
Table 24: Comparison of statistically significant (p<0.05) peaks and number of those significant peaks 
with a positive or negative log2FC during supplemented UV-B exposure. A positive log2FC indicates 
an increase in metabolite level and a negative log2FC value indicates a decrease in metabolite level. 




No. of peaks,  
p<0.05a 
No. of peaks, 
positive log2FC 
No. of peaks, 
negative log2FC 
0 vs. 2 96 33 63 
0 vs. 6 98 29 69 
0 vs. 12 110 39 71 
0 vs. 24 105 27 78 
0 vs. 48 146 29 117 
a = Significant difference was calculated using a two sample t-Test with equal variance.  
 






Figure 49: Total number of statistically significant peaks (p<0.05) with positive and negative log2 FC 
comparing control (0 h) to each time point 2, 6, 12, 24 and 48 h of UV exposed (UV-A + PAR or UV-
B + PAR) and PAR only experiments. Significance was calculated using a two- sample t-Test. Diagonal 
stipes represents positive log2FC and spots represents negative log2FC.  
Eight (8) common metabolites were identified between supplemented UV-A, 
supplemented UV-B and PAR only exposure including glu, ser, palmitic acid and 
stearic acid. Using a one-way ANOVA-single factor, comparisons of log2FC of the 
common metabolites (control, 0 h vs. each time point) between the three treatments 
were investigated (Figure 50). 
Glu showed significance between the three treatments when comparing log2FC at 0 
vs. 12 h (F (2, 6) = 6.77, p<0.05), 0 vs. 24 h (F (2, 6) = 32.70, p<0.001) and 0 vs. 48 h 
(F (2, 6) = 9.60, p<0.05) with the post-hoc t-Test (Two-sample assuming equal 
variances) showing significantly elevated levels in PAR only cultures compared to 
UV-A and UV-B with no significant differences observed between UV-A and UV-B.  
Ser showed significance comparing log2FC between 0 vs. 48 h (F (2, 6) = 11.86, 
p<0.01). Significancly reduced ser levels were observed in UV-B treated cultures (UV-
A vs. UV-B, p<0.05; PAR vs. UV-B, p<0.05) with no significance comparing 
supplemented UV-A and PAR. 
 
 




Figure 50: Log 2 FC of commonly identified metabolites using GC-MS analysis during supplemented UV-A (purple), supplemented UV-B (blue) and PAR only (orange) 
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Palmitic acid shows significanc between the three treatments comparing 0 vs 2 h (F 
(2, 6) = 10.59, p<0.05), 0 vs. 24 h (F (2, 6) = 5.79, p<0.05) and 0 vs. 48 h (F (2, 6) = 
10.89, p<0.05). The t-Test results showed no significance between log2FC of UV-A 
and PAR only exposure experiments but significant reduction in levels was observed 
between UV-A and UV-B as well as PAR and UV-B. Stearic acid shows significance 
at 0 vs. 2 h (F (2, 6) = 9.71, p<0.05) and 0 vs. 48 h (F (2, 6) = 10.22, p<0.05). A 
significant reduction was again observed in the UV-B exposed cultures (UV-A vs UV-
B and PAR only vs. UV-B).    
An additional two metabolites were identified in both supplemented UV-A and PAR 
only exposure, leu and sucrose (Figure 51). Leu showed opposite log2FC patterns 
with supplemented UV-A (UV-A + PAR) decreasing in normalised abundance 
compared to 0 h, with these metabolites increasing in abundance during the PAR only 
time-series (with no significance, p>0.05) Sucrose also showed a similar opposite 
pattern with decreasing abundance with increasing length of UV-A and increasing 
during PAR only exposure (0 vs. 12 h, p<0.05; 0 vs. 24 h, p<0.01 and 0 vs. 48 h, 
p<0.01). 
 
Figure 51: Log 2 FC of commonly identified metabolites using GC-MS analysis during supplemented 
UV-A (purple) and PAR only (orange) exposure comparing 0 h and each time point (2, 6, 12, 24 and 
48 h). A positive log2FC indicates an increase in metabolite levels, and a negative log2FC shows a 
decrease in metabolite levels. Significant differences between log2FC values was calculated using a 
two-sample t-Test, * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001. 
These opposite log2FC patterns are also observed between supplemented UV-A and 
supplemented UV-B time-series data (Figure 52). This includes significantly reduced 
oxalate levels (0 vs.6 h, p<0.01; 0 vs. 24 h, p<0.01), lactate levels (0 vs. 12 h, p<0.05), 
mystiric acid (0 vs. 6 h, p<0.05; 0 vs. 24 h, p<0.05 and 0 vs. 48 h, p<0.05) and mannose 
levels (0 vs. 24 h, p<0.05) during UV-B exposure compared to UV-A. 




Figure 52: Log 2FC of commonly identified metabolites using GC-MS analysis during 
supplemented UV-A (purple) and UV-B (blue) exposure comparing no UV (0 h) and each time 
point (2, 6, 12, 24 and 48 h). A positive log2FC indicates an increase in metabolite levels, and a 
negative log2FC shows a decrease in metabolite levels. Statistical significance between log2FC 














3.3.1 The effect of UVR on metabolite levels in C. fritschii  
UV-B exposure is known to reduce growth, photosynthesis and nitrogen fixation in 
cells to divert energy from key primary pathways to adaptive mechanisms such as; the 
production of secondary metabolites, MAAs; antioxidant production and DNA/protein 
repair [119]. These results showed no significance (p>0.05) across the time series 
suggesting acclimation of cells to UV-B where damage to photosynthetic systems are 
counterbalanced by repair and mitigation strategies. A reduction in carotenoid 
concentration (Figure 41A) was observed after 2 h (p<0.05) due to damage to 
photosystems caused by UV-B. Accumulation of total carotenoids could be indicative 
of antioxidant activity as a response to ROS production [6, 7].  
A reduction in glucose, pyruvate and lactate (Figure 44) could indicate a reduction in 
CO2 fixation via photosynthesis and further biochemical processes. This could be due 
to the reduced production of ATP and NADPH2 from photosynthesis [120].  
The 13 selected intracellular metabolites (Figure 44) were reduced across the UV-B 
time series indicating the reduction of cellular processes. A decrease in phe and tyr 
could be due to their role as precursors to many secondary metabolites such as aromatic 
nitrogen containing alkaloids [10]. M-gly and shinorine are produced via a 
combination of the shikimate/pentose phosphate pathway which also involves the 
addition of gly and ser to form the final MAAs [6,28]. The reduction of these amino 
acids coincides with an increase in MAA levels (Figure 41B).  
5-oxoproline and glu are involved in glutathione metabolism. 5-oxoproline reduction 
could be due to its interconversion into glutamate which is further converted into the 
antioxidant glutathione [121]. Glu is also produced from the assimilation of nitrogen 
during nitrogen fixation which is reduced during UV-B exposure [120]. C. fritschii is 
a nitrogen fixating species via formation of specialised cells known as heterocysts. 
During these experiments, C. fritschii was not grown under nitrogen limiting 
conditions.  
Pro has been studied in many UV-B experiments involving different photosynthetic 
organisms and it’s accumulation is thought to have a role in stress response by 
providing additional defense as a ROS scavenger and molecular chaperone [122–124]. 
Accumulation of proline has been observed in Nostoc punctiforme during 24 h of UV-
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A stress [52], in the model plant organism Arabidopsis after 24 h of UV-B treatment 
[96], and also in C. fritschii after 24 h of UV-B exposure within this study (Figure 
44).  
The movement of metabolites and substrates between cells and their surrounding 
environment (or vice versa) can occur via passive and active uptake and efflux 
systems. Reactions can also occur on cell surface membranes and as transformations 
of media components [125]. Identification of extracellular metabolite uptake and 
release from cyanobacteria is therefore a complex process due to the high turnover 
rates of intracellular processes [69]. Extracellular metabolites can be released during 
stress and as by-products of intracellular reactions [54]. Sugars such as galactose, 
arabinose, lyxose and xylose are produced/released during UV-B stress. As expected, 
this was seen in this UV-B experiment (Figure 45). Increased production of sugars is 
a strategy to avoid high intensity UVR. They can mitigate UV-B stress by providing 
an extra layer around the cells to absorb the harmful UV-B [24].  
7 metabolites from the identified biologically relevant pool were found in both intra- 
and extracellular metabolite samples (Figure 46). The fatty acid mystiric acid shows 
a similar pattern of reduced abundance in intracellular samples with concomitant 
decrease in extracellular samples with increasing length of UV-B. This could 
demonstrate the reduction in biosynthesis or the increase in intracellular turnover rate 
with an increase in the release of this metabolite into the supernatant [125]. As this is 
seen during UV-B exposure, the hypothesis of a reduction in biosynthesis is 
considered. Ethanolamine, involved in glycerophospholipid metabolism, and 2-
oxobutanoate, involved in amino acid biosynthesis show opposite patterns with 
intracellular levels decreasing with concomitant increase in extracellular levels. This 
could should evidence of metabolite flux, a movement from within cells to the 
supernatant which can occur via passive or active secretion mechanisms [125]. These 
results can help create hypotheses and give an insight into the production and 
movement of metabolites from within cells to their release into the supernatant. For 
verification, flux analysis would need to be conducted using isotopic-labelled 
metabolic intermediates to follow labelled metabolites within the cells to their 
potential release [42].  
It is widely researched the effect of UV-B on cyanobacteria with less focus on UV-A 
exposure. UV-A and UV-B have differing wavelengths and therefore have varying 
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effects on photosynthetic organisms and mechanisms of protection vary. However,  
they both indirectly damage cells via the production of ROS [27,126]. An increase in 
carotenoid levels (Figure 47B) was observed with increasing length of UV-A, this is 
consistent with previous experiments during UV-B exposure (Section 3.2.2). This 
accumulation could be due to the increased ROS production caused by increasing 
length of UV where carotenoids act as antioxidants. An initial decrease in dry weight 
(Figure 47A) could indicate the shock response of C. fritschii to initial UV-A 
exposure. An increase in biomass was then observed between 6 h and 48 h showing 
the acclimation of cells to UV-A, as supported by the GC-MS data, where less 
significance is seen between 0 h and 48 h of supplemented UV-A (PAR + UV-A, 
Figure 49). 
The metabolites, glu and phe showed negative log2FC in both supplemented UV-A 
and UV-B compared to the positive log2FC during PAR only exposure (Figure 50) 
thus suggesting the roles of these amino acids during UVR stress. A decrease in phe 
levels is consistent with the need for aromatics such as phenylpropanoids which can 
absorb harmful UVR due to their unsaturated nature and for protein synthesis [10]. 
Glu is involved in glutathione synthesis which has a role as an antioxidant and protects 
cells from ROS, an example includes the conversion of H2O2 into H2O to prevent the 
formation of •OH [121].  
The soluble sugar sucrose, a disaccharide consisting of glucose and fructose, has been 
seen to have a role in stress tolerance in both plants and cyanobacteria [99,127] which 
is consistent with the opposite effect between UV-A exposure and PAR only exposure 
(Figure 51).  
UV-A and PAR only exposure have opposite effects on the saturated fatty acids stearic 
acid and palmitic acid compared to UV-B, with the accumulation during UV-A and 
PAR only and a decrease during UV-B exposure. This trend is also seen with mystiric 
acid (Figure 52, comparing UV-A and UV-B). Saturated fatty acids provide energy 
for the rebuilding of photosynthetic apparatus which could be damaged directly during 
UV-B exposure [99].  
Overall, these results show that supplemented UV-A allows for better re-organisation 
of metabolism in C. fritschii cells compared to UV-B. Both cause changes in 
metabolite levels associated with UVR stress response such as phe, glu and sucrose. 
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Reductions in fatty acids, oxalate, mannose and lactate levels could be associated with 
UV-B stress response due to its direct and indirect  effects.  
   
3.4 Conclusion  
In summary, an untargeted GC-MS workflow was used to evaluate intra- and 
extracellular metabolites under supplemented UV-B (PAR + UV-B) and intracellular 
metabolites during supplemented UV-A (PAR + UV-A) exposure. Most significantly 
during UV-B exposure a reduction of intracellular metabolites such as the amino acids, 
tyr, phe, ser, gly and glu and the accumulation of pro, which to our knowledge has not 
been previously reported in C. fritschii. Significantly a higher proportion of 
metabolites increased in levels during UV-A exposure compared the UV-B study. An 
accumulation of the fatty acids; eicosanoic acid, stearic acid and palmitic acid was 
observed. The metabolites phe, glu and sucrose could be affected by both UV-A and 
UV-B whereas other metabolites such as fatty acids are affected by the UV-B portion 
of UVR only.  
Although a time series analysis was conducted, this only represents a minuscule 
proportion of the true changes within the metabolome. This study is important to build 
on experimental data already available for cyanobacteria and other photosynthetic 
organisms exposed to UV-B and UV-A. It is important to investigate the changes in 
primary metabolites in order to understand secondary metabolite production as 
previously discussed. Manipulating abiotic stress such as UV radiation can be used to 
enhance production of useful metabolites for uses in industrial biotechnology 
[16,21,22]. Further studies are needed to understand and verify these processes within 
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Chapter 4: Acclimation vs. Shock: The Stress Response of 
Chlorogloeopsis fritschii, PCC 6912, to UV Exposure 
Aims 
• Evaluation of the effect of acclimatising C. fritschii cultures to low levels of UV 
(acclimation phase) followed by exposure to high UV (shock phase). 
• To investigate if cultures can tolerate the higher UV levels after acclimation.  
• To evaluate the metabolite level changes over the time-series and comparing to 























Adaptation of cyanobacteria to different abiotic factors is important for their survival 
in a variety of extreme habitats. They have many strategies to overcome harmful 
environmental stimuli such as rearrangement of metabolism for efficient energy uses 
as well as production of unique secondary metabolites [9]. The ability to manipulate 
abiotic stressors to increase production of specific metabolites can be exploited for 
biotechnological uses in industry and enhance stress tolerance in specific strains [128].  
Cyanobacterial salt acclimation has been widely studied for industrial growth in 
seawater [127,129] as well as; high light acclimation [130], far-red light acclimation 
[131] and UV-B acclimation [113].  
Selection of robust and tolerant cyanobacterial strains is essential for their use in 
industrial biotechnology [132]. Many strategies have been investigated such as use of 
extremophilic strains [133], genetic manipulation such as heterologous expression of 
heat shock proteins in Synechococcus elongates [134], supplementation of media 
[135], and pre-treatment with sub-lethal doses of specific abiotic stress condition as 
seen in rice plants [136] and in Anabaena doliolum where pre-treatment of increased 
temperature showed reduction in UV-B toxicity [137].  
As previously described, UV affects cyanobacteria in a variety of ways. From targeting 
biomolecules directly to promoting the production of harmful ROS levels. They have 
various tolerance mechanisms to overcome the damage caused by UV [24]. This 
includes the accumulation of unique secondary metabolites such as carotenoids and 
MAAs [113].  
The aim of the chapter is to evaluate C. fritschii’s stress tolerance to UV (UV-A and 
UV-B) at the metabolite level and to build on results from the previous stress response 
chapter (Chapter 3). The effect of pre-treatment with low dose UV (acclimation 
phase) followed by increased levels (shock phase) to investigate if tolerance is 
enhanced to higher UV levels. These experiments will be used to evaluate if C. fritschii 
has acclimatised to the UV sufficiently to withstand the higher levels of UV (shock). 
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4.1 Experimental design  
4.1.1 Acclimation and shock vs. shock only experiments 
All experiments were carried out under continuous PAR (15 µmol m-2 s-1), a 
temperature of 27 ± 2 °C and shaking at 100 rpm for even UV exposure of cells. For 
UV exposure, cultures were transferred into Quartz Erlenmeyer flasks (H. Baumbach 
& CO.LTD, Suffolk). UV-A was supplied by a Philips TL-D 18 W black light blue 
fluorescent tube (315-400 nm, centred at 360 nm) and UV-B was supplied by a Philips 
TL 20W UVB Broadband fluorescent tube (290-315 nm, centred at 310 nm). 
4.1.1.1 Acclimation and shock  
After 6 days of pre-growth (Section 2.1), triplicate experimental C. fritschii cultures 
were acclimatised to UV-A (11.5 µmol m-2 s-1)  or UV-B (3 µmol m-2 s-1 ) for 24 h with 
constant PAR (15 µmol m-2 s-1) followed by shock exposure of 20 µmol m-2 s-1 UV-A 
or  5.5 µmol m-2 s-1 UV-B for a further 24 h (Table 25). Samples were harvested at 0, 
24, 24.5, 25.5 and 48 h for dry weight measurements (Section 1.2), pigment (Section 
1.5.1), MAA (Section 1.4.2-1.4.3) and GC-MS analysis (Sections 1.3.2 – 1.3.6). 
4.1.1.2 Shock only  
C. fritschii cultures were grown with PAR (15 µmol m-2 s-1) only for 24 h. Cultures 
were then exposed to UV-A (20 µmol m-2 s-1) or UV-B (5.5 µmol m-2 s-1) for a further 
24 h (Table 25). Samples were harvested at 0, 24, 24.5, 25.5 and 48 h for dry weight 
measurements (Section 1.2), pigment (Section 1.5.1), MAA (Section 1.4.2-1.4.3) and 
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Table 25: PAR, UV-B and UV-A intensities during acclimation and shock experiments. PAR + UV-B 
treatments were carried out separately from PAR + UV-A.   
Experiment Light Light intensity (µmol m-2 s-1) 
  0 h a 24 h b 48 h c 
 PARd 15 15 15 
Acclimation & 
shock 
UV-Be 0 3.5g 5.5h 
 UV-Af 0 11.5g 20h 
 PAR 15 15 15 
Shock only UV-B 0 0 5.5h 
 UV-A 0 0 20h 
a = control 0 h (no UV) 
b = acclimation time up to 24 h  
c = shock time, between 24 and 48 h   
d = PAR: Photosynthetically active radiation  
e = Supplemented UV-B (PAR + UV-B) 
f = Supplemented UV-A (PAR + UV-A) 
g = Low UVR 
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4.2 Results  
4.2.1 UV-B acclimation and shock vs. shock only 
4.2.1.1 Dry weight, pigment analysis and production of MAAs 
During UV-B acclimation a decrease in dry weight (Figure 53A, µ = -0.0018, Figure 
54) was observed compared to non-acclimatised control cultures (Figure 53B, µ = 
0.0047) which increased in dry weight (no significance, p<0.05). Both acclimatised 
(low UV-B) and non-acclimatised (No UV-B) cultures decreased in growth after 0.5 
h of high UV-B and acclimatised cultures decreased further after 1.5 h to a minimum 
dry weight of 116.7 mg L-1, while non-acclimatised cultures increased in growth up to 
145.6 mg L-1. A significantly lower dry weight was measured after 1.5 h of shock in 
the acclimatised cultures compared to the non-acclimatised cultures (acclimation and 
shock vs. shock only; 25.5 h, p< 0.05). After 24 h of shock UV-B exposure, cultures 
acclimatised to UV-B (Figure 53A) increased in growth up to a final dry weight 
measurement of 134.4 mg L-1 (µ = 0.0003, Figure 54) whereas the cultures not 
acclimatised to UV-B (Figure 53B) decrease in dry weight to 131.1 mg L-1 during the 
24 h shock phase (24 to 48 h, µ = -0.0053).
 
Figure 53: Dry weight analysis (mg L-1) of C. fritschii cultures during A) UV-B acclimation and shock 
and B) UV-B shock only. Data points are mean values of biological triplicates ± SE. Significant 
differences were measured using a two-sample t-Test, * = 0.05 > p ≥ 0.01, ** = 0.01 > p ≥ 0.001 and 
*** = p < 0.001. 




Figure 54: Growth rate (µ) of UV-B acclimation and shock vs. shock only of C. fritschii cultures. Low 
UV-B and no UV-B accounts for the growth rates between 0 and 24 h and high UV-B accounts for 
growth rate between 24 and 48 h. Data represents mean growth rates of biological triplicates ± SE. 
Pigment concentration showed an increase in levels of both carotenoid and chl a 
content up to 1.5 and 4.7 µg mg-1 dry weight (DW) respectively at 25.5 h with a 
significant increase observed at 24.5 h (24 vs. 24.5 h, p< 0.001) during acclimation 
and shock (Figure 55A). A statistical decrease in pigment was then observed between 
25.5 h and 48 h during high UV-B (Figure 55A; 25.5 vs. 48 h, p< 0.05). During shock 
only UV-B exposure (Figure 55B) an initial increase in levels of chl a and carotenoids 
was observed after 0.5 h of high UV-B to 2 and 6.5 µg mg-1 DW respectively. A 
significant decrease in levels was then measured for both chl a and carotenoids (24.5 
vs. 48 h, p< 0.05) to 1.5 and 4.7 µg mg-1 DW. 
 




Figure 55: Pigment content (µg/mg dry weight) of C. fritschii cultures during A) UV-B acclimation 
and shock and B) UV-B shock only.  Data points are mean values of biological triplicates ± SE. 
Statistical significance was measured using a two-sample t-Test, * = 0.05 > p ≥ 0.01, ** = 0.01 > p ≥ 
0.001 and *** = p < 0.001. 
An increase in both shinorine and m-gly (p<0.01, 0 vs. 24 h) content was observed 
after 24 h of low UV-B exposure (Figure 56A) with further increases in content during 
high UV-B exposure (m-gly, 0 vs. 24.5 h, p<0.001; 0 vs. 48 h, p<0.01). Shinorine and 
m-gly were detected during high UV-B exposure only (Figure 56B) up to 48 h with a 
significant increase (m-gly, 0 vs. 25.5 h, p<0.01; 0 vs. 48 h, p<0.01). Comparing 
between treatments (acclimation and shock vs. shock only), significantly higher levels 
of m-gly were calculated at 24 h (p< 0.01) and 24.5 h (p<0.01) in the acclimatised 
cultures.  




Figure 56: MAA content (µg/mg dry weight) of C. fritschii cultures during A) UV-B acclimation and 
shock and B) UV-B shock only.  Data points are mean values ± SE. Signifiacnt differences were 
measured using a two-sample t-Test comparing 0 h to each time point (24, 24.5, 25.5 and 48 h), * = 
0.05 > p ≥ 0.01, ** = 0.01 > p ≥ 0.001 and *** = p <0.001. 
4.2.1.2 Intracellular metabolite levels 
UV-B shock only 
During UV-B shock only, a total of 396 peaks were detected, 67 of those were 
identified and 329 were left unassigned. Initially, 171 significant peaks were detected 
using a two-sample t-Test with equal variance comparing 0 and 24 h (no UV-B). 43 
of those peaks (11% of total amount of peaks) significantly reduced in levels (negative 
log2FC) whereas 128 peaks (32% of total) had significantly increased levels (positive 
log2FC). An increase in significant peaks (185 peaks) was observed by increasing the 
intensity of UV-B (high UV-B, 24 vs. 48 h). 53 (13% of total) showed significantly 
elevated metabolite levels (positive log2FC) with 132 (33% of total) showed a 
significant decresase in normalised abundances (negative log2FC) (Figure 57).  




Figure 57: Number of detected peaks that show significant differences (p<0.05) during acclimation 
and shock (total peaks = 428) and shock only (total peaks = 396) comparing 0 vs. 24 h (low UV-B or 
no UV-B) and 24 vs. 48 h (high UV-B) using a two-sample t-Test with equal variance. The percentage 
of significant peaks with positive and negative log2 FC comparing 0 vs. 24 h (low UV-B or no UV-B) 
and 24 vs. 48 h (high UV-B) is also presented. 
UV-B acclimation and shock  
During UV-B acclimation and shock a total of 428 peaks were detected, 101 of those 
were identified and 327 left unassigned. 141 significant peaks were observed during 
the acclimation phase of low UV-B exposure (0 vs. 24 h; 33% of total peaks). 70 
peaks (17% of total) showed increasing normalised abundances (positive log2FC) and 
71 (16% of total) showed a decrease in levels (negative log2FC). After shock UV-B 
exposure (high UV-B), the number of significant peaks (24 vs. 48 h) remained the 
same (33%). An increase in peaks elevating in levels (18%, 78 peaks) and 14% 
decreasing in levels (62 peaks) was observed (Figure 57).  
UV-B acclimation and shock vs. shock only 
A greater number of significantly elevated metabolite levels were detected during the 
non-acclimation phase (UV-B shock only, 0 vs. 24 h) compared to the UV-B 
acclimation phase (0 vs. 24 h). After 24 h of high UV-B, cultures not acclimatised 
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previously to low levels of UV-B increased in significance (47%) with a significant 
reduction in metabolite levels (negative log2FC, 24 vs. 48 h). Significant differences 
in cultures acclimatised to low UV-B followed by shock exposure did not change 
between the two phases (low UV-B 0 vs. 24 h, high UV-B 24 vs 48 h) demonstrating 
that cells can withstand the more damaging effects of higher intensity UV-B after 
acclimation phase. A greater level of significantly reduced abundances was observed 
during shock only high UV-B phase (24 vs. 48 h).  
No metabolites relating to cyanobacterial metabolism were identified, with a match 
factor >60%, during the UV-B exposure experiment.  
4.2.2 UV-A acclimation and shock vs. shock only 
4.2.2.1 Dry weight, pigment analysis and production of MAAs 
Similar dry weight patterns were observed for both acclimatised (Figure 58A) and 
non-acclimatised (Figure 58B) C. fritschii cultures during UV-A exposure with no 
significance comparing each time point (two-sample t-Test; acclimation and shock vs. 
shock only at 0, 24, 24.5, 25.5 and 48 h). An increase in dry weight from 186.7 mg L-
1 to 196.7 mg L-1 was observed after 24 h of low UV-A  with no significance (p>0.05).  
A decrease during the first 24 h of non-acclimatisation (PAR only) was obsereved from 
193.3 mg L-1 to 186.7 mg L-1 again, with no significance (p> 0.05). A higher significant 
increase in dry weight was observed between 24 h and 48 h of cultures acclimatised to 
low UV-A followed by shock with high UV-A (24 vs. 48 h, p< 0.01) compared to 
shock only cultures (24 vs. 48 h, p< 0.05) but a slight increased growth rate (Figure 
59) was measured during shock only exposure (24 to 48 h, µ = 0.03) compared to 
acclimatised cultures (24 to 48 h,  µ = 0.028) with no significance calculated between 
the two (acclimation and shock vs. shock only; high UV-A, p> 0.05). The growth rates 
(Figure 59) both showed significant increase comparing low UV-A (µ = 0.002) vs. 
high UV-A (µ = 0.028, p<0.01) and no UV-A (µ = -0.002) vs. high UV-A (µ = 0.03, 
p<0.01) in both acclimatised and non-acclimatised cultures. 




Figure 58: Dry weight analysis (mg L-1) of C. fritschii cultures during A) UV-A acclimation and shock 
and B) UV-A shock only. Data points are mean values of biological triplicates ± SE. Statistical 
significance was measured using a two-sample t-Test, * = 0.05 > p ≥ 0.01, ** = 0.01 > p ≥ 0.001 and 
*** = p < 0.001 
.  
Figure 59: Growth rate (µ) of UV-A acclimation and shock vs. shock only of C. fritschii cultures. Low 
UV-A and no UV-A accounts for the growth rates between 0 and 24 h and high UV-A accounts for 
growth rate between 24 and 48 h. Data represents mean growth rates of biological triplicates ± SE 
Pigment concentration of chl a and carotenoids were measured during the time series. 
No significant difference in levels was observed during acclimation to low UV-A (0 
vs. 24 h) or during the shock, high UV-A, phase (24 vs. 48 h) in both chl a and 
carotenoid concentrations (Figure 60A). A significant increase in chl a and carotenoid 
content was measured during the non-acclimation phase (Figure 60B; 0 vs. 24 h; chl 
                                                                            
128 
 
a, p<0.05; carotenoid, p<0.001) as well as during the first 1.5 h of the shock phase 
(high UV-A: Carotenoids; 0 vs. 24.5 and 0 vs. 25.5, p<0.01). 
 
Figure 60: Pigment content (µg/mg dry weight) of C. fritschii cultures during A) UV-A acclimation 
and shock and B) UV-A shock only.  Data points are mean values of biological triplicates ± SE. 
Statistical significance was measured using a two-sample t-Test, * = 0.05 > p ≥ 0.01, ** = 0.01 > p ≥ 
0.001 and *** = p < 0.001. 
Significant increases in shinorine content was measured after low UV-A (0 vs. 24 h, 
p< 0.01), and during high UV-A exposure (p< 0.05, 0 vs. 48 h). M-gly content also 
increased after 24 h of low UV-A followed by 24 h of high UV-A exposure (0 vs. 48 
h, p<0.05) (Figure 61A). No MAAs were detected during PAR only exposure (shock 
only cultures, up to 24 h), but significant increases in shinorine and m-gly was 
measured during high UV-A exposure (shinorine, 0 vs. 24.5, 0 vs. 25.5, p<0.001; 0 vs. 
48 h, p<0.05; m-gly, 0 vs. 48 h, p<0.05) (Figure 61B). Comparing between treatments 
(acclimation and shock vs. shock only), a significant increase in shinorine levels was 
calculated in acclimatised cultures after 24 h and 25.5 h acclimation and shock vs. 
shock only, 24 h and 25.5 h p< 0.01) 




Figure 61: MAA content (pg/mg dry weight) of C. fritschii cultures during A) UV-A acclimation and 
shock and B) UV-A shock only.  Data points are mean values ± SE. Significant differences were 
measured using a two-sample t-Test comparing 0 h to each time point (24, 24.5, 25.5 and 48 h), * = 
0.05 > p ≥ 0.01, ** = 0.01 > p ≥ 0.001 and *** = p < 0.001. 
4.2.2.2 Intracellular metabolite levels 
UV-A shock only  
C. fritschii cultures were grown for 24 h under PAR only conditions (no UV-A) 
followed by 24 h of shock UV-A exposure (high UV-A). Samples for intracellular 
metabolite analysis were collected at 0, 24 and 48 h for GC-MS analysis.  
After analysis of the GC-MS data, a total of 332 peaks were detected. 127 of those 
were identified with a match factor ≥ 60% (level 2) and 205 remained unassigned 
where the acquired mass spectra had match factors < 60% (level 4). 
Using a two-sample t-Test with equal variance comparing between time points (0, 24 
and 48 h), 92 significant peaks (28% of total peaks, 332) were observed during the no 
UV-A phase (0 vs. 24 h). 15% of those increased significantly in levels (50 peaks with 
positive log2FC) and 13% decreased significantly (42 peaks with negative log2FC). 
194 significant peaks were detected during the high UV-A phase (59% of 332 total 
peaks; 24 vs. 48 h), with 16% elevating significantly in levels (52 peaks with positive 
log2FC) and 142 significantly reduced peaks (43% with negative log2FC, Figure 62). 




Figure 62: Total number of detected peaks that show significant differences (p<0.05) during 
acclimation and shock (total peaks = 293) and shock only (total peaks = 332) comparing 0 vs. 24 h (low 
UV-A or no UV-A) and 24 vs. 48 h (high UV-A) using a two-sample t-Test with equal variance. The 
number of significantly different peaks with positive and negative log2 FC comparing 0 vs. 24 h (low 
UV-A or no UV-A) and 24 vs. 48 h (high UV-A) is also presented.  
33 identified peaks could be related back to pathways within cyanobacterial 
metabolism such as central carbon and nitrogen metabolism (Table S7).  
The amino acids identified included; glu, val, pro, asp and ala. A significant decrease 
in glu (p<0.01, 0 to 24 h) was observed after 24 h of PAR only. Val increased after 24 
h, followed by a decrease after 24 h of high UV-A exposure (24 vs. 48 h, p<0.05). Asp 
also increased after 24 h of PAR only (0 vs. 24 h, p<0.05) followed by a decrease after 
shock UV-A exposure (24 vs. 48 h, p<0.05), ala increased after 24 h of high UV-A 
exposure (p<0.05, 24 vs. 48 h). Pro increased after 24 h and decreased following high 
UV-A exposure with no significance (p>0.05).  
The 3 saturated fatty acids; mystiric, palmitic and stearic acid showed similar levels 
throughout the time series. All three increased after the first 24 h of PAR only (no UV-
A) with no significance followed by a decrease in levels after 24 h of shock (high UV-
A) showing significant difference in palmitic acid (24 vs. 48 h, p<0.05) and stearic 
                                                                            
131 
 
acid (24 vs. 48 h, p<0.05) levels. Two mono-unsaturated fatty acids were detected; 
oleic acid showed an increase in levels after 24 h with a reduction after 24 h of high 
UV-A (p>0.05), palmitoleic acid accumulation was observed after 24 h (no UV-A; 0 
vs. 24 h, p<0.001) followed by a slight decrease in levels with no significance after 
high UV-A exposure.  
Galactose, sucrose and raffinose levels accumulated after shock exposure to 24 h of 
high UV-A with significance observed in galactose levels (24 vs. 48 h, p<0.001). 
Glycerol levels decreased significantly after 24 and 48 h (0 vs. 24, 0 vs. 48 h, p<0.01) 
whereas glycerol-3-phosphate levels increased after 24 h of no UV-A (0 vs. 24 h, 
p<0.05) and after 24 h of shock UV-A (0 vs. 48 h, p<0.05).  
Lactate levels increased significantly after the first 24 h (0 vs. 24 h, p<0.05) with a 
decrease in levels after shock UV-A (no significance, p>0.05).  
UV-A acclimation and shock 
293 peaks were detected with 112 identified with a chemical name and class (level 2) 
with 181 left unassigned (level 4). 104 of those peaks showed significance comparing 
0 and 24 h of low UV-A (36% of total detected, 293). 14% of those (41 peaks) 
increased significantly (41 peaks with positive log2FC) whilst 22% decreased 
significantly in levels (63 peaks with negative log2FC). 99 significant peaks were 
detected during high UV-A comparing 24 and 48 h (34% of 293 total detected).  11% 
of those had elevated levels by 48 h (33 peaks with positive log 2FC) and 23% 
decreased significantly (66 peaks with negative log2FC, Figure 62).  
27 of the identified peaks could be related back to central metabolism within 
cyanobacteria (Table S7). The three amino acid, glu, val and pro were identified. Glu 
and pro decreased in abundance during the time series with significance (glu, 0 vs. 48 
h, p<0.001; pro, 24 vs. 48 h, p<0.05). The fatty acids mystiric, palmitic and stearic 
acid showed no significant differences but levels decreased after 24 h of high UV-A. 
The sugars sucrose and trehalose increase in levels up to 48 h with no significance 
(p>0.05). Phytol, a terpanoid involved in chlorophyll metabolism decreased in levels 
after 48 h (24 h of acclimation to low UV-A followed by 24 h of high UV-A) with 
significance (p<0.05, 24 vs. 48 h). 
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UV-A acclimation and shock vs. shock only  
Despite very similar growth rates between UV-A acclimation and shock and shock 
only (Figure 59), metabolite profiles showed differences (Figure 62). A greater 
number of significantly elevated metabolites were observed in no UV-A phase 
compared to acclimation to low UV-A (0 vs. 24 h). By increasing the intensity of UV-
A, the increased total reduced metabolites showed significance after high UV-A with 
no previous acclimation compared to high UV-A with acclimation to low UV-A dose 
(24 vs. 48 h). Low UV-A has a lesser effect on C. fritschii as results indicate more 
similarity between low UV-A acclimation and no acclimation. Once the intensity of 
UV-A had increased, the cultures already acclimatised show lower significantly 
reduced levels whereas during high UV-A (without an acclimation phase), cultures 
show higher significant differences and an increase in reduced abundances as indicated 
by the negative log2FC (24 vs. 48 h).     
24 common metabolites were identified within the two treatment groups (11 
represented in Figure 63). Similar patterns were observed for mystic acid, stearic acid, 
palmitic acid, sucrose, trehalose, arabinose and glu. Differences in patterns were 
observed between pro, phytol, glycerol 3-phosphate raffinose and fructose.  




Figure 63: Common metabolites identified in both UV-A acclimation & shock and shock only cultures. 
Data points are mean values of biological replicates ± SE. Significant differences were measured using 








The intensity of UV and the duration of the acclimation phase (24 h) were chosen from 
the dry weight curves from previous experiments (Chapter 3). After 24 h of UV-A 
(Figure 47) and UV-B (Error! Reference source not found.) exposure, the dry weight 
increased indicating the acclimation of cells to UV.  
UV-A and UV-B affects cyanobacteria and other photosynthetic organisms in a variety 
of ways [24]. UV-B is more detrimental to cells as it causes direct and indirect damage 
whereas UV-A causes indirect damage by the production of ROS [27]. UV activates 
secondary metabolism resulting in the production of secondary metabolites such as 
MAAs and antioxidants that have potential industrial application [16,23].  
C. fritschii is seen to withstand higher levels of UV-B irradiation after pre-treatment 
with low dose UV-B suggesting UV stress tolerance and adaptation. Growth was 
unaffected by UV-A acclimation and shock with increased dry weight at 48 h or both 
treatments.  This is due to the less detrimental effect of UV-A on photosynthetic cells 
[27]. 
After low dose UV-B, an increase in pigment content (chl a and carotenoid) was 
observed. This is the response of cells to ROS production and the antioxidant ability 
of carotenoids as previously described (Chapter 3). Both acclimatised and non-
acclimatised cultures decreased in carotenoid content after 24 h of high levels of UV-
B. This could be due to the increased production of the sunscreen compounds MAAs 
which protect cells by absorbing excess radiation and dissipating as heat without the 
production of ROS [23]. Significant increases in pigment content in UV-A exposed 
cultures were observed during shock only again showing antioxidant abilities of 
carotenoids to ROS formation by indirect UV-A damage [138]. 
Increased MAAs were observed during UV-B low dose (acclimation) and high dose 
(shock). There were increased levels in acclimatised cultures with no significant 
differences to non-acclimatised cultures. Increased MAAs were also observed during 
low and high UV-A exposure, with again increased levels after acclimation. This again 
indicates the possible stress tolerance of C. fritschii to the increased levels of UV. 
Metabolism has already been rearranged for the production of MAAs thus preparing 
the cells for further UV protection. Further investigations are needed to assess if the 
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concentration can be increased significantly with acclimatisation followed by shock 
exposure as a tool in industrial biotechnology to increase production of MAAs [16]. 
Overall a higher number of peaks with significantly reduced levels were detected 
during high UV-A and UV-B exposure only (negative log2FC). Although metabolite 
levels decreased overall in both UV-A and UV-B experiments, cultures acclimatised 
had a lower negative impact on metabolism. This also indicates the acclimation of 
cyanobacterial cultures to low dose UV, thus preparing cell metabolism for additional 
UV exposure as mentioned above.   
During UV-B experiment, no biologically relevant metabolites relating to 
cyanobacterial metabolism were identified during the 48-h time-series. This could be 
due to a number of reasons including the identification process. For an identification 
to be made within these experiments, the mass spectrum of the sample must match 
with reference spectra at a threshold of ≥60% (level 2 identification [63]). Within these 
specific samples, no metabolites relating to cyanobacterial metabolites could be 
identified at this threshold. To overcome this in the future, standards of relevant 
metabolites should be run to confidently identify these metabolites (level 1 
identification [63].    
During the UV-A experiment, many identified metabolites had similar patterns as 
observed in the 48 h UV-A experiment (Chapter 3). Fatty acids showed increases 
during low dose UV-A and PAR only, followed by a decrease in normalised abundance 
after 24 h of shock UV-A. This decrease could be due to the higher levels of UV-A. It 
is hypothesised that saturated fatty acids are desaturated during UV exposure to 
produce unsaturated fatty acids which have roles in UV protection. These unsaturated 
fatty acids possess double bonds which are throught to quench radicals produced by 
UV radiation. This is a controversial topic which needs further exploration [139]. 
Unsaturated fatty acids are also constituents of glycerolipid membranes and control 
their fluidity. Membrane fluidity is important for tolerance and acclimatisation to 
environmental stressors [140].  
Raffinose and sucrose showed higher accumulation during UV-A shock, with only 
treatments with sucrose having a role in stress tolerance in cyanobacteria. Sucrose acts 
as a compatible solute (i.e, it does not interfere with cell metabolis) during salt stress 
[99,127]. Reduction in lactate levels during UV-A shock only could indicate the 
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rearrangement of metabolism to prioritise mechanisms of secondary metabolite 
productions [120].   
Glycerol 3-phosphate (G3P), involved in triacylglycerol (TAG) synthesis, has been 
seen to play a role in stress response in red algae [141]. Levels show accumulation in 
shock only cultures compared to decreasing levels in acclimatised cultures. TAG 
accumulation (via a decrease in G3P) can represent acclimation mechanisms [142].  
Overall these results show that acclimatising cultures to lower dose UV (UV-A and 
UV-B) followed by high dose UV allows for better re-organisation of metabolism 
within C. fritschii cells as seen by the GC-MS results. Further investigations are 
needed to evaluate the changes at the metabolite levels during UV-B acclimation and 
shock.  
4.4 Conclusion 
In summary, similar dry weight was observed throughout the UV-A time-series 
showing C. fritschii’s ability to adapt to UV-A stress over 48 h.  As this is a short-term 
study, evaluation of the long-term effects of UV-A at the metabolite level is needed as 
well as during a recovery period after UV-A exposure. An initial decrease in dry 
weight after 1.5 h of shock UV-B shows the initial direct damage to cells followed by 
further acclimation up to 24 h of shock exposure. UV-B induced production of higher 
levels of MAAs during shock exposure in both acclimatised and non-acclimatised 
cultures. A lesser negative impact on cell metabolism was observed after acclimation 
followed by shock UV-B exposure as seen in the GC-MS data indicating the stress 
tolerance and adaptation of C. fritschii. Further work is needed to identify these 
changes at the metabolite level in UV-B exposure acclimation and shock.  
To my knowledge, this is the first UV acclimation followed by shock study to 
investigate the metabolite level changes in cyanobacteria, including C. fritschii. As 
mentioned previously, these experiments add to the knowledgebase of cyanobacterial 
adaptation to UV-A and UV-B exposure at the metabolite level as measured by GC-
MS. Manipulation of abiotic stress such as UV can further increase productivity of 
industrially relevant metabolites and improvement of UV tolerance in relevant species. 
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Chapter 5: Bioactivity Assessment of Chlorogloeopsis 
fritschii, PCC 6912 in in-vitro anti-infalmmatory and 
antibacterial assays  
Aims  
• To cultivate C. fritschii under industrial conditions followed by sequential solvent 
extraction of biomass for bioactivity analysis.  
• To develop an anti-inflammatory model using HaCaT cells.  
• To use the developed method for the analysis of C. fritschii extracts. 
• To test the effect of C. fritschii extracts on HaCaT proliferation using the real time 
iCELLigenceTM system. 
• To test extracts for antibacterial activity against S. epidermis using the 
microdilution method.  




















Natural products from a variety of photosynthetic organisms such as; plants,  
macroalgae and microalgae have been widely investigated for their bioactive 
properties for uses in pharmaceuticals, cosmetics and nutraceuticals [143–146]. These 
provide sustainable alternatives to synthetic ingredients and are thought to be safer for 
human use and more environmentally friendly [147,148].  
Cyanobacteria are promising sustainable alternatives to current sources of ingredients. 
They have simple growth needs, can utilise flue gas from industry as a source of CO2 
and can be harvested throughout the year (non-seasonally). They have higher 
photosynthetic rates compared to plants and need less land area for cultivation. As 
prokaryotes they can be easily manipulated to form cell factories for higher production 
rates of valuable industrial compounds [1,16,149]. Cyanobacteria produce a vast array 
of bioactive metabolites with a variety of chemical structures. These compounds have 
potential applications as; anti-inflammatory, antimicrobial, photo-protective, 
moisturising and antioxidant ingredients for personal care products [13,16,31]. 
The skin is the largest organ of the body. Functions include maintaining homeostasis 
in a variety of conditions and providing a protective barrier against the environment 
[150]. It is made up of 2 major layers; the epidermis and dermis comprising of a variety 
of cell types such as; keratinocytes and fibroblasts [150].  
Inflammation is the response of the immune system to a variety of harmful stimuli  
involving immune cells, blood vessels and molecular mediators (such as cytokines and 
chemokines) [150]. Prolonged inflammation can result in many acute and chronic 
diseases such as cancer, diabetes, atherosclerosis, rheumatoid arthritis and 
Alzheimer’s disease [151]. 
Inflammation of the skin occurs from infections and tissue damage from external 
factors such as microorganisms and UV exposure and from our own internal response 
to stress [151,152]. This can cause atopic dermatitis, acne vulgaris (acne), psoriasis 
and erythema (sunburn) to name a few. Increased ROS levels (from UV exposure) are 
associated with oxidative stress and protein oxidation. This can initiate inflammatory 
responses which are related to increased skin ageing [153,154].  
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Keratinocytes are the primary cell type and the major source of cytokines in the 
epidermis [155]. They can be used in in vitro skin models to evaluate pro-
inflammation, anti-inflammation and proliferation [156]. HaCaT cells are a 
spontaneously immortalised keratinocyte cell line which have many similarities to 
primary keratinocytes [157]. They can be used as an alternative as they have a longer 
culture lifetime and do not vary between passages [156]. 
Cyanobacterial extracts and pure compounds have been evaluated for anti-
inflammatory, antioxidant and antibacterial properties. Examples include; C-
phycocyanin from Spirulina platensis showed anti-inflammatory activity in 
lipopolysaccharide (LPS)-treated RAW 264.7 macrophages [158]. Nostoc commune 
and Spirulina platensis lipid extracts also showed anti-inflammatory activity in LPS-
treated RAW 264.7 macrophages by reducing pro-inflammatory cytokines (TNF-α, 
IL-1β and IL-6) [159]. MeOH extracts from Nostoc commune Vauch showed 
antimicrobial activity against Bacillus subtilis, Staphylococcus aureus and Candida 
albicans using the agar diffusion assay [160]. 
This chapter aims to assess extracts from the cyanobacterium C. fritschii in in-vitro 
assays to evaluate anti-inflammatory, proliferation and antibacterial activity. To then 
use complementary GC-MS analysis of extracts for further elucidation of active 
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5.1  Material and methods 
5.1.1  Anti-inflammatory model development 
5.1.1.1 Seeding density experiment 
For the HaCaT cell seeding density experiment, a dilution series of cell concentrations 
was prepared (Table 7). Each dilution was added to a 24 microplate (1 mL well-1) and 
an E8 iCELLigence plate (320 µL well-1) to determine the concentration of cells 
required for pro-/anti-inflammatory and proliferation assays (Section 1.8.3.3.1.). 
5.1.1.2 Pro-inflammatory dose response in HaCaT cells  
For pro-inflammatory dose response in HaCaT cells, TNF-α and IL-1β at final 
concentrations of 10, 5, 1 ng mL-1 and 1, 0.5, 0.1 ng mL-1 respectively (Table 8) were 
investigated using two concentrations of FBS in DMEM (10% FBS; plate 1 and 1% 
FBS; plate 2) to determine the best mediator to induce the secretion of IL-6 and IL-8 
in HaCaT cells (Section 1.8.3.3.3). 
5.1.1.3 Pro-inflammatory dose response of TNF-α (10% FBS in DMEM)  
The procedure above (Section 5.2.1.2.) was repeated with an increased range of TNF-
α at final concentrations of; 10, 5, 1, 0.5, 0.1, 0.01 and 0 ng mL-1 (Table 9) in DMEM 
supplemented with 10% FBS only to determine the lowest concentration needed to 
stimulate IL-6 and IL-8 at sufficient quantities for anti-inflammatory experiments 
(Section 1.8.3.3.4.).  
5.1.1.4 Anti-inflammatory dose response of hydrocortisone in TNF-α induced 
inflammation in HaCaT cells.  
Anti-inflammatory dose response of hydrocortisone (HC) was investigated to 
determine the dose of HC required to inhibit TNF-α induced inflammation in HaCaT 
cells. Final concentrations of 10, 1, 0.1, 0.01, 0.001, 0.0001 and 0 µM (Table 10) were 
chosen with TNF-α (1 ng mL-1) as a pro-inflammatory mediator (Section 1.8.3.3.5.).  
5.1.1.5 Anti-inflammatory activity of pooled C. fritschii extracts in TNF-α 
induced inflammation of HaCaT cells  
Anti-inflammatory dose response of pooled C. fritschii UV-B and control extracts 
(Section 1.8.1.3. and 1.8.1.4) were investigated at final concentrations of 10, 5, 1, 0.5, 
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0.1, 0.01 and 0 µg mL-1 with HC as a control (10 µM) and TNF-α (1 ng mL-1) as a pro-
inflammatory mediator (Section 1.8.3.3.6.). 
5.1.1.6 Anti-inflammatory activity of individual C. fritschii extracts in TNF-α 
induced inflammation of HaCaT cells  
Anti-inflammatory dose response of individual C. fritschii UV-B and control extracts 
(Section 1.8.1.3. and 1.8.1.4) were investigated at final concentrations of 1, 0.5, 0.1 
and 0 µg mL-1 with HC as a control (10 µM) and TNF-α (1 ng mL-1) as a pro-
inflammatory mediator (Section 1.8.3.3.7.). 
5.1.2 Proliferation assay using iCELLigence real time analysis  
Cell proliferation assay was conducted using real time iCELLigence system. 
C.fritschii pooled control extracts 10, 5, 1, 0.5, 0.1 and 0.05 μg mL-1 (n=2) and control 
and UV-B pooled extracts at concentrations of 0.5, 0.25 and 0.1 μg mL-1 (n=2) were 
investigated (Section 1.8.4.) 
5.1.3 Anti-inflammatory activity of m-gly  
Anti-inflammatory dose response of m-gly (Section 1.8.2.) was investigated at final 
concentrations of 50, 25, 12.5, 6.25, 3.125 and 0 µM with HC as a control (10 µM) 
and TNF-α (1 ng mL-1) as a pro-inflammatory mediator (Section 1.8.3.3.8.). 
5.1.4 Antibacterial activity of C. frtischii extracts vs. S. epidermis 
Antibacterial activity of pooled and individual UV-B and control extracts were 
investigated against the test bacterium S. epidermis at concentrations ranging from 0.5 
– 0.0156 mg mL-1 and 0.5 – 0.03125 mg mL-1 respectively (Section 1.8.5.). 
5.1.5 GC-MS analysis of C. fritschii extracts  
200 µL of each extract was dried in a vacuum concentrator (Section 1.8.1.3.) and 
derivatised as in Section 1.3.3. GC-MS analysis was carried out using a PerkinElmer 
Turbo MassTM (.raw files) with the same parameters and analysis as in Section 1.3.4. 
– 1.3.7. Statistical analysis was carried out on the identified biologically relevant 
metabolites only using the statistical analysis module in MetaboAnalyst. Statistical 
analysis was carried out using each column as a different extract (n=3) and each row 
representing a metabolite (data type = peak intensity table; data format = samples in 
columns, unpaired). Missing data was replaced with half of the minimum integrated 
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signal prior to analysis. Peaks were normalised to total sum of peaks, log transformed 
and mean centred prior to statistical analysis. PCA, a one-way ANOVA (p<0.05) with 
post-hoc Tukey’s honestly significant difference (HSD) and hierachial heat map 
clustering was used to evaluate the data. A two sample t-Test with equal variance was 
also used as a univariate statistical tool to evaluate data comparing each extract in 


















                                                                            
143 
 
5.2 Results  
5.2.1 Model development of an anti-inflammatory assay using HaCaT cells 
5.2.1.1 Cell seeding density 
To begin model development, the optimum density of HaCaT cells was evaluated for 
use in anti-inflammatory assays. Cells were seeded at a variety of concentrations in a 
24 well plate and growth was assessed using microscopic analysis after 24 and 48 h 
(Figure 64). Concentrations of 1 x 103 and 5 x 103 cells mL-1 were too dilute and the 
large spaces between cells prevented proliferation. Cells at a concentration of 1 x 105 
cell mL-1 were able to reach a confluent monolayer after 24 h and therefore chosen for 
subsequent anti-inflammatory models. Inflammation can then be induced evenly 
across the monolayer of cells.  
 




Figure 64: Microscope images (x4 lens) after 24 h and 48 h of growth of different cell densities of 
HaCaT cells in a 24 well plate.  
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5.2.1.2 Pro-inflammatory mediators 
Once the correct cell seeding density was chosen (1 x 105 cells mL-1) an appropriate 
pro-inflammatory mediator was needed to induce inflammation in monolayers of 
HaCaT cells. These are signalling molecules that are secreted from immune defence 
cells to promote inflammation [161] and include tumor necrosis factor alpha (TNF-α) 
and interleukin-1β (IL-1β) [162].    
HaCaT cells were firstly exposed to varying concentrations of TNF-α (1, 5 and 10 ng 
mL-1) and IL-1β (0.1, 0.5, 1 ng mL-1) for 24 h to stimulate the secretion of the pro-
inflammatory cytokines; IL-6 and IL-8. This was tested using media supplemented 
with 1% fetal bovine serum (FBS) and 10% FBS to see the effects of media 
supplementation on the induction of inflammation. The secretion of IL-6 and IL-8 was 
measured using an enzyme-linked immunosorbent assay (ELISA). Results showed an 
increased secretion of IL-6 and IL-8 with TNF-α treatments (Figure 65A and B). 
Significance in IL-8 secretion was observed comparing vehicle control (H2O; 0 ng mL
-
1) and 5 ng mL-1 (p<0.01) and 10 ng mL-1 (p<0.001) of TNF-α in 10% FBS (Figure 
65A) and at 10 ng mL-1 of TNF-α in 1% FBS (IL-6; p<0.05, IL-8; p<0.05) (Figure 
65B). For both TNF-α and IL-1β, an increased secretion in both IL-6 and IL-8 was 
observed with 10% FBS supplementation (Figure 65A and C). From these results, 
TNF-α was therefore chosen to stimulate the secretion of IL-6 and IL-8 in HaCaT cells 
cultured in 10% DMEM.  
 




Figure 65: Evaluation of IL-6 and IL-8 secretion in A & B) TNF-α and C & D) IL-1β stimulated HaCaT 
cells. HaCaT’s were exposed to concentrations of TNF-α (1, 5 and 10 ng mL-1) and IL-1β (0.1, 0.5 and 
1 ng mL-1) and vehicle control (H2O, 0 ng mL
-1) for 24 h. Cells were cultured in A & C) 10% FBS in 
DMEM and B & D) 1% FBS in DMEM. Data represents mean values (n=3) ± standard deviation (SD). 
Significance was calculated comparing TNF-α or IL-1β concentrations to the vehicle control using a 
two-sample t-Test. * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and *** = p<0.001. 
5.2.1.3 TNF-α dose response  
A dose dependant response using varying concentrations of TNF-α in 10% FBS was 
evaluated for IL-6 and IL-8 cytokine secretion (Figure 66). Data was normalised to 
protein content to remove variations in cell growth. A significant increase in IL-6 
secretion was observed after 24 h of treatment with 0.5 (p<0.05), 5 (p<0.001) and 10 
(p<0.05) ng mL-1. Overall, a higher amount of IL-8 was secreted from HaCaT cells 
with significance at 0.5 ng mL-1 (p<0.01), 1, 5 and 10 ng mL-1(p<0.001). 




Figure 66: Evaluation of A) IL-6 and B) IL-8 secretion in TNF-α stimulated HaCaT cells. HaCaT’s 
were exposed to varying concentrations of TNF-α (0.01 - 10 ng mL-1) and vehicle control (H2O) for 24 
h. Data represents mean values (n=3) ± SD. Significance was calculated comparing TNF-α 
concentrations and vehicle control using a two-sample t-Test. * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and 
*** = p<0.001. 
5.2.1.4 Hydrocortisone dose dependant anti-inflammatory activity 
Hydrocortisone (HC) was chosen as a positive control as a known anti-inflammatory 
agent. From the previous experiment 10 ng mL-1 of TNF-α was chosen to ensure 
maximum induction of inflammation in the HaCaT cells. Dose dependant anti-
inflammatory activity was evaluated. Results showed reduced IL-6 and IL-8 secretions 
with higher HC concentrations (Figure 67) (IL-6; 0.1, 1 and 10 µM, p<0.001and IL-
8; 0.1 µM p<0.05, 1 µM p<0.01 and 10 µM p<0.001). HC at a concentration of 10 µM 
was therefore chosen to ensure high anti-inflammatory response. 




Figure 67: Hydrocortisone (HC) dose response of A) IL-6 and B) IL-8 secretion in TNF-α stimulated 
HaCaT cells. HaCaT’s were exposed to varying concentrations of hydrocortisone (10 – 0.0001 µM) or 
vehicle control (DMSO, 0 µM) for 24 h followed by incubation with TNF-α (10 ng mL-1) and HC or 
vehicle control for a further 24 h. Data represents mean values (n=3) ± SD. Significance was calculated 
comparing HC vehicle control  to HC doses using a two-sample t-Test* = 0.05>p≥0.01, ** = 
0.01>p≥0.001 and *** = p<0.001. 
Induction of HaCaT cells with TNF-α at a dose of 10 ng mL-1 induced higher levels of 
IL-8 secretions. A lower dose of 1 ng mL-1 of TNF-α was therefore chosen for further 
evaluations of C. fritschii extracts to ensure activity can be quantified. Due to the 
secretion of IL-6 below detection limit of ELISA kit with 1 ng mL-1 of TNF-α, IL-8 
only was investigated in further experiments.  
Final workflow can be seen in Figure 68. 




Figure 68: Anti-inflammatory method development workflow schematic.  
5.2.2 Analysis of C. fritschii extracts for anti-inflammatory activity 
C. fritschii metabolites were extracted sequentially with 4 solvents of differing polarity 
(Section 1.8.1). The hex, EtOAc, EtOH and MeOH extracts (10 mg mL-1 in DMSO) 
were pooled for assessment of anti-inflammatory activity using the developed model 
above (Figure 68). 
A dose response of the pooled control and UV-B extracts was investigated by 
monitoring IL-8 secretion after incubation with extracts (0.1-10 µg mL-1) and TNF-α 
(1 ng mL-1). During control dose response, a significant reduction in IL-8 secretion 
was observed after the addition of 0.1 µg mL-1 (p<0.01) and 1 µg mL-1 (p<0.01) of 
extract (Figure 69A). Similarly, UV-B exposed pooled extracts reduced IL-8 levels at 
concentrations of 0.1 µg mL-1 (p<0.05) and 0.5 µg mL-1 (UVB, p<0.05, Figure 69B).  




Figure 69: Dose response of A) control C. fritschii pooled extracts and B) UV-B exposed C. fritschii 
extracts on IL-8 secretion in TNF-α stimulated HaCaT cells. HaCaT’s were exposed to extracts or 
vehicle control (DMSO) for 24 h followed by incubation with TNF-α (1 ng mL-1) and extracts for a 
further 24 h. Data represents mean values (n=3) ± SD. Significance was calculated comparing extract 
vehicle control  and extract doses using a two-sample t-Test. * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and 
*** = p<0.001. 
In both experiments the highest concentrations (5 and 10 μg mL-1) show no 
significance (Figure 69). This could be due to the purity of the samples due to vast 
number of metabolites extracted from the C. fritschii cells that could inhibit any anti-
inflammatory activity of specific metabolites. There is no significant increase in IL-8 
secretion which suggests that the pooled extracts do not induce inflammation in HaCaT 
cells.  
After pooled extracts were assessed, the individual solvent extracts were analysed for 
activity at concentrations of 1, 0.5 and 0.1 µg mL-1 compared to the positive control 
(HC, 10 µM) for both control and UV-B extracts. These low concentrations had the 
highest significance in IL-8 reduction from the pooled extract results (Figure 69). An 
extract with the highest response at the lowest concentration is most desirable when 
looking for new active ingredients as it decreases the risk of any adverse effects.  
In the individual control extracts (Figure 70), EtOAc showed a significant reduction 
in IL-8 secretion at 0.1, 0.5 and 1 µg mL-1 (p<0.05). Other significant decreases were 
observed with EtOH (0.5 µg mL-1, p<0.05) and MeOH (0.1 µg mL-1, p<0.05) extracts. 
All extracts showed some reduction in IL-8 secretion and therefore anti-inflammatory 
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activity except for hex. None of the individual extracts increased IL-8 secretion 
significantly above that of TNF-α control (0 µg mL-1) which suggest no pro-
inflammatory activity against HaCaT cells.   
 
Figure 70: Effects of individual control C. fritschii extracts A) Hex, B) EtOAc, C) EtOH and D) MeOH 
on IL-8 secretion in TNF-α stimulated HaCaT cells. HaCaT’s were exposed to extracts or vehicle 
control (DMSO) for 24 h followed by incubation with TNF-α (1 ng mL-1) and extracts for a further 24 
h. Data represents mean values (n=3) ± SD. Significance was calculated comparing extract vehicle 
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Individual UV-B extracts showed little differences in IL-8 secretion (Figure 71). TNF-
α has not been effective in increasing IL-8 levels. No significance between TNF-α and 
blank values were observed. Although this assay has been unsuccessful in analysing 
anti-inflammatory effect of the extracts it does show that these extracts are not pro-
inflammatory. There was no significant increase in IL-8 secretion (p>0.05).  
 
Figure 71: Effects of individual UV-B exposed C. fritschii extracts A) Hex, B) EtOAc, C) EtOH and 
D) MeOH on IL-8 secretion in TNF-α stimulated HaCaT cells. HaCaT’s were exposed to extracts or 
vehicle control (DMSO) for 24 h followed by incubation with TNF-α (1 ng mL-1) and extracts for a 
further 24 h. Data represents mean values (n=3) ± SD. Significance was calculated comparing extract 
vehicle control  and extract doses using a two-sample t-Test. * = 0.05>p≥0.01, ** = 0.01>p≥0.001 and 
*** = p<0.001. 
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5.2.3 Anti-inflammatory activity of mycosporine-glycine  
M-gly is one of two MAAs produced by C. fritschii (other being shinorie). Chapters 3 
and 4 show that upregulation of MAA synthesis is seen during UV exposure. Although 
there is an increase in m-gly production during UV-B stress, the amount produced per 
gram of biomass is not enough to extract and use in anti-inflammatory models 
effectively. Due to this, heterologous expression in E. coli was used to produce a 
higher yield of m-gly to test in the developed model. This is an excellent prospect for 
industrial biotechnology by adding biosynthetic gene clusters to fast growing species 
such as E. coli to combat the low production yields of high value products.  
A promising dose response (Figure 72) was observed with the lower concentrations 
reducing IL-8 secretion the most (no significance observed, p>0.05). IL-8 increased 
with the higher concentrations of m-gly (25 and 50 μM) which could be due to the 
purity of the extract. As the m-gly had a purity of 16% many different compounds 
could also be present within the extract which could increase inflammation as 
discussed above.  
 
Figure 72: Effect of m-gly on IL-8 secretion in TNF-α stimulated HaCaT cells. HaCaT’s were exposed 
to m-gly (3.124-50 μM), HC (10 μM) or vehicle control (H2O) for 24 h followed by incubation with 
TNF-α (1 ng mL-1) and m-gly for a further 24 h. Data represents mean values (n=3) ± SD 
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5.2.4 Effect of C. fritschii extracts on HaCaT proliferation  
For proliferation assessment, real-time analysis was conducted using the RTCA 
iCELLigenceTM system where cell proliferation can be monitored label-free [163]. 
This gives advantages over the traditional end-point labelled methods such as WST-1 
and MTT assays [164,165]. Increased cell index (CI) shows the increased level of cell 
adherence to the bottom of the wells. To begin, Seeding density was optimised by 
seeding HaCaT cells at varying concentrations and measuring cell index over 48 h. 5 
x 104 cells mL-1 were confluent by 24 h whereas 1 x 104 cells mL-1 showed cell 
proliferation up to 48 h (Figure 73). A cell concentration between these two values, at 
2 x 104 cells mL-1, was therefore chosen as cells need to be in a growth phase during 
treatment to evaluate how extracts affect cell proliferation (Figure 73). 
 
Figure 73: iCELLigence data of cell density experiment over approx. 48 h. Data points are mean values 
of 2 replicates (n=2).  
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Proliferation experiments were then conducted using pooled control and UV-B 
extracts. After dosing HaCaT cells with pooled extracts for 24 h, a slight increase in 
proliferation was observed with the control extracts. A second experiment was 
conducted with an increase in proliferation time to 72 h. Both control and UV-B 
exposed extracts were evaluated at concentrations of 0.1, 0.25 and 0.5 μg mL-1 with 
little difference compared to the extract free control. 
 
Figure 74: Rate of HaCaT cell proliferation with A) control extract treatment and B) UV-B extract 
treatment. Gradient of the slope between 24 and 72 h was investigated. Data represents mean values of 
2 replicates (n=2).  
5.2.5 Analysis of C. fritschii extracts for antibacterial activity  
S. epidermis is the most common bacterium found on the human skin. It is gram- 
positive and aerobic. This test bacterium was chosen for initial screening of 
antibacterial activity of C. fritschii extracts. This was assessed using the microdilution 
method. The end point OD at 590 nm was measured after 24 h of incubation of extracts 
with bacterial culture. 
An initial investigation of pooled extracts from both control and UV-B exposed 
cultures were assessed for antibacterial activity. One replicate was used due to the 
limited amount of extract available. Comparing DMSO controls with the C. fritschii 
extracts, a decrease in growth is observed (Figure 75). UV-B samples are seen to have 
lower end point OD readings than the control growth extracts.This could relate to 
antibacterial activity of extracts but further investigations are requires due to limited 
replication (n=1).  




Figure 75: Antibacterial activity of pooled C. fritschii control and UV-B extracts at concentrations of 
0.5, 0.25, 0.125, 0.063, 0.031 and 0.016 mg mL-1 vs. S. epidermis. DMSO was used as a vehicle control. 
Data represents OD values from one reading (n=1).  
This result was investigated further to assess the individual control and UV-B extracts 
(hex, EtOAc, EtOH and MeOH) antibacterial properties against S. epidermis. These 
results are from two replicates again due to the limited amount of sample available.   
The control hex and EtOAc extracts showed a similar range of OD end point readings 
to the DMSO vehicle control (Figure 76A and B). The EtOH fraction decreased the 
growth of S. epidermis the most at concentrations of 0.5 and 0.25 mg mL-1 (Figure 
76C). MeOH extracts also decreased the growth of S. epidermis at a concentration of 
0.25 mg mL-1 compared to the DMSO vehicle control but to a lower extrent than EtOH 
(Figure 76D).  
 




Figure 76: Antibacterial activity of C. fritschii control extracts: A) Hex, B) EtOAc, C) EtOH and D) 
MeOH at concentrations of 0.03125, 0.0625, 0.125, 0.25 and 0.5 mg mL-1 with DMSO as a vehicle 
control against S. epidermis using the microdilution method. Values are mean ± range of two 
replicates (n=2).  
After exposing S. epidermis to the extracts from UV-B exposed C. fritschii cultures, 
EtOAc and MeOH extracts (Figure 77B and D) decreased the growth of the bacterium 
the most at the lowest concentration of 0.25 mg mL-1. The hexane extract (Figure 77A) 
showed no difference between the DMSO control whereas EtOH extract (Figure 77C) 
showed a decrease in end point OD at a concentration of 0.125 mg mL-1. 
 




Figure 77: Antibacterial activity of C. fritschii UV-B extracts: A) Hex, B) EtOAc, C) EtOH and D) 
MeOH at concentrations of 0.03125, 0.0625, 0.125, 0.25 and 0.5 mg mL-1 with DMSO as a vehicle 
control against S. epidermis using the microdilution method. Values are mean ± range of two 
replicates (n=2).  
From the results obtained above, the extracts with the lowest OD end-point compared 
to the DMSO control were analysed again to see if the results were repeatable (Figure 
78). Control EtOH and MeOH (Figure 78A) as well as UV-B EtOAc, EtOH and 
MeOH (Figure 78B) were investigated at concentrations of 0.0625-0.25 mg mL-1. A 
50% reduction in bacterial growth was measured with control EtOH and MeOH 
extracts at 0.25 mg mL-1 as well as at 0.125 mg mL-1. A decrease in bacterial growth 
was also observed with UV-B EtOH extracts at 0.25 mg mL-1 and 0.125 mg mL-1 and 
MeOH extracts at 0.0625 and 0.125 mg mL-1.  




Figure 78: Antibacterial activity of A) control (EtOH and MeOH) and B) UV-B (EtOAc, EtOH and 
MeOH) C. fritschii extracts at concentrations of 0.0625, 0.125 and 0.25 mg mL-1 against S. epidermis 
with DMSO as a vehicle control. Data represents mean ± range of two replicates (n=2).  
Overall, potential antibacterial activity against S. epidermis was observed with the 
EtOH and MeOH extracts as measured by an end-point OD microdilution method. Due 
to the nature of the highly pigmented extracts another type of assay would need to be 
used to reinforce this data. A non-colourimetric assay such as the disc diffusion or 
colony counting method could be investigated to complement this work [166]. More 
extract replicates are needed for statistical analysis of potential activity.   
5.2.6 GC-MS analysis of C. fritschii extracts 
Sequential solvent extraction was used to extract a variety of metabolites from C. 
fritschii biomass for bioactivity analysis. These extracts were also analysed using GC-
MS to assess metabolites for use in industrial biotechnology. Control extracts were 
evaluated only. 
A total of 146 peaks were identified (level 2, match factor ≥60%) across the four 
extraction solvents after conservative peak alignment in SpectConnect (control 
extracts only). Identified peaks were classified according to their chemical class 
including; acids, alcohols, amino acids, aldehyde, ether and ketones, aromatics, fatty 
acids/alcohols, heterocycles, hydrocarbons, N-compounds, S-compounds, sterols, 
sugar (and derivatives) and other. A greater number of peaks were detected and 
identified from the EtOAc extract (100) with the lowest peak identification from the 
hexane extract (74, Figure 79). EtOAc extracted higher numbers of acids, aromatics, 
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fatty acids, heterocycles and sterols. A higher number of sugars (and derivatives) were 
identified in the MeOH extract. 
 
Figure 79: Number of identified peaks extracted from C. fritschii biomass by chemical class using 
hexane, EtOAc, EtOH and MeOH.   
Overall, 46 metabolites relating to cyanobacterial metabolism were identified in the 
extracts (Table 26). A PCA 2D-scores plot was used to visualise the variation between 
solvent extracts and revealed a total variation of 64.9% across two principle 
components (PC1 = 46.6% and PC2 = 17.9%, Figure 80A). Clear separation is 
observed between MeOH extract and Hex, EtOAc and EtOH.  
One-way ANOVA revealed 16 metabolites with overall significance. Post-hoc 
analysis using Tukey’s honestly significant difference (HSD) revealed that MeOH 
extract contributed mostly to the significance (Table S8) as seen in the PCA 2D score 
plot and the Hierarchial heat map (Figure 80B). 




Figure 80: Visualisation of the biologically relevant metabolites identified in each solvent extracts 
using A) PCA, 2D scores plot showing 95% confidence regions and B) Hierarchial heatmap 
visualisation; data is of the mean values of each extraction solvent; MeOH, Hex, EtOAc and EtOH 
from left to right. 
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Table 26: Identified metabolites in control C. fritschii extracts (hex, EtOAc, EtOH and MeOH) including chemical class, KEGG pathway and % normalised abundance across 
all 4 extracts.  









Acetoacetate Acid AA degradation  0 23 3 75 
Phenylpropanoate Acid Biosynthesis of AA; phe metabolism  0 100 0 0 
Methylbenzoate Acid Degradation of aromatics  2 79 7 11 
Boric acid Acid 
Aminobenzoate degradation, microbial metabolism in diverse 
environments  
2 84 6 7 
Acetate Acid Glycolysis, Acetyl-CoA biosynthesis 0 0 100 0 
Pyruvic acid Acid Glycolysis, TCA, PPP, AA metabolism  0 100 0 0 
Lactic acid Acid Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  2 79 6 14 
Glycolate Acid Glyoxylate metabolism, biosynthesis of secondary metabolites 5 86 3 6 
3-Methylbenzaldehyde Acid Microbial metabolism in diverse environments  7 87 6 0 
Phosphoric acid Acid PS/oxidative phosphorylation  3 88 6 3 
2-Propanol Acid Propanoate metabolism  0 95 5 0 
Succinate Acid 
TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of 
secondary metabolites  
28 0 72 0 
Lumichrome Alcohol Riboflavin metabolism 0 75 21 4 
Phytol Alcohol Chl metabolism 0 0 2 98 
Glycerol Alcohol Pentose and glucuronate interconversion 0 0 0 100 
Propane-1,2-diol Alcohol Propanoate metabolism  1 86 0 13 
Propanoate Alcohol Propanoate metabolism  0 0 0 100 
Threonine Amino acid 
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis 
of secondary metabolites, porphyrin and chl metabolism 
0 0 0 100 
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Valine Amino acid 
Biosynthesis of AA; val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
3 91 6 0 
Serine Amino acid 
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate 
metabolism and biosynthesis of secondary metabolites. Chl 
biosynthesis, MAA biosynthesis.  
0 0 0 100 
Glycine Amino acid 
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate 
metabolism and biosynthesis of secondary metabolites. Chl 
biosynthesis, MAA biosynthesis. 
4 78 9 9 
Nicotinic acid Aromatic 
Biosynthesis of alkaloids derived from ornithine, lys and nicotinic 
acid 




Aromatic Microbial metabolism in diverse environments  4 92 4 0 
Benzoic acid Aromatic Phe metabolism and alkaloids derived from shikimate pathway 2 91 2 5 
Ribitol Aromatic Riboflavin metabolism 0 0 0 100 
Tocopherol Aromatic Ubiquinone and other terpenoid-quinone biosynthesis  0 0 0 100 
Methyl linolenate Fatty acid Biosynthesis of unsaturated FA 0 0 0 100 
Caproic acid Fatty acid FA biosynthesis 5 78 6 10 
Lauric acid Fatty acid FA biosynthesis 0 95 5 0 
Octanoic acid Fatty acid 
FA biosynthesis, biosynthesis of alkaloids from terpenoid and 
polyketides 
6 77 6 12 
Stearic acid Fatty acid FA biosynthesis, biosynthesis of unsaturated FA  25 25 25 25 
Mystiric acid Fatty acid FA biosynthesis, biosynthesis of unsaturated FA 12 83 5 0 
Capric acid Fatty acid FA biosynthesis, biosynthesis of unsaturated FA 9 85 6 0 
Palmitic acid Fatty acid FA biosynthesis, biosynthesis of unsaturated FA 0 81 7 11 
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Cyanamide N-compound Atrazine degradation 2 62 8 28 
Putrescine N-compound 
Biosynthesis of AA; Arg and pro metabolism, glutathione 
metabolism, biosynthesis of alkaloids from ornithine 
0 0 0 100 
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism 0 87 4 8 
Hydroxylamine N-compound Nitrogen metabolism  26 0 74 0 
Hydrogen sulfide S-compound Sulfur metabolism, microbial metabolism in diverse environments 3 89 4 4 
Pregnenolone Sterol Steroid biosynthesis 5 95 0 0 
Myo inositol Sugar Galactose metabolism  0 0 0 100 
Sucrose Sugar Galactose metabolism, starch and sucrose metabolism 0 0 5 95 
Trehalose Sugar Starch and sucrose metabolism 0 0 0 100 
Threonic acid Sugar acid Ascorbic acid metabolism 0 0 0 100 
Glycerate Sugar acid PPP, gly, ser and thr metabolism, glyoxylate metabolism 0 0 0 100 
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From the previous anti-inflammatory experiments, EtOAc, EtOH and MeOH extracts 
showed activity by reducing IL-8 secretion in TNF-α stimulated HaCaT cells. In the 
antibacterial activity assays, EtOH, and MeOH extracts reduced the growth of S. 
epidermis. 13 metabolites were found in all 4 extracts including; glycine, lactate, 
glycolate and stearic acid with varying levels. Overal, hex had the lowest normalised 
abundances across the identified metabolites with the highest abundances found in the 
EtOAc extract followed by MeOH and EtOH (Table 26).  
8 potentially active metabolites were identified that have uses in beauty personal care 
(Table 27). The majority of these were found in highest abundances in the EtOAc 
extract including; palmitic acid, lauric acid, nicotinic acid, glycolic acid and lactic acid. 
Methyl linoleate, phytol and α-tocopherol had the highest abundances in the MeOH 
extract.  
Table 27: Metabolites identified in C. fritschii extracts with potential activity with relevance to beauty 
personal care.  
Metabolite  Potential application/activity Ref 
Methyl linoleate Anti-inflammatory [167] 
Palmitic acid Anti-inflammatory [168,169] 
Lauric acid Antibacterial [170] 
Phytol Anti-inflammatory, antibacterial [171,172] 
α-Tocopherol Antioxidant, anti-inflammatory [173] 
Nicotinic acid Anti-inflammatory [174] 
Glycolic acid Treatment of photo-damaged skin, acne 
scars and hyperpigmentation 
[175] 
Lactic acid Treatment of photo-damaged skin, acne 
scars and hyperpigmentation 
[175] 
M-gly Sunscreen, antioxidant [32,175, 176] 
 




5.3.1 Bioactivity assessment of C. fritschii for use in beauty personal care  
An anti-inflammatory model using the HaCaT cell line was developed to test activity 
of extracts from the cyanobacterium, C. fritschii. Initial results show promising 
activity. Decreased levels in IL-8 secretion were observed with lower concentrations 
of pooled C. fritschii extracts. As many different metabolites are present in the extracts, 
higher concentrations could mask the anti-inflammatory activity of the sample. No 
significant increase in IL-8 secretion was observed suggesting that the pooled extracts 
do not induce inflammation in HaCaT cells.  
Individual extracts were then investigated to see which extract was contributing to the 
reduced IL-8 levels. The lower concentrations were chosen as these showed the most 
significant decrease in IL-8 secretion (Figure 69). The control EtOAc extract showed 
activity at all concentrations as well as the EtOH and MeOH extracts at 0.5 and 0.1 µg 
mL-1 respectively. No pro-inflammatory response or cell proliferation was observed 
with the addition of the extracts. Positive antibacterial activity of EtOH and MeOH 
extracts from control and UV-B exposed cultures against S. epidermis was also 
detected.  
All four individual control extracts were analysed by GC-MS. Based on the observed 
results of the in vitro anti-inflammatory (Figure 70) and antibacterial assay (Figure 
78). Bioactive metabolites were evaluated for differences comparing EtOAc, EtOH 
and MeOH to the hex extract (no activity). Overall, the EtOAc, EtOH and MeOH 
extracts had higher normalised abundances than the hex extract. The increased anti-
inflammatory and antibacterial activity could be due higher levels of potentially active 
metabolites (Table 27).  
Many of the metabolites detected have previously shown bioactivity. Methyl linoleate, 
present in the MeOH extract, is a derivative of linoleic acid (omega-6 polyunsaturated 
fatty acid) and has been seen to have a role in anti-inflammation [167]. The saturated 
fatty acid, palmitic acid, has been seen to possess anti-inflammatory properties by 
inhibiting phospholipase A2 [168,169]. Lauric acid has demonstrated activity against 
gram positive bacteria [170]. Phytol, a diterpene member of the acyclic alcohols has 
been widely studied for bioactivity [171]. This includes anti-inflammatory activity 
[171] and antimicrobial activity against a variety of bacterial and fungal strains [172]. 
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It is also a precursor to α-tocopherol (vitamin E). α-Tocopherol was found in MeOH 
extract and is known to be a free-radical scavenger and also has anti-inflammatory 
properties [173]. Nicotinic acid (vitamin B3) was found in the EtOAc extract and has 
been shown to reduce secretion of pro-inflammatory mediators in human monocytes 
[174]. Other potentially relevant metabolites identified are the α-hydroxy acids, lactic 
acid and glycolic acid. These can be used in formulations to treat photo-damaged skin, 
to treat acne scars and hyperpigmentation [175]. 
The drawback with GC-MS is that it is used to identify low molecular weight 
metabolites. Other high molecular weight metabolites with potential bioactivity, such 
as polyphenols [178], could be investigated using LC-MS [43]. Combining analytical 
techniques would increase the pool of identified metabolites. 
One of the major bottlenecks of the use of cyanobacteria in industrial biotechnology 
is the consistent ability to extract high value metabolites at high concentrations for 
commercial use. Heterologous expression in fast growing E. coli was used to produce 
m-gly at high enough concentration for bioactivity testing; due to the limited 
concentration produced by C. fritschii. The partially pure m-gly reduced IL-8 secretion 
within the developed model and although a high error within the experiment was 
observed, a dose dependent trend was seen. M-gly and other MAAs have been 
extensively researched for their use as natural sunscreen ingredients due to their strong 
photoprotective abilities [31], as seen in human skin fibroblast cells  [176]. MAAs are 
known to be multifunctional and also act as antioxidants by quenching radicals [119]. 
Antioxidant activity of m-gly was shown using the Trolox equivalent antioxidant 
capacity (TEAC) as well as anti-inflammatory activity in UV exposed HaCaT cells 
[177].  
Results obtained from this chapter give an insight into the potential of C. fritschii 









The development of an anti-inflammatory model was achieved. This model can be 
used to test a variety of extracts from cyanobacteria and other microorganisms. 
Combining both bioactivity and metabolic analysis gives an insight into the activity of 
fractions and the potential metabolites associated with the observed activity. Overall 
these results show potential for further investigation of anti-inflammatory and 
antibacterial activity of C. fritschii. Further work is needed to verify the results 
presented in this chapter including the fractionation of active extracts for potential 
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Chapter 6: General discussion 
This chapter discusses the main findings within this thesis (Chapters 2-5) with focus 
on the relevance to the field, challenges and future work to build on knowledge of the 
use of cyanobacteria as a sustainable source of industrially relevant ingredients.  
Cyanobacterial biotechnology has the potential to solve the demand for naturally 
sourced environmentally friendly resources as an alternative to fossil fuel derived 
ingredients for use in industrial biotechnology [16,21,179]. The research presented 
within this thesis adds considerably to current literature on cyanobacterial research at 
the metabolite level. Investigating at the metabolite level closely relates to the 
physiology of an organism and is important in determining the adaptation to abiotic 
stress and production of useful industrially relevant metabolites [43]. The overall aim 
of this work was to evaluate the metabolite profile of the less investigated 
cyanobacterium C. fritschii as a potential candidate for use in industrial biotechnology 
with the goal of identifying commonly used and novel metabolites with commercial 
potential as sustainable ingredients in consumer goods. This was achieved by 
constructing a GC-MS workflow to evaluate the changes in low molecular weight 
metabolite levels over varying time-series under standard growth conditions (Chapter 
2), between axenic and xenic cultures (Chapter 2) and during UV exposure (UV-A 
and UV-B, Chapter 3 and 4). Manipulation of abiotic stress such as UV can further 
increase productivity of industrially relevant metabolites such as MAAs and improve 
UV tolerance in relevant species [16,21,22] which was also investigated in this thesis 
(Chapter 4). C. fritschii extracts were also assessed using in-vitro anti-inflammatory, 
proliferation and antibacterial assays with complementary GC-MS analysis for further 
elucidation of active ingredients with relevance to personal care products (Chapter 5). 
The focus was on identifying biologically relevant metabolites with roles in 
cyanobacterial metabolism for evaluation of growth phases, adaptation to UV stress 
and applications for use in consumer goods. It is important to investigate these changes 
in primary metabolites in order to understand secondary metabolite production. 
Overall, this work builds on the knowledge-base of C. fritschii with to my knowledge 
the first metabolite profiling of C. fritschii as measured by GC-MS.   
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Cyanobacteria have received much attention for their potential uses in industrial 
biotechnology [16]. Due to their long evolutionary history they have adaptive 
capabilities to survive in many extreme environments [6,9]. These adaptations include 
the production of metabolites that can be exploited in industry as sustainable sources 
of natural ingredients [16].  
Throughout this work, C. fritschii has demonstrated the production of metabolites with 
potential industrial relevance (Chapter 2-5) including active metabolites with 
relevance to consumer goods (Chapter 5). C. fritschii extracts showed promising 
activity in in-vitro anti-inflammatory and antibacterial assays in Chapter 5. 
Combining both bioactivity assessments and GC-MS gave an insight into the 
potentially active metabolites within each active extract. Metabolites including methyl 
linoleate, palmitic acid, lauric acid, phytol, α-tocopherol, nicotinic acid, glycolic acid 
and lactic acid have shown previous anti-inflammatory, antibacterial, antioxidant and 
activity in the treatment of photo-damaged skin which have potential uses in beauty 
personal care [167–175]. Some of these metabolites also have been identified 
throughout the experimental analysis of C. fritschii. Metabolites such as succinate, 
fumarate, malate, lactic acid, glycolic acid and pyruvic acid were identified throughout 
the thesis in various experiments. These can also be exploited in industrial 
biotechnology as platform chemicals [110]. The photoprotective compounds MAAs 
were chosen as targeted metabolites with potential applications in industrial 
biotechnology as natural sunscreens and antioxidants [31]. The MAAs shinorine and 
m-gly were detected during UV-B exposure in Chapter 3 and during UV-A and UV-
B exposure in Chapter 4. A major challenge in industrial biotechnology is the ability 
to produce target valuable compounds in sufficient quantities under repeatable 
conditions [180]. Different approaches can be considered for increasing cyanobacterial 
productivity and yield of useful metabolites [132]. This includes the manipulation of 
abiotic stressors such as UV to increase production of specific metabolites and enhance 
stress tolerance of specific strains [128]. This was explored in Chapter 4 where C. 
fritschii was seen to withstand higher levels of UV-B irradiation after pre-treatment 
with low dose UV-B suggesting UV stress tolerance and adaptation. Cultures 
acclimatised to low dose UV (both UV-A and UV-B treatments) had a lower negative 
impact on metabolism. This indicates the acclimation of cyanobacterial cultures to low 
dose UV, thus preparing cell metabolism for additional UV exposure. Increased MAA 
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levels were observed during UV low dose acclimation followed by shock UV exposure 
Chapter 4. Other approaches include the genetic manipulation of cyanobacteria to 
upregulate the production of specific metabolites forming cyanobacterial cell factories 
[181] and genetic modification of fast-growing microorganisms to include specific 
biosynthetic gene clusters from cyanobacterial pathways. An example includes the 
heterologous expression of m-gly gene cluster in E. coil as seen in Chapter 5 [182]. 
Sufficient yield of the partially pure m-gly extract from E. coli was used to test 
potential anti-inflammatory activity. This showed a promising observational dose 
response which warrants the further exploration of the bioactive potential of MAAs.   
Metabolite profiling can be used to view the physiological changes at the metabolite 
level in response to changing environments and is a useful tool in cyanobacterial 
research [43]. The effect of UV-B on cyanobacteria and other photosynthetic 
organisms has been widely researched with less focus on UV-A exposure. UV-A and 
UV-B have different effects on photosynthetic organisms and mechanisms of 
protection vary [27,126]. Within Chapter 3 a significantly higher proportion of 
metabolites increased in levels during UV-A exposure compared the UV-B study thus 
showing that supplemented UV-A is less detrimental to C. fritschii cells compared to 
UV-B. Many identified metabolite level changes could be related to stress response as 
seen in other photosynthetic organisms such as the accumulation of pro which is 
thought to have a role in providing additional defense as a ROS scavenger and 
molecular chaperone [122–124]. Accumulation of proline has been observed in Nostoc 
punctiforme during 24 h of UV-A stress [52], in the model plant organism Arabidopsis 
after 24 h of UV-B treatment [96], and also in C. fritschii after 24 h of UV-B exposure 
in Chapter 3. With the depletion of the stratospheric ozone layer much research has 
been conducted on the effect of increased UV-B levels on photosynthetic organisms 
[96,97,183]. The effect of UV on C. fritschii within this work also has relevance within 
this field by providing an insight into the adaptive response to UV.   
Combining intracellular and extracellular analysis is useful in the study of 
cyanobacteria  and other microorganisms providing a more holistic picture of 
metabolite production during growth and its response to different environmental 
conditions [69,70]. Little work has been undertaken on monitoring both intracellular 
and extracellular metabolites in cyanobacteria as seen in the UV-B experiment within 
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this thesis (Chapter 3).  Further experimental analysis would combine both 
intracellular and extracellular assessment which could be used to monitor and optimise 
the release of industrially relevant metabolites [68,69,184].  
The main bottleneck of this research was the slow growth of axenic C. fritschii cultures 
reducing the amount of biomass available for analysis. Xenic cultures were observed 
to grow at faster rates and to higher OD. This resulted in the comparison of axenic and 
xenic cultures. A more realistic approach was taken to use xenic cultures (unialgal) in 
subsequent experiments. The presence of other microorganisms had a limited effect 
on the metabolites produced as seen in Chapter 2 and would not produce the chosen 
targeted metabolites MAAs for analysis during UV exposure Chapters 3 and 4. 
Future research would include the characterisation of the specific microorganisms 
present within C. fritschii cultures, using a combination of metabolomics, 
metagenomics and transcriptomics [4]  followed by controlled co-culture experiments 
to determine contributions to the metabolites detected [104]. In terms of industrial 
biotechnology controlled addition of microorganisms, to promote microbial consortia 
and symbiotic relationships, could results in higher productivity and yield [104].    
The limited biomass from cultivation of C. fritschii reduced the number of 
experimental analyses. GC-MS was therefore chosen due to its high sensitivity. By 
increasing the amount of biomass, more analytical techniques can be utilised to extend 
the pool of metabolites identified such as LC-MS and NMR. 
Time-course metabolomics is becoming a more common approach in evaluating 
metabolite levels to allow better insight into the physiology of the cells [111]. This 
approach was used throughout the research to evaluate the changes in metabolite levels 
over growth and increasing length of UV exposure. As seen in Chapters 2-4 many 
metabolites were not identified within all time-points due to the high turnover rates of 
intracellular processes. Growth profiles and metabolite level changes in Chapter 2 
(120 d experiment) showed patterns consistent with growth phases as seen in 
Skeletonema marinoi [94], Chlorella sorokiniana [106] Pharobacter gallaeciensis 
DSM 17395 [107] and Synechococcus elongates PCC 7942 [108]. With a gap of 8 
days between each sampling point much biological data is lost and difficulties are 
presented in biological interpretation due to a high turnover of intracellular metabolites 
as previously mentioned. Combination of long-term analysis with shorter term 
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sampling points at each growth phase would give a better insight in the changes in 
metabolite levels.  
Missing values in GC-MS analysis is a common drawback [103], here missing values 
are assumed to be below detection limit and replaced with half of the minimum 
integrated signal. Evaluation of time-series data provided many challenges. Many 
aspects of GC-MS data analysis requires manual evaluation but with the availability 
of AMDIS for spectral deconvolution, NIST and GMD for identification as well as 
online tools such as SpectConnect [81] for conservative peak alignment and 
MetaboAnalyst [82] for data visualisation and statistical analysis, data can be analysed 
with automation from freely available software. The same analysis approach was used 
throughout for consistency of work in all chapters. Challenges still remain with correct 
identification of peaks. As an untargeted approach was chosen to evaluate as many 
metabolites as possible, a match factor of >60% was chosen comparing experimental 
mass spectra to reference library entries. This method successfully identified many 
chemical compounds with a sub-section relating to cyanobacterial metabolism (level 
2 identification [63]), many remained as unknowns (level 4 [63]). During the UV-B 
experiment (Chapter 4), no biologically relevant metabolites were identified. This 
could be due to a number of reasons including the identification process, where 
detected mass spectra were detected with a match factor less than the threshold of 60% 
comparing to references. Further investigations of this work would rely on analysis of 
standards to improve confidence of identifications (level 1 identification [63]). By 
using a more targeted approach, the analysis of the specific biologically and 
industrially relevant metabolites identified within this thesis (Chapters 2-5) can be 
analysed.  
Cultivation up to 20 L under industrial conditions was achieved in Chapter 5. Further 
work in upscaling to higher volumes is needed to assess metabolite levels and growth 









These studies present the first metabolomic data set for C. fritschii as measured by 
GC-MS providing a good base platform for further systems biology. This study is 
important to build on experimental data already available for cyanobacteria and other 
photosynthetic organisms and microorganisms during standard growth and UV 
exposure. The metabolites identified over the time-courses within this thesis represent 
only a minuscule proportion of the metabolome of C. fritschii. By expanding the 
analytical platforms used and by taking a systems biology approach, through 
integration of -omics data (metabolomics, transcriptomics and genomics) and in-vitro 
bioactivity assessment, potential useful pathways and metabolites can be identified. 
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Appendices: Supplementary Tables  
Table S1: Identified intracellular metabolites detected during 28 d experiment (axenic) including chemical class and possible biosynthetic pathways (KEGG). 
Name  Class Pathway 
Methylbenzoate  Acid Degradation of aromatics  
Glyoxylate Acid Glyoxylate metabolism, AA metabolism  
Boric acid Acid  Aminobenzoate degradation, microbial metabolism in diverse environments  
3-Hydroxy-L-1-pyrroline-5-
carboxylate 
Acid  Arg and pro metabolism 
3-Hydroxybutanoic acid  Acid  Butanoate metabolism  
Lactic acid Acid  Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  
Glycolate  Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites 
Oxalate Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites 
Phosphoric acid  Acid  PS/oxidative phosphorylation  
Propanoate Acid  Propanoate metabolism  
Fumarate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, secondary metabolites 
Malate  Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
Succinate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
1-Butanol  Alcohol  Butanoate metabolism, microbial metabolism, degradation of aromatic compounds 
Phytol Alcohol  Chl metabolism 
Propane-1,3-diol Alcohol  Glycerolipid metabolism 
Ethane-1,2-diol Alcohol  Glyoxylate and dicarboxylate metabolism 
Glycerol  Alcohol  Pentose and glucuronate interconversion 
2-Propanol  Alcohol  Propanoate metabolism  
Propane-1,2-diol Alcohol  Propanoate metabolism  
                                                                            
176 
 
Name  Class Pathway 
Ornithine  Amino acid  
Biosynthesis of AA and seconary metabolites. Arg and pro metabolism. Glutathione 
metabolism 
Proline Amino acid Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite biosynthesis 
Tyrosine  Amino acid  
Biosynthesis of AA and alkaloids derived from shikimate pathway, terpernoid-quinone 
biosynthesis 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. Forms L-ornithine/L-
glutamine 
Lysine  Amino acid  Biosynthesis of AA and biosynthesis of alkaloids 
Threonine  Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of secondary 
metabolites, porphyrin and chl metabolism 
Isoleucine  Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
Valine  Amino acid  
Biosynthesis of AA; val, leu and ile metabolism, biosynthesis of alkaloids/secondary 
metabolites 
Aspartate  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism. Arg, gly, ser and thr metabolism, cys 
and met metabolism. Carbon fixation 
Arginine  Amino acid  Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite biosynthesis 
Serine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis.  
Glycine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis. 
Phenylalanine Amino acid  
Biosynthesis of AA. Phe metabolism via shikimate pathway, Tyr metabolism, biosynthesis 
of alkaloids derived from shikimate pathway and ornithine.  
5-Oxoproline Amino acid  Glutathione metabolism  
Cyanuric acid  Aromatic  Atrazine degredation 
Histamine  Aromatic  Biosynthesis of alkaloids derived from histidine and pyrine, secondary metabolites 
Benzoic acid  Aromatic  Phe metabolism and alkaloids derived from shikimate pathway 
Lumichrome  Aromatic  Riboflavin metabolism 
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Name  Class Pathway 
Tocopherol  Aromatic  Ubiquinone and other terpenoid-quinone biosynthesis  
4-Methylbenzaldehyde  Aromatic  Xylene degredation  
Octanoic acid  Ester  FA biosynthesis, biosynthesis of alkaloids from terpenoid and polyketides 
Lauric acid  Fatty acid  FA biosynthesis 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  
Eicosanoic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism 
Hydroxylamine  N-compound Nitrogen metabolism  
Sperimine N-compound  Arg and pro metabolism, glutathione metabolism 
Sperimidine  N-compound  Arg and pro metabolism, glutathione metabolism, phenlpropanoid metabolism 
Adenosine Nucleoside Purine metabolism 
Cyanamide  Other  Atrazine degradation 
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments 
Rhamnose  Sugar Fructose and mannose metabolism  
Mannose Sugar 
Fructose and mannose metabolism, amino sugar and nucleotide metabolism, galactose 
metabolism  
Fructose Sugar Fructose and mannose metabolism, galactose metabolism, starch and sucrose metabolism 
Galactose Sugar  Galactose metabolism 
Raffinose  Sugar  Galactose metabolism 
Sucrose  Sugar  Galactose metabolism, starch and sucrose metabolism 
Lyxose  Sugar  Pentose and glucuronate interconversion 
Trehalose  Sugar  Starch and sucrose metabolism 
Xylulose-5-phosphate Sugar phosphate  Pentose phosphate pathway 
*AA = amino acid, FA = fatty acid, PPP = pentose phosphate pathway, TCA=tricarboxylic acid cycle 
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Table S2: Identified intracellular metabolites detected during 28 d experiment (xenic) including chemical class and possible biosynthetic pathways (KEGG). 
Name  Class Pathway 
Methylbenzoate  Acid Degradation of aromatics  
Boric acid Acid  Aminobenzoate degradation, microbial metabolism in diverse environments  
3-Hydroxy-L-1-pyrroline-5-
carboxylate 
Acid  Arg and pro metabolism 
2-Oxobutanoate Acid  
Biosynthesis of AA; cys and met metabolism, thr metabolism. Val, leu and ile 
biosynthesis 
3-Hydroxybutanoic acid  Acid  Butanoate metabolism  
Malonate  Acid  FA biosynthesis 
5-Oxoproline Acid  Glutathione metabolism  
Lactic acid Acid  Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  
Oxalate Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites 
Phosphoric acid  Acid  PS/oxidative phosphorylation  
Propanoate Acid  Propanoate metabolism  
Fumarate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, secondary metabiltes 
Malate  Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
Succinate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
1-Butanol  Alcohol  Butanoate metabolism, microbial metabolism, degradation of aromatic compounds 
Phytol Alcohol  Chl metabolism 
Propane-1,3-diol Alcohol  Glycerolipid metabolism 
Ethane-1,2-diol Alcohol  Glyoxylate and dicarboxylate metabolism 
Glycerol  Alcohol  Pentose and glucuronate interconversion 
2-Propanol  Alcohol  Propanoate metabolism  
Propane-1,2-diol Alcohol  Propanoate metabolism  
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Name  Class Pathway 
Ornithine  Amino acid  
Biosynthesis of AA and seconary metabolites. Arg and pro metabolism. Glutathione 
metabolism 
Alanine  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism, cys and met metabolism, carbon fixation 
and biosynthesis of secondary metabolites 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. Forms L-ornithine/L-
glutamine 
Lysine  Amino acid  Biosynthesis of AA and biosynthesis of alkaloids 
Threonine  Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of secondary 
metabolites, porphyrin and chl metabolism 
Valine  Amino acid  
Biosynthesis of AA; val, leu and ile metabolism, biosynthesis of alkaloids/secondary 
metabolites 
Aspartate  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism. Arg, gly, ser and thr metabolism, cys 
and met metabolism. Carbon fixation 
Serine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis.  
Glycine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis. 
Phenylalanine Amino acid  
Biosynthesis of AA. Phe metabolism via shikimate pathway, Tyr metabolism, biosynthesis 
of alkaloids derived from shikimate pathway and ornithine.  
Arginine  Amino acid  Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite biosynthesis 
Proline Amino acid  Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite biosynthesis 
Histamine  Aromatic  Biosynthesis of alkaloids derived from histidine and pyrine, secondary metabolites 
Benzoic acid  Aromatic  Phe metabolism and alkaloids derived from shikimate pathway 
Lumichrome  Aromatic  Riboflavin metabolism 
3-Hydroxyphenylacetate  Aromatic  Tyr and phe metabolism  
Tocopherol  Aromatic  Ubiquinone and other terpenoid-quinone biosynthesis  
Octanoic acid  Ester  FA biosynthesis, biosynthesis of alkaloids from terpenoid and polyketides 
Eicosanoic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
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Name  Class Pathway 
Lauric acid  Fatty acid  FA biosynthesis 
Capric acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  
Putrescine  N-compound 
Biosynthesis of AA; Arg and pro metabolism, glutathione metabolism, biosynthesis of 
alkaloids from ornithine 
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism 
Urea N-compound Metabolic pathways, microbial metabolism  
Hydroxylamine  N-compound Nitrogen metabolism  
Sperimidine  N-compound  Arg and pro metabolism, glutathione metabolism, phenlpropanoid metabolism 
Adenosine Nucleoside Purine metabolism 
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments 
Rhamnose  Sugar Fructose and mannose metabolism  
Glucose Sugar Glycolysis, PPP, biosynthesis of secondary metabolites. 
Raffinose  Sugar  Galactose metabolism 
Sucrose  Sugar  Galactose metabolism, starch and sucrose metabolism 
Lyxose  Sugar  Pentose and glucuronate interconversion 
Trehalose  Sugar  Starch and sucrose metabolism 
Xylulose-5-phosphate Sugar phosphate  Pentose phosphate pathway 
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Table S3: Identified intracellular metabolites detected during 120 d experiment including chemical class and possible biosynthetic pathways (KEGG). 
Name  Class Pathway 
Methylbenzoate  Acid Degradation of aromatics  
Lactic acid Acid Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  
3-Hydroxy-L-1-pyrroline-5-
carboxylate 
Acid  Arg and pro metabolism 
Adipic acid 2TMS  Acid  Biosynthesis of AA 
4-Hydroxybutyric acid  Acid  Carbon fixation pathways in prokaryotes 
Oxalate Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites 
Glycolate  Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites 
4-Methoxycinnamic acid  Acid  Phenylpropanoid biosynthesis  
Phosphoric acid  Acid  PS/oxidative phosphorylation  
Propanoate Acid  Propanoate metabolism  
Fumarate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, secondary metabiltes 
Malate  Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
Citrate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
Succinate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
1-Butanol  Alcohol  Butanoate metabolism, microbial metabolism, degradation of aromatic compounds 
Phytol Alcohol  Chl metabolism 
Glycerol  Alcohol  Pentose and glucuronate interconversion 
Ornithine  Amino acid  
Biosynthesis of AA and seconary metabolites. Arg and pro metabolism. Glutathione 
metabolism 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. Forms L-ornithine/L-
glutamine 
Lysine  Amino acid  Biosynthesis of AA and biosynthesis of alkaloids 
Valine  Amino acid  Biosynthesis of AA; val, leu and ile metabolism, biosynthesis of alkaloids 
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Name  Class Pathway 
Aspartate  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism. Arg, gly, ser and thr metabolism, cys 
and met metabolism. Carbon fixation 
Glycine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis. 
Phenylalanine Amino acid  
Biosynthesis of AA. Phe metabolism via shikimate pathway, Tyr metabolism, biosynthesis 
of alkaloids derived from shikimate pathway and ornithine.  
Proline  Amino acid  Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite biosynthesis 
Cyanuric acid  Aromatic  Atrazine degredation 
Hydroxyquinol Aromatic  Benzoate degradation 
Benzoic acid  Aromatic  Phe metabolism and alkaloids derived from shikimate pathway 
1-Hydroxy-3-methoxy-6-
methylanthraquinone 
Aromatic  Polyketide synthesis  
4-Hydroxyanthraquinone-2-
carboxylic acid 
Aromatic  Polyketide synthesis  
Adenine  Aromatic  Purine metabolism 
lumichrome Aromatic  Riboflavin metabolism 
Lauric acid  Fatty acid  FA biosynthesis 
Caprylic acid Fatty acid  FA biosynthesis, biosynthesis of alkaloids from terpenoid and polyketide 
Eicosanoic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Capric acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Palmitoleic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Oleic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism 
Urea N-compound Metabolic pathways, microbial metabolism  
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Name  Class Pathway 
Hydroxylamine  N-compound Nitrogen metabolism  
Adenosine  Nucleoside Purine metabololism  
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments 
Sorbose  Sugar  Fructose and mannose metabolism 
Fructose Sugar  Fructose and mannose metabolism, galactose metabolism, starch and sucrose metabolism 
Galactose Sugar  Galactose metabolism 
Raffinose  Sugar  Galactose metabolism 
Sucrose  Sugar  Galactose metabolism, starch and sucrose metabolism 
Glucose  Sugar  Glycolysis, PPP biosynthesis of secondary metabolites 
Trehalose  Sugar  Starch and sucrose metabolism 
Glycerate Sugar acid  PPP, gly, ser and thr metaboim, glyoxylate metabolism 
Glycerol 3-phosphate  Sugar phosphate  Glycerolipid/glycerophospholipid metabolism, metabolism of secondary metabolites  
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Table S4: Identified intracellular metabolites detected during 48 h of PAR only including chemical class and possible biosynthetic pathways (KEGG). 
Name  Class Pathway 
Boric acid Acid  Aminobenzoate degradation-microbial metabolism in diverse environments  
3-Hydroxy-L-1-pyrroline-5-
carboxylate 
Acid  Arg and pro metabolism 
5-Oxoproline Acid  Glutathione metabolism  
Phosphoric acid  Acid  PS/oxidative phosphorylation  
Gluconic acid-1,4-lactone  Acid  PPP 
Glycerate Acid  PPP, gly, ser and thr metaboim, glyoxylate metabolism 
Malate  Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
Citrate Acid  TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of secondary metabolites  
Glycerol  Alcohol Pentose and glucuronate interconversion 
Propan-2-ol Alcohol Propanoate metabolism 
Ornithine  Amino acid  
Biosynthesis of AA and seconary metabolites. Arg and pro metabolism. Glutathione 
metabolism 
Alanine  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism, cys and met metabolism, carbon fixation 
and biosynthesis of secondary metabolites 
Tyrosine  Amino acid  
Biosynthesis of AA and alkaloids derived from shikimate pathway, terpernoid-quinone 
biosynthesis 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. Forms L-ornithine/L-
glutamine 
Lysine  Amino acid  Biosynthesis of AA and biosynthesis of alkaloids 
Methionine  Amino acid  Biosynthesis of AA; cys and met metabolism and secondary metabolism 
Threonine Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of secondary 
metabolites, porphyrin and chl metabolism 
Leucine  Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
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Name  Class Pathway 
Isoleucine  Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
Aspartate  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism. Arg, gly, ser and thr metabolism, cys 
and met metabolism. Carbon fixation 
Serine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis.  
Glycine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis 
of secondary metabolites. Chl biosynthesis, MAA biosynthesis. 
Phenylalanine Amino acid  
Biosynthesis of AA. Phe metabolism via shikimate pathway, Tyr metabolism, biosynthesis 
of alkaloids derived from shikimate pathway and ornithine.  
Cyanuric acid  Aromatic  Atrazine degredation 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  
Hydroxylamine  N-compound Nitrogen metabolism  
Adenosine Nucleoside Purine metabolism 
Cyanamide  Other Atrazine degradation 
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments 
Sorbose  Sugar Fructose and mannose metabolism 
Rhamnose  Sugar Fructose and mannose metabolism  
Fructose Sugar Fructose and mannose metabolism, galactose metabolism, starch and sucrose metabolism 
Sucrose  Sugar Galactose metabolism, starch and sucrose metabolism 
Glucose  Sugar Glycolysis, PPP biosynthesis of secondary metabolites 
Trehalose  Sugar Starch and sucrose metabolism 
Mannose 6-phosphate Sugar phosphate  Fructose and mannose metabolism, synthesis of secondary metabolites 
Glycerol 3-phosphate  Sugar phosphate  Glycerolipid/glycerophospholipid metabolism, metabolism of secondary metabolites  
*AA = amino acid, FA = fatty acid, PPP = pentose phosphate pathway, TCA=tricarboxylic acid cycle 
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Table S5: Identified intracellular and extracellular metabolites detected during UV-B + PAR including chemical class and possible biosynthetic pathways (KEGG). 
Name  Class Pathway 
Intra/Extra-
cellular 
Boric acid Acid Aminobenzoate degradation, microbial metabolism in diverse environments  Intra 
Phosphoric acid  Acid PS/oxidative phosphorylation  Intra 
2-Oxobutanoate Acid  
Biosynthesis of AA; cys and met metabolism, thr metabolism. Val, leu and 
ile biosynthesis 
Intra 
4-Hydroxybutyric acid  Acid  Carbon fixation pathways in prokaryotes Intra 
Methylbenzoate  Acid  Degradation of aromatics  Intra 
5-Oxoproline Acid  Glutathione metabolism  Intra 
Pyruvic acid Acid  Glycolysis, TCA, PPP, AA metabolism  Intra 
Lactic acid Acid  Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  Intra 
Oxalate Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites Intra 
Methylmalonate Acid  Pyrimidine metabolism, AA degredation, propanoate metabolism.  Intra 
Butane-2,3-diol Alcohol Butanoate metabolism  Intra 
Ethane-1,2-diol Alcohol  Glyoxylate and dicarboxylate metabolism Intra 
1-Propanol Alcohol  Propanoate metabolism  Intra 
2-Propanol  Alcohol  Propanoate metabolism  Intra 
Tyrosine  Amino acid 
Biosynthesis of AA and alkaloids derived from shikimate pathway, 
terpernoid-quinone biosynthesis 
Intra 
Serine Amino acid 
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism 
and biosynthesis of secondary metabolites. Chl biosynthesis, MAA 
biosynthesis.  
Intra 
Glycine Amino acid 
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism 
and biosynthesis of secondary metabolites. Chl biosynthesis, MAA 
biosynthesis.  
Intra 
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Name Class Pathway 
Intra/Extra-
cellular 
Phenylalanine Amino acid 
Biosynthesis of AA. Phe metabolism via shikimate pathway, Tyr 
metabolism, biosynthesis of alkaloids derived from shikimate pathway and 
ornithine.  
Intra 
Proline Amino acid 
Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite 
biosynthesis 
Intra 
Glutamate  Amino acid 
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. Forms 
L-ornithine/L-glutamine 
Intra 
4-Methylbenzaldehyde  Aromatic Xylene degredation  Intra 
Mystiric acid Fatty acid FA biosynthesis, biosynthesis of unsaturated FA Intra 
Palmitic acid  Fatty acid FA biosynthesis, biosynthesis of unsaturated FA Intra 
Stearic acid  Fatty acid FA biosynthesis, biosynthesis of unsaturated FA  Intra 
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism Intra 
Hydroxylamine  N-compound Nitrogen metabolism  Intra 
Mannose Sugar 
Fructose and mannose metabolism, amino sugar and nucleotide metabolism, 
galactose metabolism  
Intra 
D-Glucose Sugar Glycolysis, PPP biosynthesis of secondary metabolites. Intra 
2-Oxobutanoate Acid 
Biosynthesis of AA; cys and met metabolism, thr metabolism. Val, leu and 
ile biosynthesis 
Extra 
Glycolate  Acid Glyoxylate metabolism, biosynthesis of secondary metabolites Extra 
Citrate Acid 
TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of 
secondary metabolites  
Extra 
Fumarate Acid TCA, Pyruvate metabolism, glyoxylate metabolism, secondary metabiltes Extra 
Malate  Acid 
TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of 
secondary metabolites  
Extra 
Succinate Acid 
TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of 
secondary metabolites  
Extra 
Oxalate Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites Extra 
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Name Class Pathway 
Intra/Extra-
cellular 
Benzoic acid  Acid  Phe metabolism and alkaloids derived from shikimate pathway Extra 
Gluconic lactone  Acid  PPP Extra 
Arabitol  Alcohol Pentose and glucuronate interconversion Extra 
Glycerol  Alcohol Pentose and glucuronate interconversion Extra 
Leucine Amino acid 
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
Extra 
Ethanolamine Amino alcohol Glycerophosphlipid metabolism, pyruvate metabolism Extra 
Tocopherol  Aromatic Ubiquinone and other terpenoid-quinone biosynthesis  Extra 
Lauric acid  Fatty acid  FA biosynthesis Extra 
Octanoic acid  Fatty acid  FA biosynthesis, biosynthesis of alkaloids from terpenoid and polyketides Extra 
Capric acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Extra 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Extra 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Extra 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  Extra 
Putrescine  N-compound 
Biosynthesis of AA; Arg and pro metabolism, glutathione metabolism, 
biosynthesis of alkaloids from ornithine 
Extra 
Hydroxylamine  N-compound Nitrogen metabolism  Extra 
Fructose Sugar 
Fructose and mannose metabolism, galactose metabolism, starch and 
sucrose metabolism 
Extra 
Galactose Sugar Galactose metabolism Extra 
Arabinose  Sugar Pentose and glucuronate interconversion Extra 
Lyxose  Sugar Pentose and glucuronate interconversion Extra 
Xylose Sugar Pentose and glucuronate interconversion Extra 
Trehalose  Sugar Starch and sucrose metabolism Extra 
Glycerate Sugar acid  PPP, gly, ser and thr metaboim, glyoxylate metabolism Extra 
*AA = amino acid, FA = fatty acid, PPP = pentose phosphate pathway, TCA=tricarboxylic acid cycle 
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Table S6: Identified intracellular metabolites detected during UV-A + PAR including chemical class and possible biosynthetic pathways (KEGG). 
Name  Class Pathway 
Glyoxylate Acid Glyoxylate metabolism, AA metabolism  
2-Oxobutanoate Acid  Biosynthesis of AA; cys and met metabolism, thr metabolism. Val, leu and ile biosynthesis 
4-Hydroxybutyric acid  Acid  Carbon fixation pathways in prokaryotes 
5-Oxoproline Acid  Glutathione metabolism  
Boric acid Acid  Aminobenzoate degradation, microbial metabolism in diverse environments  
Hydroxyisovalerate  Acid  Val, leu and ile degradation 
Lactic acid Acid  Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  
Methylbenzoate  Acid  Degradation of aromatics  
Oxalate Acid  Glyoxylate metabolism, biosynthesis of secondary metabolites 
Phosphoric acid  Acid  PS/oxidative phosphorylation  
Propan-2-ol Alcohol Propanoate metabolism 
1-Butanol  Alcohol  Butanoate metabolism, microbial metabolism, degradation of aromatic compounds 
Ethane-1,2-diol Alcohol  Glyoxylate and dicarboxylate metabolism 
Propane-1,3-diol Alcohol  Glycerolipid metabolism 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. Forms L-ornithine/L-
glutamine 
Leucine  Amino acid  
Biosynthesis of AA; gly, ser, val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
Phenylalanine Amino acid  
Biosynthesis of AA. Phe metabolism via shikimate pathway, Tyr metabolism, biosynthesis 
of alkaloids derived from shikimate pathway and ornithine.  
Serine Amino acid  
Biosynthesis of AA; gly, ser and thr metabolism, glyoxylate metabolism and biosynthesis of 
secondary metabolites. Chl biosynthesis, MAA biosynthesis.  
Histamine  Aromatic  Biosynthesis of alkaloids derived from histidine and pyrine, secondary metabolites 
Lumichrome  Aromatic  Riboflavin metabolism 
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Name  Class Pathway 
Eicosanoic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism 
Cyanamide  Other  Atrazine degradation 
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments 
Mannose Sugar 
Fructose and mannose metabolism, amino sugar and nucleotide metabolism, galactose 
metabolism  
Sucrose  Sugar  Galactose metabolism, starch and sucrose metabolism 
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Table S7: Identified intracellular metabolites detected during acclimation & shock and shock only UV-A + PAR experiments including chemical class and possible biosynthetic 
pathways (KEGG). 
Name  Class Pathway Acc&Shock/Shock 
Methylbenzoate  Acid Degradation of aromatics  Acc&Shock 
Boric acid Acid  





Acid  Arg and pro metabolism Acc&Shock 
Lactic acid Acid  Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  Acc&Shock 
Phosphoric acid  Acid  PS/oxidative phosphorylation  Acc&Shock 
Malate  Acid  
TCA, Pyruvate metabolism, glyoxylate metabolism, biosynthesis of 
secondary metabolites  
Acc&Shock 
Phytol Alcohol  Chl metabolism Acc&Shock 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. 
Forms L-ornithine/L-glutamine 
Acc&Shock 
Valine  Amino acid  
Biosynthesis of AA; val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
Acc&Shock 
Proline Amino acid  
Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite 
biosynthesis 
Acc&Shock 
Cyanuric acid  Aromatic  Atrazine degredation Acc&Shock 
1-Hydroxy-3-methoxy-6-
methylanthraquinone 
Aromatic  Polyketide synthesis  Acc&Shock 
4-Hydroxyanthraquinone-2-
carboxylic acid 
Aromatic  Polyketide synthesis  Acc&Shock 
Adenine  Aromatic  Purine metabolism Acc&Shock 
Lumichrome  Aromatic  Riboflavin metabolism Acc&Shock 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Acc&Shock 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Acc&Shock 
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Name  Class Pathway Acc&Shock/Shock 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  Acc&Shock 
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism Acc&Shock 
Cyanamide  Other  Atrazine degradation Acc&Shock 
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments Acc&Shock 
Fructose Sugar 
Fructose and mannose metabolism, galactose metabolism, starch and 
sucrose metabolism 
Acc&Shock 
Arabinose  Sugar Pentose and glucuronate interconversion Acc&Shock 
Raffinose  Sugar  Galactose metabolism Acc&Shock 
Sucrose  Sugar  Galactose metabolism, starch and sucrose metabolism Acc&Shock 
Trehalose  Sugar  Starch and sucrose metabolism Acc&Shock 
Glycerol 3-phosphate  
Sugar 
phosphate  
Glycerolipid/glycerophospholipid metabolism, metabolism of 
secondary metabolites  
Acc&Shock 
Methylbenzoate  Acid Degradation of aromatics  Shock 
Boric acid Acid  





Acid  Arg and pro metabolism Shock 
Lactic acid Acid  Glycolysis/fructose and mannose metabolism, pyruvate metabolism.  Shock 
Phosphoric acid  Acid  PS/oxidative phosphorylation  Shock 
Fumarate Acid  
TCA, Pyruvate metabolism, glyoxylate metabolism, secondary 
metabiltes 
Shock 
Phytol Alcohol  Chl metabolism Shock 
Glycerol  Alcohol  Pentose and glucuronate interconversion Shock 
Glutamate  Amino acid  
Biosynthesis of AA; arg, ala, asp and glu, arg and pro metabolism. 
Forms L-ornithine/L-glutamine 
Shock 
Valine  Amino acid  
Biosynthesis of AA; val, leu and ile metabolism, biosynthesis of 
alkaloids/secondary metabolites 
Shock 
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Name  Class Pathway Acc&Shock/Shock 
Aspartate  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism. Arg, gly, ser and 
thr metabolism, cys and met metabolism. Carbon fixation 
Shock 
Alanine  Amino acid  
Biosynthesis of AA; ala, asp and glu metabolism, cys and met 
metabolism, carbon fixation and biosynthesis of secondary 
metabolites 
Shock 
Proline Amino acid  
Biosynthesis of AA; Arg and pro biosynthesis, secondary metabolite 
biosynthesis 
Shock 
5-Oxoproline Amino acid  Glutathione metabolism  Shock 
1-Hydroxy-3-methoxy-6-
methylanthraquinone 
Aromatic  Polyketide synthesis  Shock 
4-Hydroxyanthraquinone-2-
carboxylic acid 
Aromatic  Polyketide synthesis  Shock 
Lumichrome  Aromatic  Riboflavin metabolism Shock 
Mystiric acid Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Shock 
Palmitoleic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Shock 
Palmitic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Shock 
Oleic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA Shock 
Stearic acid  Fatty acid  FA biosynthesis, biosynthesis of unsaturated FA  Shock 
Ethanolamine N-compound Glycerophosphlipid metabolism, pyruvate metabolism Shock 
Cyanamide  Other  Atrazine degradation Shock 
Hydrogen sulfide  S-compound  Sulfur metabolism, microbial metabolism in diverse environments Shock 
Cholest-2-eno[2,3-b]indole, 1'-
acetyl-6'-methoxy- 
Sterol Sterol synthesis Shock 
Fructose Sugar 
Fructose and mannose metabolism, galactose metabolism, starch and 
sucrose metabolism 
Shock 
Galactose Sugar Galactose metabolism Shock 
Arabinose  Sugar Pentose and glucuronate interconversion Shock 
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Name  Class Pathway Acc&Shock/Shock 
Raffinose  Sugar  Galactose metabolism Shock 
Sucrose  Sugar  Galactose metabolism, starch and sucrose metabolism Shock 
Trehalose  Sugar  Starch and sucrose metabolism Shock 
Glycerol 3-phosphate  
Sugar 
phosphate  
Glycerolipid/glycerophospholipid metabolism, metabolism of 
secondary metabolites  
Shock 
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Table S8: One-way ANOVA results showing metabolites with overall significance (p <0.05) including Tukey’s Honestly Significant difference (HSD) post-hoc test results of 
significant pairs of solvent extracts. Data was normalised by sum, log transformed and mean centred prior to analysis. Missing data points were assumed to be lower than 
detection limit and replaced with half of the minimum integrated signal for statistical analysis.  
 ANOVA Tukey’s HSD 
Metabolite p-value Tukey's HSD  1 Tukey's HSD 2 Tukey's HSD 3 Tukey's HSD 4 
Valine 2.17E-13 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Glycerol 1.35E-07 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Threonic acid 2.42E-07 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Glycerate 5.01E-07 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Putrescine  9.54E-07 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Ribitol 1.18E-06 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Serine  4.79E-06 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Pregnenolone  0.000209 EtOH vs Hex MeOH vs Hex EtOH vs EtOAc MeOH vs EtOAc 
Sucrose  0.000232 EtOAc vs Hex MeOH vs Hex EtOH vs EtOAc MeOH vs EtOAc 
Hydroxylamine  0.000365 EtOAc vs Hex MeOH vs Hex EtOH vs EtOAc MeOH vs EtOH 
Propane-1,2-diol 0.000927 EtOH vs Hex  EtOH vs EtOAc MeOH vs EtOH  
3-Methylbenzaldehyde  0.001185 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Capric acid  0.001594 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Mystric acid  0.002547 MeOH vs Hex MeOH vs EtOAc MeOH vs EtOH  
Lauric acid  0.007996 EtOAc vs Hex MeOH vs EtOAc   
Methylbenzoate  0.016976 MeOH vs Hex MeOH vs EtOH   
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